AP Site Map | Contact Us | Bookmark
Log In/Sign Up
 
 
APP
About
Line
Course Library
Line
CLD
Line
Clinical Workshops
Line
Advisors
Line
Faculty
Line
Supporters
Line
FAQs
Line
Contact Us
Line
Login
Line
My Profile
OEC
Featured CME Topics
Line
CLDF
Line
GiHF
Line
Suggested Reading
Line
Journal Articles
Line
Practice Guidelines
Line
Convention Calendar
 
 
Journal Articles
Higher Education for Nurse Practitioners
and Physician Assistants
   
 
  Hep B Hep C IBD IBS
 
     
 
Hepatitis B (HBV) Articles
 
  Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Systematic Review to Update the 2004 U.S. Preventive Services Task Force Recommendation [Internet]
Chou R, Dana T, Bougatsos C, Blazina I, Zakher B, Khangura J. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 May. Report No.: 12-05172-EF-1.?U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews.
 
  Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer
Levaggi A1, DE Maria A2, Dozin B3, Iacono G4, Bighin C5, Giraudi S4, Lambertini M5, D'Alonzo A4, Poggio F5, Pronzato P5, Del Mastro L4. Anticancer Res. 2014 Jul;34(7):3715-20.
 
  Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy
Jang JW. World J Gastroenterol. 2014 Jun 28;20(24):7675-7685.
 
  The impact of oral antiviral therapy on long-term survival of hepatitis B surface antigen-positive patients on haemodialysis
Ow MM1, de Zoysa JR, Gane EJ. N Z Med J. 2014 Jun 20;127(1396):34-42.
 
  Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy
Lee HW1, Yoo EJ1, Kim BK2, Kim SU2, Park JY2, Kim DY2, Ahn SH3, Han KH3. Am J Gastroenterol. 2014 Jun 24. doi: 10.1038/ajg.2014.157. [Epub ahead of print]
 
  The bloodborne pathogen standard in private practice
Davis D1, Carlton A, Wisch JS. Community Support Oncol. 2014 Mar;12(3):82-3.
 
  Vertical transmission of hepatitis B virus: challenges and solutions
Gentile I, Borgia G. Int J Womens Health. 2014 Jun 10;6:605-11. doi: 10.2147/IJWH.S51138. eCollection 2014.
 
  Screening, detecting and enhancing the yield of previously undiagnosed hepatitis B and C in patients with acute medical admissions to hospital: A pilot project undertaken at the Vancouver General Hospital
Kapeluto J, Kadatz M, Wormsbecker A, Sidhu K, Yoshida EM. Can J Gastroenterol Hepatol. 2014 Jun;28(6):315-8.
 
  Hepatitis B in Pregnancy
Whittaker G, Herrera JL. South Med J. 2014 Mar;107(3):195-200.
 
  Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection
Spradling PR1, Bulkow L2, Teshale EH3, Negus S4, Homan C4, Simons B4, McMahon BJ5. J Hepatol. 2014 Jun 6. pii: S0168-8278(14)00393-6. doi: 10.1016/j.jhep.2014.05.045. [Epub ahead of print]
 
  Cirrhosis Regression in Patients With Viral Hepatitis B and C: A Systematic Review
Manne V1, Akhtar E, Saab S. J Clin Gastroenterol. 2014 Jun 11. [Epub ahead of print]
 
  Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Systematic Review to Update the 2004 U.S. Preventive Services Task Force Recommendation [Internet]
Chou R, Dana T, Bougatsos C, Blazina I, Zakher B, Khangura J. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 May. Report No.: 12-05172-EF-1.?U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews.
 
  Current recommendations of managing HBV infection in preconception or pregnancy
Park JS1, Pan C. Front Med. 2014 Jun;8(2):158-65. doi: 10.1007/s11684-014-0340-4. Epub 2014 May 29.
 
  Management of chronic hepatitis B in children: an unresolved issue
Della Corte C1, Nobili V, Comparcola D, Cainelli F, Vento S. J Gastroenterol Hepatol. 2014 May;29(5):912-9. doi: 10.1111/jgh.12550.
 
  Hepatitis B virus DNA quantification with the three-in-one (3io) method allows accurate single-step differentiation of total HBV DNA and cccDNA in biopsy-size liver samples
Taranta A1, Tien Sy B2, Zacher BJ1, Rogalska-Taranta M3, Manns MP1, Bock CT4, Wursthorn K5. J Clin Virol. 2014 May 2. pii: S1386-6532(14)00148-6. doi: 10.1016/j.jcv.2014.04.015. [Epub ahead of print]
 
  Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: U.S. Preventive Services Task Force Recommendation Statement
LeFevre ML. Ann Intern Med. 2014 May 27. doi: 10.7326/M14-1018. [Epub ahead of print]
 
  Prevention of Liver Cancer Through the Early Detection of Risk-Related Behavior Among Hepatitis B or C Carriers
Fan JY1, Huang TJ, Jane SW, Chen MY. Cancer Nurs. 2014 May 15. [Epub ahead of print]
 
  Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study
Yang F1, Zhu HL2, He C2, Li JJ2, Xiang B2, Cui X2, Huang J2, Ji J2, Ma HB2, Liu T2. Indian J Hematol Blood Transfus. 2014 Jun;30(2):97-104. doi: 10.1007/s12288-012-0195-2. Epub 2012 Oct 30.
 
  Current Treatment Guidelines for Chronic Hepatitis B and Their Application.
Uribe LA1, O'Brien CG, Wong RJ, Gish RR, Tsai N, Nguyen MH. J Clin Gastroenterol. 2014 May 22. [Epub ahead of print]
 
  Hepatic Steatosis Is Highly Prevalent in Hepatitis B Patients and Negatively Associated with Virological Factors
Wang MM1, Wang GS, Shen F, Chen GY, Pan Q, Fan JG. Dig Dis Sci. 2014 May 18. [Epub ahead of print]
 
  Bridging Basic Science and Clinical Research - The EASL Monothematic Conference on Translational Research in Viral Hepatitis
Boettler T1, Moradpour D2, Thimme R1, Zoulim F3. J Hepatol. 2014 May 15. pii: S0168-8278(14)00357-2. doi: 10.1016/j.jhep.2014.05.016. [Epub ahead of print]
 
  Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
Seto WK1, Hui AJ2, Wong VW3, Wong GL3, Liu KS1, Lai CL1, Yuen MF1, Chan HL3. Gut. 2014 May 15. pii: gutjnl-2014-307237. doi: 10.1136/gutjnl-2014-307237. [Epub ahead of print]
 
  A drug safety evaluation of rituximab and risk of hepatitis B
Riedell P1, Carson KR. Expert Opin Drug Saf. 2014 May 12:1-11. [Epub ahead of print]
 
  Hepatitis B virus genotypes: Global distribution and clinical importance
Sunbul M. World J Gastroenterol. 2014 May 14;20(18):5427-5434.
 
  Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation
Manne V, Allen RM, Saab S. Gastroenterol Hepatol (N Y). 2014 Mar;10(3):175-9.
 
  Early identification and linkage to care of persons with chronic hepatitis B virus infection - three u.s. Sites, 2012-2014
Beckett GA, Ramirez G, Vanderhoff A, Nichols K, Chute SM, Wyles DL, Schoenbachler BT, Bedell DT, Cabra R, Ward JW; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC. MMWR Morb Mortal Wkly Rep. 2014 May 9;63(18):399-401.
 
  Impact of Viral Hepatitis on Outcomes after Liver Resection for Hepatocellular Carcinoma: Results from a North American Center
Lee JJ1, Kim PT, Fischer S, Fung S, Gallinger S, McGilvray I, Moulton CA, Wei AC, Greig PD, Cleary SP. Ann Surg Oncol. 2014 May 8. [Epub ahead of print]
 
  Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of Hepatitis B Virus
Greenup AJ1, Tan PK1, Nguyen V1, Glass A1, Davison S1, Chatterjee U2, Holdaway S3, Samarasinghe D3, Jackson K4, Locarnini S4, Levy MT5. J Hepatol. 2014 May 3. pii: S0168-8278(14)00301-8. doi: 10.1016/j.jhep.2014.04.038. [Epub ahead of print]
 
  The impact of hepatitis B on heart transplantation: 19 years of national experience in Korea
Shin HS1, Cho HJ1, Jeon ES2, Hwang HY3, Kim JJ4, Kim KB3, Oh BH1, Lee HY1. Ann Transplant. 2014 Apr 23;19:182-7. doi: 10.12659/AOT.889680.
 
  Viral infections in pregnancy: advice for healthcare workers
Chin TL1, Macgowan AP2, Jacobson SK2, Donati M3. J Hosp Infect. 2014 Mar 12. pii: S0195-6701(14)00066-8. doi: 10.1016/j.jhin.2013.12.011. [Epub ahead of print]
 
  Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection
Sagnelli E1, Pisaturo M, Martini S, Sagnelli C, Filippini P, Coppola N.
 
  Prognostic Evaluation of Patients Undergoing Living-Donor Liver Transplant By APACHE II and MELD Scores
Zhang ZY1, Chen R, Zhou ZQ, Peng CH, Zhou GW. Exp Clin Transplant. 2014 Apr 28. doi: 10.6002/ect.2013.0289. [Epub ahead of print]
 
  Cost-Effectiveness of Testing Hepatitis B-Positive Pregnant Women for Hepatitis B e Antigen or Viral Load
Fan L1, Owusu-Edusei K Jr, Schillie SF, Murphy TV. Obstet Gynecol. 2014 May;123(5):929-37. doi: 10.1097/AOG.0000000000000124.
 
  A simple and inexpensive point-of-care test for hepatitis B surface antigen detection: serological and molecular evaluation
Gish RG1, Gutierrez JA, Navarro-Cazarez N, Giang K, Adler D, Tran B, Locarnini S, Hammond R, Bowden S. J Viral Hepat. 2014 Apr 30. doi: 10.1111/jvh.12257. [Epub ahead of print]
 
  Notes from the field: investigation of infectious disease risks associated with a nontransplant anatomical donation center - Arizona, 2014
de Perio MA, Bernard BP, Delaney LJ, Pesik N, Cohen NJ; National Institute for Occupational Safety and Health, CDC. MMWR Morb Mortal Wkly Rep. 2014 May 2;63(17):384-5.
 
  Telbivudine during the second and third trimester of pregnancy interrupts HBV intrauterine transmission: a systematic review and meta-analysis
Lu YP, Liang XJ, Xiao XM, Huang SM, Liu ZW, Li J, Hocher B, Chen YP. Clin Lab. 2014;60(4):571-86.
 
  A prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy
Tamori A1, Hino M, Kawamura E, Fujii H, Uchida-Kobayashi S, Morikawa H, Nakamae H, Enomoto M, Murakami Y, Kawada N. J Gastroenterol Hepatol. 2014 Apr 14. doi: 10.1111/jgh.12604. [Epub ahead of print]
 
  Characteristics and Management of Patients with Chronic Hepatitis B in an Integrated Care Setting
Sarkar M1, Shvachko VA, Ready JB, Pauly MP, Terrault NA, Peters MG, Manos MM. Dig Dis Sci. 2014 Apr 12. [Epub ahead of print]
 
  The clinical significance of occult HBV infection
Squadrito G, Spinella R, Raimondo G. Ann Gastroenterol. 2014;27(1):15-19.
 
  Hepatitis B vaccination and screening awareness in primary care practitioners
Said A1, Jou JH2. Hepat Res Treat2014;2014:373212. doi: 10.1155/2014/373212. Epub. 2014 Mar 6.
 
  The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis
Conway R1, Doran MF, O'Shea FD, Crowley B, Cunnane G. Clin Rheumatol. 2014 Apr 13. [Epub ahead of print]
 
  Association of Nucleos(t)ide Analogue Therapy with Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B-a Nationwide Cohort Study
Wu CY1, Lin JT2, Ho HJ3, Su CW4, Lee TY5, Wang SY6, Wu C6, Wu JC7. Gastroenterology. 2014 Apr 1. pii: S0016-5085(14)00445-4. doi: 10.1053/j.gastro.2014.03.048. [Epub ahead of print]
 
  Risk of Hip Fracture Associated with Untreated and Treated Chronic Hepatitis B Virus Infection
Byrne DD1, Newcomb CW2, Carbonari DM3, Nezamzadeh MS3, Leidl KB2, Herlim M2, Yang YX1, Hennessy S3, Kostman JR4, Leonard MB5, Russell Localio A2, Lo Re V 3rd6. J Hepatol. 2014 Apr 5. pii: S0168-8278(14)00218-9. doi: 10.1016/j.jhep.2014.04.001. [Epub ahead of print]
 
  Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007
Byrne DD1, Newcomb CW2, Carbonari DM3, Nezamzadeh MS3, Leidl KB2, Herlim M2, Yang YX4, Hennessy S3, Kostman JR5, Leonard MB6, Localio R2, Lo Re V 3rd7. Ann Epidemiol. 2014 Mar 5. pii: S1047-2797(14)00075-1. doi: 10.1016/j.annepidem.2014.02.013. [Epub ahead of print]
 
  Distinct Seromarkers Predict Different Milestones of Chronic Hepatitis B Progression
Liu J1, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, You SL, Hsiao CK, Chen CJ; for the R.E.V.E.A.L.-HBV Study Group. Hepatology. 2014 Feb 20. doi: 10.1002/hep.27083. [Epub ahead of print]
 
  Characterization of Chronic Hepatitis B Cases Among Foreign-Born Persons in Six Population-Based Surveillance Sites, United States 2001-2010
Liu SJ1, Iqbal K, Shallow S, Speers S, Rizzo E, Gerard K, Poissant T, Klevens RM. J Immigr Minor Health. 2014 Apr 5. [Epub ahead of print]
 
  Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis
Liu F, Wang X, Wei F, Hu H, Zhang D, Hu P1, Ren H. Virol J. 2014 Mar 28;11(1):59. doi: 10.1186/1743-422X-11-59.
 
  Prevention of Neonatal Hepatitis B Virus Transmission
Bleich LM1, Swenson ES. J Clin Gastroenterol. 2014 Mar 24. [Epub ahead of print]
 
  Management of hepatitis B during pregnancy
Patton H1, Tran TT2. Nat Rev Gastroenterol Hepatol. 2014 Apr 1. doi: 10.1038/nrgastro.2014.30. [Epub ahead of print]
 
  Hepatitis B in pregnancy
Dyson JK1, Waller J2, Turley A3, Michael E3, Moses S4, Valappil M4, Hudson M5, Bassendine M5, McPherson S5. Frontline Gastroenterol. 2014 Apr;5(2):111-117. Epub 2013 Oct 17.
 
  Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
Singal AG1, Pillai A2, Tiro J3. PLoS Med. 2014 Apr 1;11(4):e1001624. doi: 10.1371/journal.pmed.1001624. eCollection 2014.
 
  Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region
Bottero J1, Boyd A2, Lemoine M3, Carrat F4, Gozlan J5, Collignon A6, Boo N7, Dhotte P8, Varsat B9, Muller G10, Cha O11, Valin N12, Nau J13, Campa P12, Silbermann B14, Bary M15, Girard PM1, Lacombe K1. PLoS One. 2014 Mar 24;9(3):e92266. doi: 10.1371/journal.pone.0092266. eCollection 2014.
 
  Immune response to hepatitis B vaccination in drug using populations: A systematic review and meta-regression analysis
Kamath G1, Shah DP1, Hwang LY2. Vaccine. 2014 Mar 11. pii: S0264-410X(14)00299-0. doi: 10.1016/j.vaccine.2014.02.072. [Epub ahead of print]
 
  Hepatitis B Reactivation and Rituximab: A New Boxed Warning and Considerations for Solid Organ Transplantation
Martin ST1, Cardwell SM, Nailor MD, Gabardi S. Am J Transplant. 2014 Mar 4. doi: 10.1111/ajt.12649. [Epub ahead of print]
 
  Efficacy and safety of tenofovir disoproxil fumarate in asian-americans with chronic hepatitis B in community settings
Pan CQ1, Trinh H2, Yao A3, Bae H4, Lou L5, Chan S6; Study 123 Group. PLoS One. 2014 Mar 4;9(3):e89789. doi: 10.1371/journal.pone.0089789. eCollection 2014.
 
  Student vaccination requirements of u.s. Health professional schools: a national survey
Libby TE1, Lindley MC, Ahmed F, Stevenson J, Grabowsky M, Strikas RA. J Allied Health. 2014 Spring;43(1):12-21.
 
  The importance of baseline viral load when assessing relative efficacy in treatment-naive HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis
Mealing S, Ghement I, Hawkins N, Scott DA, Lescrauwaet B, Watt M, Thursz M, Lampertico P, Mantovani L, Morais E, Bregman B, Cucherat M. Syst Rev. 2014 Mar 7;3(1):21. [Epub ahead of print]
 
  WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs
Walsh N1, Verster A2, Rodolph M2, Akl EA3. Int J Drug Policy. 2014 Jan 26. pii: S0955-3959(14)00012-7. doi: 10.1016/j.drugpo.2014.01.009. [Epub ahead of print]
 
  The pharmaceuticalization of sexual risk: Vaccine development and the new politics of cancer prevention
Mamo L1, Epstein S2. Soc Sci Med. 2014 Jan;101:155-65. doi: 10.1016/j.socscimed.2013.11.028. Epub 2013 Nov 21.
 
  Reported reasons for testing among hepatitis B virus infected patients, - Chronic Hepatitis Cohort Study (CHeCS), United States, 2006-2010
Gerbi GB1, Rupp LB, Ko SC, Moorman A, Holmberg SD, Xu F; The CHeCS Investigators. Liver Int. 2014 Mar 3. doi: 10.1111/liv.12509. [Epub ahead of print]
 
  Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study
Tseng KC, Chen CY, Tsai HW, Chang TT, Chuang WL, Hsu PI, Liu WC, Cheng PN. Antivir Ther. 2014 Feb 28. doi: 10.3851/IMP2754. [Epub ahead of print]
 
  Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
Zhou F1, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, Moore M, Murphy TV, Cortese M, Rodewald L. Pediatrics. 2014 Mar 3. [Epub ahead of print]
 
  An update on hepatitis B, d, and e viruses
Price J. Top Antivir Med. 2013 Dec;21(5):157-63.
 
  Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD-EEG
Montagnese S, De Rui M, Schiff S, Ceranto E, Valenti P, Angeli P, Cillo U, Zanus G, Gatta A, Amodio P, Merkel C. Liver Int. 2014 Feb 12. doi: 10.1111/liv.12490. [Epub ahead of print]
 
  Effect of a liver cancer education program on hepatitis B screening among asian americans in the Baltimore-washington metropolitan area, 2009-2010
Juon HS1, Lee S2, Strong C3, Rimal R4, Kirk GD5, Bowie J5. Prev Chronic Dis. 2014 Feb 6;11:E18. doi: 10.5888/pcd11.130258.
 
  Incomplete Hepatitis B Immunization, Maternal Carrier Status and Increased Risk of Liver Diseases: A 20-year Cohort Study of 3.8 Million Vaccinees
Chien YC, Jan CF, Chiang CJ, Kuo HS, You SL, Chen CJ. Hepatology. 2014 Feb 4. doi: 10.1002/hep.27048. [Epub ahead of print]
 
  Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients with Normal Levels of Alanine Aminotransferase and High Levels of HBV DNA
Chan HL1, Chan CK2, Hui AJ3, Chan S4, Poordad F5, Chang TT6, Mathurin P7, Flaherty JF8, Lin L8, Corsa A8, Gaggar A8, Subramanian GM8, McHutchison JG8, Lee S9, Gane EJ10. Gastroenterology. 2014 Jan 23. pii: S0016-5085(14)00103-6. doi: 10.1053/j.gastro.2014.01.044. [Epub ahead of print]
 
  Lamivudine Compared With Newer Antivirals for Prophylaxis of Hepatitis B Core Antibody Positive Livers: A Cost-Effectiveness Analysis
Wright AJ, Fishman JA, Chung RT. Am J Transplant. 2014 Jan 24. doi: 10.1111/ajt.12598. [Epub ahead of print]
 
  The validity of serum markers for fibrosis staging in chronic hepatitis B and C
Li J, Gordon SC, Rupp LB, Zhang T, Boscarino JA, Vijayadeva V, Schmidt MA, Lu M; the Chronic Hepatitis Cohort Study (CHeCS) Investigators. J Viral Hepat. 2014 Jan 29. doi: 10.1111/jvh.12224. [Epub ahead of print]
 
  Non-invasive assessment of liver fibrosis using real-time tissue elastography in patients with chronic hepatitis B
Hu Q1, Zhu SY2, Kang LK1, Wang XY1, Lun HM3, Xu CM1. Clin Radiol. 2014 Feb;69(2):194-9. doi: 10.1016/j.crad.2013.10.003. Epub 2013 Nov 26.
 
  Long-term efficacy and safety of emtricitabine plus tenofovir DF vs tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients
Berg T, Zoulim F, Moeller B, Trinh H, Marcellin P, Chan S, Kitrinos KM, Dinh P, Flaherty Jr JF, McHutchison JG, Manns M. J Hepatol. 2013 Nov 29. pii: S0168-8278(13)00826-X. doi: 10.1016/j.jhep.2013.11.024. [Epub ahead of print]
 
  Presence of anti-interferon antibodies is not associated with non-response to peginterferon treatment in chronic hepatitis B
Arends P, van der Eijk AA, Sonneveld MJ, Hansen BE, Janssen HL, Haagmans BL. Antivir Ther. 2013 Dec 3. doi: 10.3851/IMP2711. [Epub ahead of print]
 
  Hepatitis B Virus (HBV) Infection, Immunity and Susceptibility Among Men Who Have Sex with Men (MSM), Los Angeles County, USA
Pitasi MA, Bingham TA, Sey EK, Smith AJ, Teshale EH. AIDS Behav. 2013 Nov 26. [Epub ahead of print]
 
  The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease
Pais R, Rusu E, Ratziu V. Clin Liver Dis. 2014 Feb;18(1):165-78. doi: 10.1016/j.cld.2013.09.015.
 
  Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals
Godbole G, Irish D, Basarab M, Mahungu T, Fox-Lewis A, Thorne C, Jacobs M, Dusheiko G, Rosenberg WM, Suri D, Millar AD, Nastouli E. BMC Pregnancy Childbirth. 2013 Dec 1;13:222. doi: 10.1186/1471-2393-13-222.
 
  A Rationalized Approach to the Treatment of Patients Infected with Hepatitis B
Cox NR, Patel K, Tillmann HL. Mol Diagn Ther. 2013 Dec 3. [Epub ahead of print]
 
  Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants
Solmone M, Giombini E, Vincenti D, Rozera G, Testa A, Moscetti A, Catalano M, Abbate I, Capobianchi MR, Menzo S. Antivir Ther. 2013 Nov 25. doi: 10.3851/IMP2700. [Epub ahead of print]
 
  Sexual transmission of viral hepatitis
Gorgos L. Infect Dis Clin North Am. 2013 Dec;27(4):811-36. doi: 10.1016/j.idc.2013.08.002. Epub 2013 Oct 31.
 
  Durability of efficacy after telbivudine off-treatment in chronic hepatitis B patients
Chen DB1, Chen YM1, Liu J1, Xie DY1, Lu CR1, Huang ZL1, Zhu RH1, Gao ZL2. J Clin Virol. 2014 Jan;59(1):50-4. doi: 10.1016/j.jcv.2013.11.002. Epub 2013 Nov 13.
 
  Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs
Lee YH, Bae SC, Song GG. Int J Rheum Dis. 2013 Oct;16(5):527-31. doi: 10.1111/1756-185X.12154.
 
  Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
Kim YJ, Kim K, Hwang SH, Kim SS, Lee D, Cheong JY, Cho SW. Clin Mol Hepatol. 2013 Sep;19(3):300-4. doi: 10.3350/cmh.2013.19.3.300. Epub 2013 Sep 30.
 
  Clinical outcomes and risk factors of hepatitis B virus recurrence in patients who received prophylaxis with entecavir and hepatitis B immunoglobulin following liver transplantation
Kim YK, Kim SH, Lee SD, Park SJ. Transplant Proc. 2013 Oct;45(8):3052-6. doi: 10.1016/j.transproceed.2013.08.065.
 
  Assessment of current criteria for primary non-response in chronic hepatitis B patients receiving entecavir therapy
Yang YJ, Shim JH, Kim KM, Lim YS, Lee HC. Hepatology. 2013 Oct 29. doi: 10.1002/hep.26910. [Epub ahead of print]
 
  Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis
Ye XG, Su QM. World J Gastroenterol. 2013 Oct 21;19(39):6665-78. doi: 10.3748/wjg.v19.i39.6665.
 
  Adjuvant Therapy after Curative Resection for Hepatocellular Carcinoma Associated with Hepatitis Virus
Kubo S, Takemura S, Sakata C, Urata Y, Uenishi T. Liver Cancer. 2013 Jan;2(1):40-46.
 
  Analysis of S gene mutation of the hepatitis B virus in adult liver transplant recipients showing resistance to hepatitis B immunoglobulin therapy
Park GC, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Shin YW, Kim SH, Chang KH, Namgoong JM, Park CS, Park HW, Park YH, Kang SH, Jung BH, Lee SG. Transplant Proc. 2013 Oct;45(8):3047-51. doi: 10.1016/j.transproceed.2013.08.055.
 
  HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Kim GA, Lim YS, An J, Lee D, Shim JH, Kim KM, Lee HC, Chung YH, Lee YS, Suh DJ. Gut. 2013 Oct 25. doi: 10.1136/gutjnl-2013-305517. [Epub ahead of print]
 
  Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
Wong GL, Wong VW. World J Gastroenterol. 2013 Oct 21;19(39):6515-22. doi: 10.3748/wjg.v19.i39.6515.
 
  Differences Between Hepatocellular Carcinoma and Hepatitis B Virus Infection in Patients With and Without Cirrhosis
Kim JM, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC. Ann Surg Oncol. 2013 Oct 17. [Epub ahead of print]
 
  Seroprevalence of HIV, Hepatitis B Virus, and HCV Among Injection Drug Users in Connecticut: Understanding Infection and Coinfection Risks in a Nonurban Population
Akselrod H, Grau LE, Barbour R, Heimer R. Am J Public Health. 2013 Oct 17. [Epub ahead of print]
 
  Liver transplantation in lymphoma patients with hepatitis B virus reactivation
Kim JM, Kwon CH, Joh JW, Ko SW, Park JB, Kim SJ, Lee JH, Kim GS, Kim SJ, Lee SK. Transplant Proc. 2013 Oct;45(8):2988-91. doi: 10.1016/j.transproceed.2013.08.085.
 
  Hepatitis viruses and non-Hodgkin's lymphoma: A review
Datta S, Chatterjee S, Policegoudra RS, Gogoi HK, Singh L. World J Virol. 2012 Dec 12;1(6):162-173.
 
  Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis
Lunemann S, Malone DF, Hengst J, Port K, Grabowski J, Deterding K, Markova A, Bremer B, Schlaphoff V, Cornberg M, Manns MP, Sandberg JK, Ljunggren HG, Björkström NK, Wedemeyer H. J Infect Dis. 2013 Nov 1. [Epub ahead of print]
 
  De novo combination therapy adefovir plus lamivudine as a treatment for women of child-bearing age with HBeAg-positive chronic hepatitis B Before Pregnancy
Li-Na M, Xiang-Chun D, Xiao-Yan L, Chun-Qiong X, Liu SW, Yan X. J Med Virol. 2013 Oct 25. doi: 10.1002/jmv.23828. [Epub ahead of print]
 
  Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
Yim HJ, Hwang SG. Clin Mol Hepatol. 2013 Sep;19(3):195-209. doi: 10.3350/cmh.2013.19.3.195. Epub 2013 Sep 30.
 
  Analysis of rheumatoid factor according to various hepatitis B virus infectious statuses
Choi ST, Lee HW, Song JS, Lee SK, Park YB.
 
  Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial
Pande C, Sarin SK, Patra S, Kumar A, Mishra S, Srivastava S, Bhutia K, Gupta E, Mukhopadhyay CK, Dutta AK, Trivedi SS. J Viral Hepat. 2013 Nov;20(11):801-10. doi: 10.1111/jvh.12102. Epub 2013 Apr 23.
 
  Elevation in Serum Concentration of Bone-Specific Alkaline Phosphatase without Elevation in Serum Creatinine Concentration Secondary to Adefovir Dipivoxil Therapy in Chronic Hepatitis B Virus Infection
Abe H, Seki N, Sugita T, Aida Y, Ishiguro H, Miyazaki T, Itagaki M, Sutoh S, Aizawa Y. Hepat Res Treat. 2013;2013:739247. doi: 10.1155/2013/739247. Epub 2013 Sep 9.
 
  De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis
Lian JS, Zeng LY, Chen JY, Jia HY, Zhang YM, Xiang DR, Yu L, Hu JH, Lu YF, Zheng L, Li LJ, Yang YD. World J Gastroenterol. 2013 Oct 7;19(37):6278-83. doi: 10.3748/wjg.v19.i37.6278.
 
  Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis
Akuta N, Suzuki F, Kobayashi M, Hara T, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Saitoh S, Ikeda K, Kumada H. J Med Virol. 2014 Jan;86(1):131-8. doi: 10.1002/jmv.23790. Epub 2013 Oct 12.
 
  On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir
Wong GL, Chan HL, Tse YK, Chan HY, Tse CH, Lo AO, Wong VW. Hepatology. 2013 Oct 1. doi: 10.1002/hep.26739. [Epub ahead of print]
 
  HBsAg quantification for identification of liver disease in chronic hepatitis B virus carriers
Larsson SB, Eilard A, Malmström S, Hannoun C, Dhillon AP, Norkrans G, Lindh M. Liver Int. 2013 Oct 1. doi: 10.1111/liv.12345. [Epub ahead of print]
 
  Association between Mannose-binding lectin gene polymorphisms and hepatitis B virus infection: a meta-analysis
Xu HD, Zhao MF, Wan TH, Song GZ, He JL, Chen Z. PLoS One. 2013 Oct 8;8(10):e75371. doi: 10.1371/journal.pone.0075371.
 
  Chronic Hepatitis B Management Based on Standard Guidelines in Community Primary Care and Specialty Clinics
Ku KC, Li J, Ha NB, Martin M, Nguyen VG, Nguyen MH. Dig Dis Sci. 2013 Oct 13. [Epub ahead of print]
 
  Does Anti-HBV Therapy Benefit the Prognosis of HBV-Related Hepatocellular Carcinoma Following Hepatectomy?
Yu LH, Li N, Shi J, Guo WX, Wu MC, Cheng SQ. Ann Surg Oncol. 2013 Oct 12. [Epub ahead of print]
 
  IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients
Zhang Q, Lapalus M, Asselah T, Laouénan C, Moucari R, Martinot-Peignoux M, Bieche I, Estrabaud E, De Muynck S, Boyer N, Bedossa P, Vidaud M, Marcellin P, Lada O. J Viral Hepat. 2013 Oct 10. doi: 10.1111/jvh.12177. [Epub ahead of print]
 
  Lamivudine resistance leading to de novo hepatitis B infection in recipients of hepatitis B core antibody positive liver allografts
Leong J, Coty P, Fiel MI, Chang C, Florman S, Schiano T. Hepatol Res. 2013 Sep 25. doi: 10.1111/hepr.12249. [Epub ahead of print]
 
  Antihepatitis B therapy: a review of current medications and novel small molecule inhibitors
Qiu LP, Chen L, Chen KP. Fundam Clin Pharmacol. 2013 Oct 4. doi: 10.1111/fcp.12053. [Epub ahead of print]
 
  Clinical implications of the titer of serum hepatitis B surface antigen during the natural history of hepatitis B virus infection
Suh SJ, Bae SI, Kim JH, Kang K, Yeon JE, Byun KS. J Med Virol. 2014 Jan;86(1):117-23. doi: 10.1002/jmv.23767. Epub 2013 Sep 30.
 
  Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
Cheng HR, Kao JH, Wu HL, Chen TC, Tseng TC, Liu CH, Su TH, Chen PJ, Chen DS, Liu CJ. Liver Int. 2013 Sep 11. doi: 10.1111/liv.12324. [Epub ahead of print]
 
  Prevention and Risk Factors of Hepatitis B Recurrence after Living Donor Liver Transplantation
Na GH, Kim DG, Han JH, Kim EY, Lee SH, Hong TH, You YK, Choi JY. J Gastroenterol Hepatol. 2013 Oct 3. doi: 10.1111/jgh.12403. [Epub ahead of print]
 
  Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population
Gordon SC, Lamerato LE, Rupp LB, Li J, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Vijayadeva V, Boscarino JA, Henkle EM, Oja-Tebbe N, Lu M; Checs Investigators. Clin Gastroenterol Hepatol. 2013 Oct 6. pii: S1542-3565(13)01511-5. doi: 10.1016/j.cgh.2013.09.062. [Epub ahead of print]
 
  Plasma Levels of Adiponectin and Primary Liver Cancer Risk in Middle-Aged Japanese Adults with Hepatitis Virus Infection: A Nested Case-Control Study
Michikawa T, Inoue M, Sawada N, Sasazuki S, Tanaka Y, Iwasaki M, Shimazu T, Yamaji T, Mizokami M, Tsugane S; for the Japan Public Health Center–based Prospective Study Group. Cancer Epidemiol Biomarkers Prev. 2013 Nov 19. [Epub ahead of print]
 
  The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis
Zhang M, Wu R, Jiang J, Minuk GY, Niu J. Alcohol. 2013 Nov;47(7):553-8. doi: 10.1016/j.alcohol.2013.07.003. Epub 2013 Sep 13.
 
  Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study
Huang YW, Wang TC, Lin SC, Chang HY, Chen DS, Hu JT, Yang SS, Kao JH. Clin Infect Dis. 2013 Dec;57(12):1695-702. doi: 10.1093/cid/cit603. Epub 2013 Sep 18.
 
  Effect of a carbohydrate-containing late-evening snack on energy metabolism and fasting substrate utilization in adults with acute-on-chronic liver failure due to Hepatitis B
Hou W, Li J, Lu J, Wang JH, Zhang FY, Yu HW, Zhang J, Yao QW, Wu J, Shi SY, Mager DR, Meng QH. Eur J Clin Nutr. 2013 Sep 18. doi: 10.1038/ejcn.2013.163. [Epub ahead of print]
 
  Hepatitis B Management in Vulnerable Populations: Gaps in Disease Monitoring and Opportunities for Improved Care
Burman BE, Mukhtar NA, Toy BC, Nguyen TT, Chen AH, Yu A, Berman P, Hammer H, Chan D, McCulloch CE, Khalili M. Dig Dis Sci. 2013 Sep 20. [Epub ahead of print]
 
  Role of Hepatitis B Surface Antigen (HBsAg) in Identifying True Inactive HBsAg Carriers Infected With Genotype C Hepatitis B Virus
Yim SY, Um SH, Jung JY, Seo YS, Yim HJ, Ryu HS, Chun HJ, Jeen YT, Kim CD, Keum B, Lee HS. J Clin Gastroenterol. 2013 Sep 16. [Epub ahead of print]
 
  Association between viral hepatitis B infection and halitosis
Han DH, Lee SM, Lee JG, Kim YJ, Kim JB. Acta Odontol Scand. 2013 Sep 23. [Epub ahead of print]
 
  Does prolidase indicate worsening of hepatitis B infection?
Duygu F, Aksoy N, Cicek AC, Butun I, Unlu S. J Clin Lab Anal. 2013 Sep;27(5):398-401. doi: 10.1002/jcla.21617.
 
  Safety of tenofovir during pregnancy for the mother and fetus: a systematic review
Wang L, Kourtis AP, Ellington S, Legardy-Williams J, Bulterys M. Clin Infect Dis. 2013 Dec;57(12):1773-81. doi: 10.1093/cid/cit601. Epub 2013 Sep 17.
 
  Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: Evaluation of the immature platelet fraction
Dou J, Lou Y, Wu J, Lu Y, Jin Y. Platelets. 2013 Sep 18. [Epub ahead of print]
 
  Predictors of Significant Fibrosis in Chronic Hepatitis B Patients With Low Viremia
Abdo AA, Bzeizi KI, Babatin MA, Alsohaibani F, Almana H, Alsaad KO, Alghamdi H, Al-Hamoudi W, Alswat K, Alfaleh FZ, Myers RP, Sanai FM. J Clin Gastroenterol. 2013 Sep 25. [Epub ahead of print]
 
  Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative
He D, Guo S, Chen W, Chen X, Yan G, Wang J, Li M, Zhu P, Huang H, Wang Y. BMC Infect Dis. 2013 Oct 3;13:458. doi: 10.1186/1471-2334-13-458.
 
  Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants
Zhang M, Ge G, Yang Y, Cai X, Fu Q, Cai J, Huang Z. Virol J. 2013 Sep 22;10:292. doi: 10.1186/1743-422X-10-292.
 
  Kinetics of Hepatitis B Virus Load During Haemodialysis Sessions and ?-Interferon: A Prospective Study
Fabrizi F, Lunghi G, Alongi G, Aucella F, Barbisoni F, Bisegna S, Mangano S, Romei-Longhena G, Artoni A, Bettoni G, Messa P, Martin P. Kidney Blood Press Res. 2013 Sep 4;37(4-5):286-294. [Epub ahead of print]
 
  Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Zhu XJ, Sun XH, Zhou ZH, Liu SQ, Lv H, Li M, Li L, Gao YQ. Evid Based Complement Alternat Med. 2013;2013:620230. doi: 10.1155/2013/620230. Epub 2013 Aug 24.
 
  Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma
Kaseb AO, Shama M, Sahin IH, Nooka A, Hassabo HM, Vauthey JN, Aloia T, Abbruzzese JL, Subbiah IM, Janku F, Curley S, Hassan MM. Oncology. 2013;85(4):197-203. doi: 10.1159/000354698. Epub 2013 Sep 19.
 
  Quality of life, depression, and anxiety among hepatitis B patients
Keskin G, Gümüs AB, Orgun F. Gastroenterol Nurs. 2013 Sep-Oct;36(5):346-56. doi: 10.1097/SGA.0b013e3182a788cc.
 
  Antiviral treatment for hepatitis B virus recurrence following liver transplantation
Lee S, Kwon CH, Moon HH, Kim TS, Roh Y, Song S, Shin M, Kim JM, Park JB, Kim SJ, Joh JW, Lee SK. Clin Transplant. 2013 Sep-Oct;27(5):E597-604. doi: 10.1111/ctr.12212.
 
  Telbivudine Improves Renal Function in Patients With Chronic Hepatitis B
Gane EJ, Deray G, Liaw YF, Lim SG, Lai CL, Rasenack J, Wang Y, Papaptheodoridis G, Di Bisceglie A, Buti M, Samuel D, Uddin A, Bosset S, Trylesinski A. Gastroenterology. 2013 Sep 22. pii: S0016-5085(13)01359-0. doi: 10.1053/j.gastro.2013.09.031. [Epub ahead of print]
 
  Real-world application of the roadmap model in chronic hepatitis B patients with telbivudine therapy
Yu HC, Lin KH, Hsu PI, Tsay FW, Wang HM, Tsai TJ, Lai KH. Clin Ther. 2013 Sep;35(9):1386-99. doi: 10.1016/j.clinthera.2013.07.329.
 
  Comparison of tenofovir and entecavir in patients with chronic HBV infection
Ceylan B, Yardimci C, Fincanci M, Eren G, Tozalgan U, Muderrisoglu C, Akkoyunlu Y. Eur Rev Med Pharmacol Sci. 2013 Sep;17(18):2467-73.
 
  Anti-TNF therapy in patients with HBV infection-analysis of 87 patients with inflammatory arthritis
Ye H, Zhang XW, Mu R, Fang LK, Gu JR, Lin J, Du JF, Chen JW, Chen YJ, Wu LJ, Pang XF, Li ZG. Clin Rheumatol. 2013 Sep 29. [Epub ahead of print]
 
  Impact of lamivudine-resistance mutations on entecavir treatment outcome in hepatitis B
Koffi J, Egounlety R, Pradat P, Lebosse F, Si-Ahmed SN, Lussier V, Chevallier P, Bailly F, Zoulim F. Eur J Gastroenterol Hepatol. 2013 Sep 9. [Epub ahead of print]
 
  Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis
Xia P, Zhou M, Dong DS, Xing YN, Bai Y. Tumour Biol. 2013 Sep 12. [Epub ahead of print]
 
  Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy
Fu SJ, Shen SL, Li SQ, Hua YP, Hu WJ, Liang LJ, Peng BG. Med Oncol. 2013 Dec;30(4):721. doi: 10.1007/s12032-013-0721-6. Epub 2013 Sep 13.
 
  Lactic acidosis during telbivudine treatment for HBV: a case report and literature review
Jin JL, Hu P, Lu JH, Luo SS, Huang XY, Weng XH, Zhang JM. World J Gastroenterol. 2013 Sep 7;19(33):5575-80. doi: 10.3748/wjg.v19.i33.5575.
 
  Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study
Liang J, Jiang MJ, Deng X, Xiao Zhou X. Hepat Mon. 2013 May 23;13(6):e7862. doi: 10.5812/hepatmon.7862.
 
  National, state, and local area vaccination coverage among children aged 19-35 months - United States, 2012
Centers for Disease Control and Prevention (CDC).
 
  Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: a pilot study
Du QW, Ding JG, Sun QF, Hong L, Cai FJ, Zhou QQ, Wu YH, Fu RQ. Med Sci Monit. 2013 Sep 9;19:751-6. doi: 10.12659/MSM.889443.
 
  Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy
Papatheodoridis G, Goulis J, Manolakopoulos S, Margariti A, Exarchos X, Kokkonis G, Hadziyiannis E, Papaioannou C, Manesis E, Pectasides D, Akriviadis E. J Hepatol. 2013 Sep 6. pii: S0168-8278(13)00646-6. doi: 10.1016/j.jhep.2013.08.023. [Epub ahead of print]
 
  Chronic hepatitis D at a standstill: where do we go from here?
Ciancio A, Rizzetto M. Nat Rev Gastroenterol Hepatol. 2013 Sep 10. doi: 10.1038/nrgastro.2013.164. [Epub ahead of print]
 
  An Overview of Hepatitis B Virus Surface Antigen Mutant in the Asia Pacific
Hudu SA, Malik YA, Niazlin MT, Harmal NS, Sekawi Z. Curr Issues Mol Biol. 2013 Sep 6;16(2):69-78. [Epub ahead of print]
 
  Possible origins and evolution of the hepatitis B virus (HBV)
Locarnini S, Littlejohn M, Aziz MN, Yuen L. Semin Cancer Biol. 2013 Sep 3. pii: S1044-579X(13)00082-5. doi: 10.1016/j.semcancer.2013.08.006. [Epub ahead of print]
 
  Quantification of serum hepatitis B surface antigen in predicting the response of pegylated interferon alfa-2a in HBeAg-positive chronic hepatitis B with prior lamivudine exposure
Weng M, Zeng WZ, Wu XL, Zhang Y, Jiang MD, Wang Z, Zhou DJ, He X. Virol J. 2013 Sep 6;10(1):277. [Epub ahead of print]
 
  Hepatitis B antivirals and resistance
Devi U, Locarnini S. Curr Opin Virol. 2013 Oct;3(5):495-500. doi: 10.1016/j.coviro.2013.08.006. Epub 2013 Sep 7.
 
  Effects of hepatitis B virus X protein on human T cell cytokines
Lou X, Hou Y, Liang D. Can J Microbiol. 2013 Sep;59(9):620-6. doi: 10.1139/cjm-2013-0259. Epub 2013 Jul 12.
 
  Predictors of survival in hepatitis B virus related decompensated cirrhosis on tenofovir therapy: An Indian perspective
Srivastava M, Rungta S, Dixit VK, Shukla SK, Singh TB, Jain AK. Antiviral Res. 2013 Nov;100(2):300-5. doi: 10.1016/j.antiviral.2013.08.020. Epub 2013 Sep 5.
 
  Viral Breakthrough Is Associated With Resistance Using Direct Acting Agents in Patients Treated for Chronic Hepatitis C Infection
Zhou K, Ferguson J, Bau S, Saab S. J Clin Gastroenterol. 2013 Sep 16. [Epub ahead of print]
 
  Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents
Conteduca V, Sansonno D, Russi S, Pavone F, Dammacco F. J Infect. 2013 Sep 4. pii: S0163-4453(13)00251-X. doi: 10.1016/j.jinf.2013.08.019. [Epub ahead of print]
 
  Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
Hsu C, Tsou HH, Lin SJ, Wang MC, Yao M, Hwang WL, Kao WY, Chiu CF, Lin SF, Lin J, Chang CS, Tien HF, Liu TW, Chen PJ, Cheng AL; Taiwan Cooperative Oncology Group. Hepatology. 2013 Sep 3. doi: 10.1002/hep.26718. [Epub ahead of print]
 
  Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in china
Bian T, Yan H, Shen L, Wang F, Zhang S, Cao Y, Zhang S, Zhang Y, Bi S. J Virol. 2013 Nov;87(22):12196-206. doi: 10.1128/JVI.02127-13. Epub 2013 Sep 4.
 
  Prevention of hepatitis B virus infection and liver cancer
Chang MH. Recent Results Cancer Res. 2014;193:75-95. doi: 10.1007/978-3-642-38965-8_5.
 
  Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study
Yin J, Li N, Han Y, Xue J, Deng Y, Shi J, Guo W, Zhang H, Wang H, Cheng S, Cao G. J Clin Oncol. 2013 Oct 10;31(29):3647-55. doi: 10.1200/JCO.2012.48.5896. Epub 2013 Sep 3.
 
  The oncogenic role of hepatitis B virus
Rivière L, Ducroux A, Buendia MA. Recent Results Cancer Res. 2014;193:59-74. doi: 10.1007/978-3-642-38965-8_4.
 
  Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants
Tong HV, Toan NL, Song LH, Bock CT, Kremsner PG, Velavan TP. J Viral Hepat. 2013 Oct;20(10):687-98. doi: 10.1111/jvh.12089. Epub 2013 May 7.
 
  Current role of Lamivudine regarding therapeutic response and resistance in children with chronic hepatitis B
Hong SJ, Kim YH, Choe BH, Park HJ, Tak WY, Kweon YO. Pediatr Gastroenterol Hepatol Nutr. 2013 Jun;16(2):80-8. doi: 10.5223/pghn.2013.16.2.80. Epub 2013 Jun 30.
 
  On-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational study
Chen YC, Hsu CW, Chang MY, Yeh CT.
 
  Racial disparities in hepatitis B infection in Ohio: screening and immunization are critical for early clinical management
Misra R, Jiobu K, Zhang J, Liu Q, Li F, Kirkpatrick R, Ho J. J Investig Med. 2013 Oct;61(7):1121-8. doi: 10.231/JIM.0b013e3182a70f10.
 
  Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA
Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P. J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16.
 
  Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance
Seo SY, Kim IH, Sohn JY, Lee S, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG. Intervirology. 2013 Aug 24. [Epub ahead of print]
 
  HBV induced HCC: major risk factors from genetic to molecular level
Ayub A, Ashfaq UA, Haque A. Biomed Res Int. 2013;2013:810461. doi: 10.1155/2013/810461. Epub 2013 Aug 7.
 
  Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection
Nakano M, Kawaguchi T, Nakamoto S, Kawaguchi A, Kanda T, Imazeki F, Kuromatsu R, Sumie S, Satani M, Yamada S, Torimura T, Kakuma T, Yokosuka O, Sata M. Oncol Rep. 2013 Nov;30(5):2049-55. doi: 10.3892/or.2013.2700. Epub 2013 Aug 27.
 
  Hepatitis B virus-induced hepatocellular carcinoma
Xu C, Zhou W, Wang Y, Qiao L. Cancer Lett. 2013 Aug 25. pii: S0304-3835(13)00610-1. doi: 10.1016/j.canlet.2013.08.035. [Epub ahead of print]
 
  Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus
Zhang X, Zhang F, Wu D, Bao C, Zhu P, Zhang X, Huang C, He D, Tao Y, Fang Y, Gu J, Wu H, Sun L, Yang X, Huang F, Xu H, Zhao D, Zhang M, Zheng Y, Li Z. Int J Rheum Dis. 2013 Aug;16(4):408-12. doi: 10.1111/1756-185X.12125. Epub 2013 Jul 2.
 
  Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up
Cheng YL, Wang YJ, Kao WY, Chen PH, Huo TI, Huang YH, Lan KH, Su CW, Chan WL, Lin HC, Lee FY, Wu JC. PLoS One. 2013 Aug 22;8(8):e72049. doi: 10.1371/journal.pone.0072049.
 
  Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010
Tohme RA, Bulkow L, Homan CE, Negus S, McMahon BJ. J Clin Virol. 2013 Oct;58(2):396-400. doi: 10.1016/j.jcv.2013.08.012. Epub 2013 Aug 16.
 
  Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B
Chao DC, Hu KQ. Drug Des Devel Ther. 2013 Aug 20;7:777-88. doi: 10.2147/DDDT.S33947.
 
  Safety and Efficacy of Protease Inhibitors to Treat Hepatitis C After Liver Transplantation, a Multicenter Experience
Coilly A, Roche B, Dumortier J, Leroy V, Botta-Fridlund D, Radenne S, Pageaux GP, Si-Ahmed SN, Guillaud O, Antonini TM, Haim-Boukobza S, Roque-Afonso AM, Samuel D, Duclos-Vallee JC. J Hepatol. 2013 Aug 29. pii: S0168-8278(13)00613-2. doi: 10.1016/j.jhep.2013.08.018. [Epub ahead of print]
 
  Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B
Lai CL, Ahn SH, Lee KS, Um SH, Cho M, Yoon SK, Lee JW, Park NH, Kweon YO, Sohn JH, Lee J, Kim JA, Han KH, Yuen MF. Gut. 2013 Aug 31. doi: 10.1136/gutjnl-2013-305138. [Epub ahead of print]
 
  Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma
Matsui T, Kang JH, Nojima M, Tomonari A, Aoki H, Yamazaki H, Yane K, Tsuji K, Andoh S, Andoh S, Sakai H, Maemori M, Maguchi H, Tanaka Y. J Med Virol. 2013 Nov;85(11):1900-6. doi: 10.1002/jmv.23694. Epub 2013 Aug 7.
 
  Is HBsAg quantification ready, for prime time?
Chevaliez S. Clin Res Hepatol Gastroenterol. 2013 Aug 7. pii: S2210-7401(13)00147-2. doi: 10.1016/j.clinre.2013.07.004. [Epub ahead of print]
 
  Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis
Thiele M, Gluud LL, Dahl EK, Krag A. BMJ Open. 2013 Aug 14;3(8). pii: e003265. doi: 10.1136/bmjopen-2013-003265.
 
  Expert recommendations on application of interferon for chronic hepatitis B
Wan MB, Weng XH. J Dig Dis. 2013 Aug 23. doi: 10.1111/1751-2980.12096. [Epub ahead of print]
 
  MicroRNAs may solve the mystery of chronic hepatitis B virus infection
Wei YF, Cui GY, Ye P, Chen JN, Diao HY. World J Gastroenterol. 2013 Aug 14;19(30):4867-76. doi: 10.3748/wjg.v19.i30.4867.
 
  Screening for hepatitis B virus and hepatitis C virus at a community fair: a single-center experience
Woo GA, Hill MA, de Medina MD, Schiff ER. Gastroenterol Hepatol (N Y). 2013 May;9(5):293-9.
 
  An assessment of the performance of self-reported vaccination status for hepatitis B, National Health and Nutrition Examination Survey 1999-2008
Denniston MM, Byrd KK, Klevens RM, Drobeniuc J, Kamili S, Jiles RB. Am J Public Health. 2013 Oct;103(10):1865-73. doi: 10.2105/AJPH.2013.301313. Epub 2013 Aug 15.
 
  Effect of Tenofovir With and Without Interferon on Hepatitis D Virus Replication in HIV-Hepatitis B Virus-Hepatitis D Virus-Infected Patients
Boyd A, Miailhes P, Brichler S, Scholtès C, Maylin S, Delaugerre C, Chevallier-Queyron P, Gordien E, Girard PM, Lacombe K. AIDS Res Hum Retroviruses. 2013 Sep 24. [Epub ahead of print]
 
  Treatment of patients with HBV-related decompensated cirrhosis and liver transplanted patients
Roche B, Samuel D. Clin Liver Dis. 2013 Aug;17(3):451-73. doi: 10.1016/j.cld.2013.05.003. Epub 2013 Jun 27.
 
  Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan
Chen CT, Chen JY, Wang JH, Chang KC, Tseng PL, Kee KM, Chen PF, Tsai LS, Chen SC, Lin SC, Lu SN. Kaohsiung J Med Sci. 2013 Aug;29(8):451-9. doi: 10.1016/j.kjms.2012.12.006. Epub 2013 Feb 9.
 
  The importance of hemovigilance in the transmission of infectious diseases
Martins PR, Martins RA, Barbosa Vde F, Pereira Gde A, Moraes-Souza H, Silva SS. Rev Bras Hematol Hemoter. 2013;35(3):180-4. doi: 10.5581/1516-8484.20130040.
 
  HBsAg quantification to predict natural history and treatment outcome in chronic hepatitis B patients
Martinot-Peignoux M, Asselah T, Marcellin P. Clin Liver Dis. 2013 Aug;17(3):399-412. doi: 10.1016/j.cld.2013.05.006. Epub 2013 Jun 27.
 
  Hepatitis B in HIV-infected patients
Soriano V, Poveda E, Vispo E, Barreiro P. Clin Liver Dis. 2013 Aug;17(3):489-501. doi: 10.1016/j.cld.2013.05.008. Epub 2013 Jul 8.
 
  Impact of therapy on the long-term outcome of chronic hepatitis B
Liaw YF. Clin Liver Dis. 2013 Aug;17(3):413-23. doi: 10.1016/j.cld.2013.05.005. Epub 2013 Jun 21.
 
  Long-term results of treatment with nucleoside and nucleotide analogues (entecavir and tenofovir) for chronic hepatitis B
Asselah T, Marcellin P. Clin Liver Dis. 2013 Aug;17(3):445-50. doi: 10.1016/j.cld.2013.05.001. Epub 2013 Jul 3.
 
  Results of treatment of chronic hepatitis B with pegylated interferon
Viganò M, Mangia G, Lampertico P. Clin Liver Dis. 2013 Aug;17(3):425-43. doi: 10.1016/j.cld.2013.05.004. Epub 2013 Jul 3.
 
  Prognostic impact of telomere maintenance gene polymorphisms in hepatocellular carcinoma patients with chronic Hepatitis B
Jung SW, Park NH, Shin JW, Park BR, Kim CJ, Lee JE, Shin ES, Kim JA, Chung YH. Hepatology. 2013 Aug 1. doi: 10.1002/hep.26655. [Epub ahead of print]
 
  Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B
Publicover J, Gaggar A, Nishimura S, Van Horn CM, Goodsell A, Muench MO, Reinhardt RL, van Rooijen N, Wakil AE, Peters M, Cyster JG, Erle DJ, Rosenthal P, Cooper S, Baron JL. J Clin Invest. 2013 Sep 3;123(9):3728-39. doi: 10.1172/JCI68182. Epub 2013 Aug 8.
 
  Quantitative Elastography of Liver Fibrosis and Spleen Stiffness in Chronic Hepatitis B Carriers: Comparison of Shear-Wave Elastography and Transient Elastography with Liver Biopsy Correlation
Leung VY, Shen J, Wong VW, Abrigo J, Wong GL, Chim AM, Chu SH, Chan AW, Choi PC, Ahuja AT, Chan HL, Chu WC. Radiology. 2013 Aug 2. [Epub ahead of print]
 
  Why isn't evidence based practice improving health care for minorities in the United States?
Lee H, Fitzpatrick JJ, Baik SY. Appl Nurs Res. 2013 Aug 5. pii: S0897-1897(13)00041-4. doi: 10.1016/j.apnr.2013.05.004. [Epub ahead of print]
 
  Survey of Asian Patients with Hepatitis B Infection: Limited Knowledge of Transmission and Screening of Family Members
Vijayan T, Zheng P, Nguyen C, Brown AM, Chen YW, Peters MG. J Immigr Minor Health. 2013 Aug 3. [Epub ahead of print]
 
  Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: A clinical study
Ruan P, Xu SY, Zhou BP, Huang J, Gong ZJ. J Int Med Res. 2013 Oct;41(5):1732-1739. Epub 2013 Aug 1.
 
  Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients
Wang CC, Tseng TC, Wang PC, Lin HH, Kao JH. J Formos Med Assoc. 2013 Aug 1. pii: S0929-6646(13)00205-2. doi: 10.1016/j.jfma.2013.06.003. [Epub ahead of print]
 
  Hospitalizations due to hepatitis C in Los Angeles County, 2007-2009: case characteristics and factors associated with mortality
Sie L, Gatto NM, Bancroft E. J Viral Hepat. 2013 Sep;20(9):628-37. doi: 10.1111/jvh.12086. Epub 2013 Mar 20.
 
  Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B
Venkatesh SK, Wang G, Lim SG, Wee A. Eur Radiol. 2013 Aug 9. [Epub ahead of print]
 
  Nanoparticles encapsulating HBV-CpG induce therapeutic immunity against hepatitis B virus infection
Lv S, Wang J, Dou S, Yang X, Ni X, Sun R, Tian Z, Wei H. Hepatology. 2013 Aug 1. doi: 10.1002/hep.26654. [Epub ahead of print]
 
  Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients
Singla B, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. J Med Virol. 2013 Jul;85(7):1155-62. doi: 10.1002/jmv.23608.
 
  Targeted case finding for hepatitis B using dry blood spot testing in the British-Chinese and South Asian populations of the North-East of England
McPherson S, Valappil M, Moses SE, Eltringham G, Miller C, Baxter K, Chan A, Shafiq K, Saeed A, Qureshi R, Hudson M, Bassendine MF. J Viral Hepat. 2013 Sep;20(9):638-44. doi: 10.1111/jvh.12084. Epub 2013 Mar 12.
 
  Physicians infrequently adhere to hepatitis vaccination guidelines for chronic liver disease
Thudi K, Yadav D, Sweeney K, Behari J. PLoS One. 2013 Jul 26;8(7):e71124. doi: 10.1371/journal.pone.0071124. Print 2013.
 
  The Hepatitis B Vaccine Protects Re-Exposed Health Care Workers, But Does Not Provide Sterilizing Immunity
Werner JM, Abdalla A, Gara N, Ghany MG, Rehermann B. Gastroenterology. 2013 Jul 31. pii: S0016-5085(13)01134-7. doi: 10.1053/j.gastro.2013.07.044. [Epub ahead of print]
 
  Impact of transient elastography on clinical decision-making in patients with chronic viral hepatitis
Feuth T, Arends JE, Lieveld FI, Mundt MW, Hoepelman AI, Siersema PD, van Erpecum KJ. Scand J Gastroenterol. 2013 Sep;48(9):1074-81. doi: 10.3109/00365521.2013.819441. Epub 2013 Jul 25.
 
  Cost-effectiveness of questionnaires in preventing transfusion-transmitted infections
de Kort W, van den Burg P, Geerligs H, Pasker-de Jong P, Marijt-van der Kreek T. Transfusion. 2013 Jul 25. doi: 10.1111/trf.12349. [Epub ahead of print]
 
  Epigenetic Mechanism Involved in the HBV/HCV-Related Hepatocellular Carcinoma Tumorigenesis
Rongrui L, Na H, Zongfang L, Fanpu J, Shiwen J. Curr Pharm Des. 2013 Jul 19. [Epub ahead of print]
 
  Efficacy and safety of entecavir treatment in a heterogeneous CHB population from a 'real-world' clinical practice setting in China
Hou JL, Jia JD, Wei L, Zhao W, Wang YM, Cheng M, Tang X, Tan DM, Ren H, Tang H, Cohen D, Llamoso C. J Viral Hepat. 2013 May 29. doi: 10.1111/jvh.12115. [Epub ahead of print]
 
  Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective
Wesdorp DJ, Knoester M, Braat AE, Coenraad MJ, Vossen AC, Claas EC, van Hoek B. J Clin Virol. 2013 Sep;58(1):67-73. doi: 10.1016/j.jcv.2013.06.035. Epub 2013 Jul 20.
 
  The natural course of chronic hepatitis B virus infection and its management
Hadziyannis SJ, Vassilopoulos D, Hadziyannis E. Adv Pharmacol. 2013;67:247-91. doi: 10.1016/B978-0-12-405880-4.00007-X.
 
  Hepatitis B and C reactivation with tumor necrosis factor inhibitors: synopsis and interpretation of screening and prophylaxis recommendations
Fuchs I, Abu-Shakra M, Sikuler E. Isr Med Assoc J. 2013 Jun;15(6):303-7.
 
  The current status of combination therapy of Chronic Hepatitis B
Chen EQ, Tang H. Eur Rev Med Pharmacol Sci. 2013 Aug;17(15):2023-31.
 
  A Chinese Medicine, Kuan-Sin-Yin Decoction, Improves Liver Function in Hepatitis B Virus Carriers: A Randomized, Controlled Study
Lee CJ, Cheng CH, Li YH, Liu CY, Hsu CH. J Altern Complement Med. 2013 Jul 17. [Epub ahead of print]
 
  Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure
Dong X, Gong Y, Zeng H, Hao Y, Wang X, Hou J, Wang J, Li J, Zhu Y, Liu H, Han J, Zhou H, Shen L, Gao T, Zhou T, Yang S, Li S, Chen Y, Meng Q, Li H. Liver Int. 2013 Jun 19. doi: 10.1111/liv.12248. [Epub ahead of print]
 
  Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection
Kim SU, Song KJ, Chang HY, Shin EC, Park JY, Kim do Y, Han KH, Chon CY, Ahn SH. PLoS One. 2013 Jul 17;8(7):e69166. doi: 10.1371/journal.pone.0069166. Print 2013.
 
  Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapy
Chen J, Wang J, Yang J, Zhang W, Song X, Chen L. PLoS One. 2013 Jul 8;8(7):e69400. doi: 10.1371/journal.pone.0069400. Print 2013.
 
  Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies
Xu JH, Fu JJ, Wang XL, Zhu JY, Ye XH, Chen SD.
 
  RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B
Chen B, Ye B, Zhang J, Ying L, Chen Y.
 
  Association of treatment and outcomes of doctor-shopping behavior in patients with hepatocellular carcinoma
Hsieh CI, Chung KP, Yang MC, Li TC. Patient Prefer Adherence. 2013 Jul 11;7:693-701. doi: 10.2147/PPA.S43631. Print 2013.
 
  Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis
Price H, Dunn D, Pillay D, Bani-Sadr F, de Vries-Sluijs T, Jain MK, Kuzushita N, Mauss S, Núñez M, Nüesch R, Peters M, Reiberger T, Stephan C, Tan L, Gilson R. PLoS One. 2013 Jul 10;8(7):e68152. doi: 10.1371/journal.pone.0068152. Print 2013.
 
  Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype
Brunetto MR, Marcellin P, Cherubini B, Yurdaydin C, Farci P, Hadziyannis SJ, Rothe V, Regep L, Bonino F. J Hepatol. 2013 Jul 18. pii: S0168-8278(13)00528-X. doi: 10.1016/j.jhep.2013.07.017. [Epub ahead of print]
 
  The reliability of HBV core antibody in serological screening for hepatitis B virus
Ba Alawi F, Robertson PW, LePage AK, Jayamaha J, Baleriola C, Rawlinson WD. Pathology. 2013 Aug;45(5):501-5. doi: 10.1097/PAT.0b013e3283631cf9.
 
  Hepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1)
Zhang X, Xing H, Feng X, Zhang H, Wang Y, Yan H. Virol J. 2013 Jul 12;10(1):232. [Epub ahead of print]
 
  Frequent Emergency Department Visits are More Prevalent in Psychiatric, Alcohol Abuse, and Dual Diagnosis Conditions than in Chronic Viral Illnesses Such as Hepatitis and Human Immunodeficiency Virus
Minassian A, Vilke GM, Wilson MP. J Emerg Med. 2013 Jul 8. pii: S0736-4679(13)00467-8. doi: 10.1016/j.jemermed.2013.05.007. [Epub ahead of print]
 
  Impact of liver fibrosis on prognosis following liver resection for hepatitis B-associated hepatocellular carcinoma
Wang Q, Fiel MI, Blank S, Luan W, Kadri H, Kim KW, Manizate F, Rosenblatt AG, Labow DM, Schwartz ME, Hiotis SP. Br J Cancer. 2013 Aug 6;109(3):573-81. doi: 10.1038/bjc.2013.352. Epub 2013 Jul 11.
 
  Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections
Lin MT, Chou YP, Hu TH, Yu HC, Hsu YC, Tsai MC, Tseng PL, Chang KC, Yen YH, Chiu KW. Arch Virol. 2013 Jul 16. [Epub ahead of print]
 
  A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection
Ceylan B, Mete B, Fincanci M, Aslan T, Akkoyunlu Y, Ozgune? N, Colak O, Gunduz A, Senates E, Ozaras R, Inci A, Tabak F. Wien Klin Wochenschr. 2013 Aug;125(15-16):453-460. Epub 2013 Jul 17.
 
  Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach
Schiffer JT, Swan DA, Stone D, Jerome KR. PLoS Comput Biol. 2013 Jul;9(7):e1003131. doi: 10.1371/journal.pcbi.1003131. Epub 2013 Jul 4.
 
  Characteristics and prediction of hepatitis B e-antigen negative hepatitis following seroconversion in patients with chronic hepatitis B
Morita S, Matsumoto A, Umemura T, Shibata S, Kamijo N, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Yoshizawa K, Tanaka E. Hepatol Res. 2013 Jul 16. doi: 10.1111/hepr.12208. [Epub ahead of print]
 
  Chronic hepatitis B prognostic markers other than pre-treatment viral load predicted composite treatment outcome
Aung MN, Leowattana W, Win KN, Tangpukdee N, Muangnoicharoen S. J Infect Dev Ctries. 2013 Jul 15;7(7):541-9. doi: 10.3855/jidc.2759.
 
  Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection
Wang L, Chen H, Fan C, Gong Z. J Med Virol. 2013 Nov;85(11):1907-12. doi: 10.1002/jmv.23689. Epub 2013 Jul 12.
 
  Too much of a good thing? When to stop catch-up vaccination
Hutton DW, Brandeau ML. Med Decis Making. 2013 Oct;33(7):920-36. doi: 10.1177/0272989X13493142. Epub 2013 Jul 15.
 
  Demographic and serological characteristics of Asian Americans with hepatitis B infection diagnosed at community screenings
Xu JJ, Tien C, Chang M, Rhee J, Tien A, Bae HS, Ho FC, Chan LS, Fong TL. J Viral Hepat. 2013 Aug;20(8):575-81. doi: 10.1111/jvh.12073. Epub 2013 Mar 25.
 
  Risk Assessment of Liver-related Events Using Transient Elastography in Patients With Chronic Hepatitis B Receiving Entecavir
Kim MN, Kim SU, Park JY, Kim DY, Han KH, Chon CY, Ahn SH. J Clin Gastroenterol. 2013 Jun 26. [Epub ahead of print]
 
  As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3? pathway
Liu L, Dong Z, Liang J, Cao C, Sun J, Ding Y, Wu D. Oncogene. 2013 Jul 1. doi: 10.1038/onc.2013.236. [Epub ahead of print]
 
  Accuracy of International Guidelines for Identifying Significant Fibrosis in Hepatitis B e Antigen-negative Patients With Chronic Hepatitis
Sanai FM, Babatin MA, Bzeizi KI, Alsuhaibani F, Al-Hamoudi W, Alsaad KS, Almana H, Handoo FA, Al-Ashgar H, Alghamdi H, Ibrahim A, Aljumah A, Alalwan A, Altraif IH, Al-Hussaini H, Myers RP, Abdo AA. Clin Gastroenterol Hepatol. 2013 Jun 28. pii: S1542-3565(13)00876-8. doi: 10.1016/j.cgh.2013.05.038. [Epub ahead of print]
 
  Occult hepatitis B in patients on hemodialysis: a review
Fontenele AM, Filho NS, Ferreira AS. Ann Hepatol. 2013 Jul-Aug;12(4):527-31.
 
  Identification of ?-taxilin as an essential factor for the life cycle of hepatitis B virus
Hoffmann J, Boehm C, Himmelsbach K, Donnerhak C, Roettger H, Weiss TS, Ploen D, Hildt E. J Hepatol. 2013 Jun 28. pii: S0168-8278(13)00437-6. doi: 10.1016/j.jhep.2013.06.020. [Epub ahead of print]
 
  Hepatitis B infection increases the risk of non-Hodgkin lymphoma: A meta-analysis of observational studies
Dalia S, Chavez J, Castillo JJ, Sokol L. Leuk Res. 2013 Sep;37(9):1107-15. doi: 10.1016/j.leukres.2013.06.007. Epub 2013 Jun 26.
 
  Prophylaxis of hepatitis B infection in solid organ transplant recipients
John S, Andersson KL, Kotton CN, Hertl M, Markmann JF, Cosimi AB, Chung RT. Therap Adv Gastroenterol. 2013 Jul;6(4):309-19. doi: 10.1177/1756283X13487942.
 
  Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma
Bayliss J, Lim L, Thompson AJ, Desmond P, Angus P, Locarnini S, Revill PA. J Hepatol. 2013 Jun 25. pii: S0168-8278(13)00434-0. doi: 10.1016/j.jhep.2013.06.018. [Epub ahead of print]
 
  Increased regulatory T cells and impaired functions of circulating CD8 T lymphocytes is associated with viral persistence in Hepatitis B virus-positive newborns
Shrivastava S, TrehanPati N, Patra S, Kottilil S, Pande C, Trivedi SS, Sarin SK. J Viral Hepat. 2013 Aug;20(8):582-91. doi: 10.1111/jvh.12078. Epub 2013 Feb 14.
 
  Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis
Zheng Y, Zhang S, Tan Grahn HM, Ye C, Gong Z, Zhang Q. Hepat Mon. 2013 Apr 1;13(4):e6496. doi: 10.5812/hepatmon.6496. Print 2013 Apr.
 
  Virological Response and Muscular Adverse Events during Long-Term Clevudine Therapy in Chronic Hepatitis B Patients
Kim BK, Ko SY, Kwon SY, Park E, Kim JH, Choe WH, Lee CH. Hepat Mon. 2013 Apr 1;13(4):e6056. doi: 10.5812/hepatmon.6056. Print 2013 Apr.
 
  Fibroscan can avoid liver biopsy in Indian patients with Chronic Hepatitis B
Goyal R, Mallick SR, Mahanta M, Kedia S, Shalimar, Dhingra R, Sharma H, Das P, Gupta SD, Panda S, Acharya SK. J Gastroenterol Hepatol. 2013 Jun 28. doi: 10.1111/jgh.12318. [Epub ahead of print]
 
  Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen - a prospective cohort study with paired transient elastography examination
Wong GL, Chan HL, Yu Z, Chan HY, Tse CH, Wong VW. J Gastroenterol Hepatol. 2013 Jun 28. doi: 10.1111/jgh.12312. [Epub ahead of print]
 
  Correlation between interleukin?23 receptor gene polymorphisms and risk of hepatitis B virus infection in patients
Peng Q, Qin Y, Chen Z, Deng Y, Xu J, Li S, Qin X. Mol Med Rep. 2013 Aug;8(2):613-20. doi: 10.3892/mmr.2013.1558. Epub 2013 Jun 26.
 
  Complementary laboratory indices for predicting the disease status of patients with hepatitis B virus infection
Chen F, He JL, Zheng M, Zhu HH, Li SP, Wang K, Zhang XX, Zhao YR, Wu SS, Chen Z. J Viral Hepat. 2013 Aug;20(8):566-74. doi: 10.1111/jvh.12067. Epub 2013 Feb 6.
 
  Ultrasensitive Amplification Refractory Mutation System Real-Time PCR (ARMS RT-PCR) Assay for Detection of Minority Hepatitis B Virus-Resistant Strains in the Era of Personalized Medicine
Ntziora F, Paraskevis D, Haida C, Manesis E, Papatheodoridis G, Manolakopoulos S, Elefsiniotis I, Karamitros T, Vassilakis A, Hatzakis A. J Clin Microbiol. 2013 Sep;51(9):2893-900. doi: 10.1128/JCM.00936-13. Epub 2013 Jun 26.
 
  The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy
Su CW, Chiou YW, Tsai YH, Teng RD, Chau GY, Lei HJ, Hung HH, Huo TI, Wu JC. PLoS One. 2013 Jun 21;8(6):e66457. Print 2013.
 
  Normal vitamin D levels are associated with spontaneous hepatitis B surface antigen seroclearance
Mahamid M, Nseir W, Abu Elhija O, Shteingart S, Mahamid A, Smamra M, Koslowsky B. World J Hepatol. 2013 Jun 27;5(6):328-31. doi: 10.4254/wjh.v5.i6.328.
 
  The Efficacy and Safety of Nucleos(t)ide Analogues in Patients with Spontaneous Acute Exacerbation of Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Yu W, Zhao C, Shen C, Wang Y, Lu H, Fan J. PLoS One. 2013 Jun 11;8(6):e65952. doi: 10.1371/journal.pone.0065952. Print 2013.
 
  Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B
Huang YH, Hsiao LT, Hong YC, Chiou TJ, Yu YB, Gau JP, Liu CY, Yang MH, Tzeng CH, Lee PC, Lin HC, Lee SD. J Clin Oncol. 2013 Aug 1;31(22):2765-72. doi: 10.1200/JCO.2012.48.5938. Epub 2013 Jun 17.
 
  Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B
Perrillo R, Buti M, Durand F, Charlton M, Gadano A, Cantisani G, Loong CC, Brown K, Hu W, Lopez-Talavera JC, Llamoso C. Liver Transpl. 2013 Aug;19(8):887-95. doi: 10.1002/lt.23690.
 
  Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival
Groeschl RT, Hong JC, Christians KK, Turaga KK, Tsai S, Pilgrim CH, Gamblin TC. HPB (Oxford). 2013 Jun 19. doi: 10.1111/hpb.12134. [Epub ahead of print]
 
  Comparison of survival and tumor recurrence rates in patients undergoing liver transplantation for hepatitis B-related hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou Criteria
Gao T, Xia Q, Qiu DK, Feng YY, Chi JC, Wang SY, Xi ZF, Zhang JJ, Xu N, Chen SY, Qiu YL, Shen LW, Zhou TT, Dong XJ, Li QG, Li H. J Dig Dis. 2013 Jun 19. doi: 10.1111/1751-2980.12083. [Epub ahead of print]
 
  Liver transplantation for hepatitis B-induced liver disease: long-term outcome and effectiveness of antiviral therapy for prevention of recurrent hepatitis B infection
Perrakis A, Förtsch T, Del Medico A, Croner RS, Vassos N, Yedibela S, Lohmüller C, Zopf S, Hohenberger W, Müller V. Transplant Proc. 2013 Jun;45(5):1953-6. doi: 10.1016/j.transproceed.2012.11.020.
 
  Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age
Li WC, Lee YY, Chen IC, Sun C, Chiu FH, Chuang CH. Liver Int. 2013 May 20. doi: 10.1111/liv.12224. [Epub ahead of print]
 
  Analysis of hepatitis B virus genotyping and drug resistance gene mutations based on massively parallel sequencing
Han Y, Zhang Y, Mei Y, Wang Y, Liu T, Guan Y, Tan D, Liang Y, Yang L, Yi X. J Virol Methods. 2013 Jun 14;193(2):341-347. doi: 10.1016/j.jviromet.2013.06.015. [Epub ahead of print]
 
  Hepatitis B viral factors and treatment responses in chronic hepatitis B
Lin CL, Kao JH. J Formos Med Assoc. 2013 Jun;112(6):302-11. doi: 10.1016/j.jfma.2013.02.001. Epub 2013 Mar 17.
 
  Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients
Lü W, Yang HH, Fan YM, Li T, Zhang LF, Mui C, Fan HW, Zhou BT, Liu ZY, Ng H, Liu XQ. Chin Med J (Engl). 2013 Jun;126(12):2333-6.
 
  Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study
Fang J, Li W, Tan Z, Li D. Int Urol Nephrol. 2013 Jun 12. [Epub ahead of print]
 
  A genome-wide association study identified new variants associated with the risk of chronic hepatitis B
Kim YJ, Young Kim H, Lee JH, Jong Yu S, Yoon JH, Lee HS, Yong Kim C, Youn Cheong J, Won Cho S, Hwa Park N, Lae Park B, Namgoong S, Hyo Kim L, Sub Cheong H, Doo Shin H. Hum Mol Genet. 2013 Jun 26. [Epub ahead of print]
 
  Resolving ambiguity in the phylogenetic relationship of genotypes A, B, and C of hepatitis B virus
Jiang Y, Wang M, Zheng H, Wang WR, Jin L, He Y. BMC Evol Biol. 2013 Jun 11;13:120. doi: 10.1186/1471-2148-13-120.
 
  Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?
Abu-Amara M, Feld JJ. Semin Liver Dis. 2013 May;33(2):157-66. doi: 10.1055/s-0033-1345719. Epub 2013 Jun 8.
 
  Topographical Impact of Hepatitis B-related Hepatocellular Carcinoma on Local Recurrence After Radiofrequency Ablation
Kim JS, Kim W, So YH, Yu SJ, Kim BG. J Clin Gastroenterol. 2013 Jun 6. [Epub ahead of print]
 
  Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels
Loggi E, Bihl FK, Cursaro C, Granieri C, Galli S, Brodosi L, Furlini G, Bernardi M, Brander C, Andreone P. PLoS One. 2013 Jun 4;8(6):e65327. doi: 10.1371/journal.pone.0065327. Print 2013.
 
  Molecular mechanisms of HBV-associated hepatocarcinogenesis
Guerrieri F, Belloni L, Pediconi N, Levrero M. Semin Liver Dis. 2013 May;33(2):147-56. doi: 10.1055/s-0033-1345721. Epub 2013 Jun 8.
 
  Past Exposure to Hepatitis B: A Risk Factor for Increase in Mortality?
Jinjuvadia R, Liangpunsakul S, Antaki F. J Clin Gastroenterol. 2013 Jun 6. [Epub ahead of print]
 
  Antiviral therapy for chronic hepatitis B in pregnancy
Pan CQ, Lee HM. Semin Liver Dis. 2013 May;33(2):138-46. doi: 10.1055/s-0033-1345718. Epub 2013 Jun 8.
 
  Immunosuppression and HBV reactivation
Shouval D, Shibolet O. Semin Liver Dis. 2013 May;33(2):167-77. doi: 10.1055/s-0033-1345722. Epub 2013 Jun 8.
 
  Off therapy durability of response to Entecavir therapy in hepatitis B e antigen negative chronic hepatitis B patients
Jeng WJ, Sheen IS, Chen YC, Hsu CW, Chien RN, Chu CM, Liaw YF. Hepatology. 2013 Jun 6. doi: 10.1002/hep.26549. [Epub ahead of print]
 
  Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes a to j
Liu CJ, Kao JH. Semin Liver Dis. 2013 May;33(2):97-102. doi: 10.1055/s-0033-1345716. Epub 2013 Jun 8.
 
  Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis e antigen negative chronic hepatitis B patients receiving nucleos(t)ide analogues
Wong GL, Chan HL, Lo AO, Chan HY, Tse CH, Chim AM, Wong VW. Antivir Ther. 2013 Jun 5. doi: 10.3851/IMP2615. [Epub ahead of print]
 
  The molecular virology of hepatitis B virus
Glebe D, Bremer CM. Semin Liver Dis. 2013 May;33(2):103-12. doi: 10.1055/s-0033-1345717. Epub 2013 Jun 8.
 
  New therapeutic targets and drugs for the treatment of chronic hepatitis B
Fletcher SP, Delaney WE 4th. Semin Liver Dis. 2013 May;33(2):130-7. doi: 10.1055/s-0033-1345713. Epub 2013 Jun 8.
 
  Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
Sitia G, Iannacone M, Guidotti LG. J Hepatol. 2013 Jun 3. pii: S0168-8278(13)00373-5. doi: 10.1016/j.jhep.2013.05.040. [Epub ahead of print]
 
  Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine
Gilca V, De Serres G, Boulianne N, Murphy D, Ouakki M, De Wals P, Trudeau G, Massé R, Dionne M. Hum Vaccin Immunother. 2013 Jun 6;9(8). [Epub ahead of print]
 
  Reduced Toll-like receptor-3 expression in chronic hepatitis B patients and its restoration by interferon therapy
Huang YW, Lin SC, Wei SC, Hu JT, Chang HY, Huang SH, Chen DS, Chen PJ, Hsu PN, Yang SS, Kao JH. Antivir Ther. 2013 Jun 6. doi: 10.3851/IMP2630. [Epub ahead of print]
 
  A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma
Clark A, Gerlach F, Tong HV, Hoan NX, Song LH, Toan NL, Bock CT, Kremsner PG, Velavan TP. Infect Genet Evol. 2013 Jun 6;18C:257-261. doi: 10.1016/j.meegid.2013.05.025. [Epub ahead of print]
 
  Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B
Su ZJ, Yu XP, Guo RY, Ming DS, Huang LY, Su ML, Deng Y, Lin ZZ. Diagn Microbiol Infect Dis. 2013 Aug;76(4):437-44. doi: 10.1016/j.diagmicrobio.2013.04.026. Epub 2013 Jun 7.
 
  Chronic hepatitis B: a treatment update
Wong V, Chan H. Semin Liver Dis. 2013 May;33(2):122-9. doi: 10.1055/s-0033-1345715. Epub 2013 Jun 8.
 
  The potential of 1018 ISS adjuvant in hepatitis B vaccines: Introduction
Eng NF, Bhardwaj N, Mulligan R, Diaz-Mitoma F. Hum Vaccin Immunother. 2013 May 31;9(8). [Epub ahead of print]
 
  Acute hepatitis B outbreaks in 2 skilled nursing facilities and possible sources of transmission: north Carolina, 2009-2010
Seña AC, Moorman A, Njord L, Williams RE, Colborn J, Khudyakov Y, Drobenuic J, Xia GL, Wood H, Moore Z. Infect Control Hosp Epidemiol. 2013 Jul;34(7):709-16. doi: 10.1086/670996. Epub 2013 May 16.
 
  Editorial: Prophylaxis in HBV-Infected Liver Transplant Patients: End of the HBIG Era?
Terrault N. Am J Gastroenterol. 2013 Jun;108(6):949-51. doi: 10.1038/ajg.2013.122.
 
  Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents
Wu TW, Chu CC, Ho TY, Chang Liao HW, Lin SK, Lin M, Lin HH, Wang LY. Hum Genet. 2013 Jun 6. [Epub ahead of print]
 
  Albumin Fusion of Interleukin-28B: Production and Characterization of Its Biological Activities and Protein Stability
Zhao J, Si Y, Cheng M, Yang Y, Niu Y, Li X, Liu X, Yang W. PLoS One. 2013 May 31;8(5):e64301. doi: 10.1371/journal.pone.0064301. Print 2013.
 
  Similar evolution of Hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy
Lavocat F, Dény P, Pichoud C, Hawajri NA, Kitrinos K, Borroto-Esoda K, Zoulim F. J Hepatol. 2013 Jun 3. pii: S0168-8278(13)00371-1. doi: 10.1016/j.jhep.2013.05.038. [Epub ahead of print]
 
  Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: A 20-year follow-up study in Thailand
Poovorawan Y, Chongsrisawat V, Theamboonlers A, Crasta PD, Messier M, Hardt K. Hum Vaccin Immunother. 2013 May 31;9(8). [Epub ahead of print]
 
  Hepatitis B virus reactivation associated with atorvastatin
Wu DC. Int J Infect Dis. 2013 May 29. pii: S1201-9712(13)00169-0. doi: 10.1016/j.ijid.2013.04.001. [Epub ahead of print]
 
  Role of serum dehydroepiandrosterone sulfate level on the clearance of chronic hepatitis B virus infection
Wu JF, Tsai WY, Tung YC, Chen HL, Ni YH, Hsu HY, Chang MH. J Gastroenterol. 2013 Jun 1. [Epub ahead of print]
 
  Incidence of diabetes mellitus in a population-based cohort of persons with chronic hepatitis B virus infection
Spradling PR, Simons B, Narayanan M, Xing J, Homan C, Bulkow L, Cagle H, Schraer CD, McMahon BJ. J Viral Hepat. 2013 Jul;20(7):510-3. doi: 10.1111/jvh.12071. Epub 2013 Mar 25.
 
  Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B
Cheng PN, Tsai HW, Chiu YC, Ho CH, Wu IC, Chang TT. J Clin Virol. 2013 Aug;57(4):323-30. doi: 10.1016/j.jcv.2013.04.012. Epub 2013 Jun 2.
 
  Differential roles of serum HBV DNA and HBsAg level in predicting virological breakthrough in patients receiving lamivudine therapy
Su CW, Wu CY, Hung HH, Wu CH, Sheen IJ, Wu JC. J Gastroenterol Hepatol. 2013 Jun 4. doi: 10.1111/jgh.12283. [Epub ahead of print]
 
  Hepatitis B Knowledge, Screening, and Vaccination among Hmong Americans
Kue J, Thorburn S. J Health Care Poor Underserved. 2013;24(2):566-78. doi: 10.1353/hpu.2013.0081.
 
  The Metabolomic Window into Hepatobiliary Disease
Beyo?lu D, Idle JR. J Hepatol. 2013 May 25. pii: S0168-8278(13)00362-0. doi: 10.1016/j.jhep.2013.05.030. [Epub ahead of print]
 
  Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues
Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A. J Viral Hepat. 2013 Jul;20(7):502-9. doi: 10.1111/jvh.12054. Epub 2013 Feb 6.
 
  Challenges in Cancer Vaccine Development for Hepatocellular Carcinoma
Buonaguro L, Petrizzo A, Tagliamonte M, Lina Tornesello M, Buonaguro FM. J Hepatol. 2013 May 25. pii: S0168-8278(13)00363-2. doi: 10.1016/j.jhep.2013.05.031. [Epub ahead of print]
 
  Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus
Hu Y, Chen J, Wen J, Xu C, Zhang S, Xu B, Zhou YH. BMC Pregnancy Childbirth. 2013 May 24;13(1):119. [Epub ahead of print]
 
  Development of a non-invasive fibrosis test for chronic hepatitis B patients and comparison with other unpatented scores
Hsu CW, Liang KH, Huang SF, Tsao KC, Yeh CT. BMC Res Notes. 2013 May 27;6:212. doi: 10.1186/1756-0500-6-212.
 
  Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
Singal AK, Salameh H, Kuo YF, Fontana RJ. Aliment Pharmacol Ther. 2013 Jul;38(2):98-106. doi: 10.1111/apt.12344. Epub 2013 May 28.
 
  Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association
Hope VD, Eramova I, Capurro D, Donoghoe MC. Epidemiol Infect. 2013 May 29:1-17. [Epub ahead of print]
 
  Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B
Kim do Y, Chang HY, Lim SM, Kim SU, Park JY, Kim JK, Lee KS, Han KH, Chon CY, Ahn SH. Gut Liver. 2013 May;7(3):329-34. doi: 10.5009/gnl.2013.7.3.329. Epub 2013 Apr 9.
 
  Significance of viral status on recurrence of hepatitis B-related hepatocellular carcinoma after curative therapy: A meta-analysis
Qu LS, Liu JX, Kuai XL, Xu ZF, Jin F, Zhou GX. Hepatol Res. 2013 May 27. doi: 10.1111/hepr.12172. [Epub ahead of print]
 
  Entecavir plus adefovir rescue therapy for chronic hepatitis B patients after multiple treatment failures in real-life practice
Xu XH, Li GL, Qin Y, Li Q, He FQ, Li JY, Pan QR, Deng JY. Virol J. 2013 May 25;10(1):162. [Epub ahead of print]
 
  Deceased Organ Donor Screening for HIV, Hepatitis B, and Hepatitis C Viruses: A Survey of Organ Procurement Organization Practices
Theodoropoulos N, Jaramillo A, Ladner DP, Ison MG. Am J Transplant. 2013 May 24. doi: 10.1111/ajt.12260. [Epub ahead of print]
 
  High Levels of HBV after the Onset Lead to Chronic Infection in Patients with Acute Hepatitis B
Yotsuyanagi H, Ito K, Yamada N, Takahashi H, Okuse C, Yasuda K, Suzuki M, Moriya K, Mizokami M, Miyakawa Y, Koike K. Clin Infect Dis. 2013 May 23. [Epub ahead of print]
 
  Partial virological response to adefovir add-on Lamivudine rescue therapy in patients with Lamivudine-resistant chronic hepatitis B
Chon YE, Park JY, Ahn SH, Kim do Y, Han KH, Chon CY, Choi A, Kim SU. Digestion. 2013;87(3):196-203. doi: 10.1159/000348853. Epub 2013 May 9.
 
  Comparison of the AdvanSure HBV Real-time PCR Test with Three Other HBV DNA Quantification Assays
Kim H, Shin S, Oh EJ, Kahng J, Kim Y, Lee HK, Kwon HJ. Ann Clin Lab Sci. 2013 Spring;43(2):230-7.
 
  Breast feeding and immunoprophylaxis efficacy of mother-to-child transmission of hepatitis B virus
Zhang L, Gui X, Fan J, Wang B, Ji H, Yisilafu R, Li F, Zhou Y, Tong Y, Kong X, Ye P, Zong L. J Matern Fetal Neonatal Med. 2013 Jun 20. [Epub ahead of print]
 
  Progression from Excessive to Deficient Syndromes in Chronic Hepatitis B: A Dynamical Network Analysis of miRNA Array Data
Chen QL, Lu YY, Zhang GB, Song YN, Zhou QM, Zhang H, Zhang W, Su SB. Evid Based Complement Alternat Med. 2013;2013:945245. doi: 10.1155/2013/945245. Epub 2013 Apr 16.
 
  Differences in metabolites of different tongue coatings in patients with chronic hepatitis B
Zhao Y, Gou XJ, Dai JY, Peng JH, Feng Q, Sun SJ, Cao HJ, Zheng NN, Fang JW, Jiang J, Su SB, Liu P, Hu YY, Zhang YY. Evid Based Complement Alternat Med. 2013;2013:204908. doi: 10.1155/2013/204908. Epub 2013 Apr 17.
 
  Notes from the field: transmission of HBV among assisted-living-facility residents - virginia, 2012
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2013 May 17;62(19):389.
 
  Reversal of cirrhosis: An achievable goal of hepatitis B antiviral therapy
Liaw YF. J Hepatol. 2013 May 11. pii: S0168-8278(13)00333-4. doi: 10.1016/j.jhep.2013.05.007. [Epub ahead of print]
 
  Association between cytotoxic T-lymphocyte associated protein 4 gene +49 A/G polymorphism and chronic infection with hepatitis B virus: A meta-analysis
Xu H, Zhao M, He J, Chen Z. J Int Med Res. 2013 Jun;41(3):559-67. doi: 10.1177/0300060513483387. Epub 2013 May 13.
 
  Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma
Loomba R, Liu J, Yang HI, Lee MH, Lu SN, Wang LY, Iloeje UH, You SL, Brenner D, Chen CJ; REVEAL–HBV Study Group. Clin Gastroenterol Hepatol. 2013 May 10. pii: S1542-3565(13)00618-6. doi: 10.1016/j.cgh.2013.04.043. [Epub ahead of print]
 
  Treatment of patients with dual hepatitis C and B by peginterferon ? and ribavirin reduced risk of hepatocellular carcinoma and mortality
Liu CJ, Chu YT, Shau WY, Kuo RN, Chen PJ, Lai MS. Gut. 2013 May 15. [Epub ahead of print]
 
  Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings
Xu DZ, Wang XY, Shen XL, Gong GZ, Ren H, Guo LM, Sun AM, Xu M, Li LJ, Guo XH, Zhen Z, Wang HF, Gong HY, Xu C, Jiang N, Pan C, Gong ZJ, Zhang JM, Shang J, Xu J, Xie Q, Wu TF, Huang WX, Li YG, Xu J, Yuan ZH, Wang B, Zhao K, Wen YM; for the YIC Efficacy Trial Study Team. J Hepatol. 2013 May 11. pii: S0168-8278(13)00295-X. doi: 10.1016/j.jhep.2013.05.003. [Epub ahead of print]
 
  Antiviral activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B virus
Lee DK, Kang JY, Shin HS, Park IH, Ha NJ. Arch Pharm Res. 2013 May 9. [Epub ahead of print]
 
  Management of Hepatitis B: My Practice and how it relates to the Guidelines
Yapali S, Talaat N, Lok AS. Clin Gastroenterol Hepatol. 2013 May 6. pii: S1542-3565(13)00606-X. doi: 10.1016/j.cgh.2013.04.036. [Epub ahead of print]
 
  Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection
Biswas S, Candotti D, Allain JP. J Virol. 2013 May 8. [Epub ahead of print]
 
  Treatment and non-treatment related ocular manifestations in patients with chronic hepatitis B or C
Tsoumani A, Theopistos V, Katsanos K, Asproudis I, Tsianos EV. Eur Rev Med Pharmacol Sci. 2013 Apr;17(8):1123-31.
 
  The comparison of the efficacy of pegylated interferon ?-2a and ?-2b in chronic hepatitis B patients
Dogan UB, Golge N, Akin MS. Eur J Gastroenterol Hepatol. 2013 May 4. [Epub ahead of print]
 
  Association of polymorphisms in the interleukin-4 gene with response to hepatitis B vaccine and susceptibility to hepatitis B virus infection: A meta-analysis
Cui W, Sun CM, Deng BC, Liu P. Gene. 2013 Aug 1;525(1):35-40. doi: 10.1016/j.gene.2013.04.065. Epub 2013 May 4.
 
  The effect of coffee consumption on the development of hepatocellular carcinoma in hepatitis B virus endemic area
Jang ES, Jeong SH, Lee SH, Hwang SH, Ahn SY, Lee J, Park YS, Hwang JH, Kim JW, Kim N, Lee DH, Kim HY. Liver Int. 2013 Apr 4. doi: 10.1111/liv.12186. [Epub ahead of print]
 
  Virologic response during up to 2 years of entecavir plus adefovir combination therapy in multiple drug-refractory chronic hepatitis B patients: A Randomized Trial.
Lim YS, Lee JY, Lee D, Shim JH, Lee HC, Lee YS, Suh DJ. Antimicrob Agents Chemother. 2013 May 6. [Epub ahead of print]
 
  Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma
Nishikawa H, Osaki Y, Arimoto A, Kita R, Kimura T. Anticancer Res. 2013 May;33(5):2211-9.
 
  Education Provides Significant Benefits to Patients with Hepatitis B Virus or Hepatitis C Virus Infection: A Systematic Review
Shah HA, Abu-Amara M. Clin Gastroenterol Hepatol. 2013 Apr 29. pii: S1542-3565(13)00584-3. doi: 10.1016/j.cgh.2013.04.024. [Epub ahead of print]
 
  Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with peginterferon alfa-2a and adefovir
Takkenberg RB, Jansen L, de Niet A, Zaaijer HL, Weegink CJ, Terpstra V, Dijkgraaf MG, Molenkamp R, Jansen PL, Koot M, Rijckborst V, Janssen HL, Beld MG, Reesink HW. Antivir Ther. 2013 May 2. doi: 10.3851/IMP2580. [Epub ahead of print]
 
  Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B
Zhang L, Hao CQ, Liu JF, Wang M. Virol J. 2013 Apr 29;10:134. doi: 10.1186/1743-422X-10-134.
 
  High Prevalence of Occult Hepatitis C Virus Infection in Patients with Chronic Hepatitis B Virus Infection
Castillo I, Bartolomé J, Quiroga JA, Carreño V. J Med Microbiol. 2013 May 2. [Epub ahead of print]
 
  Cesarean Section Reduces Perinatal Transmission of HBV Infection from Hepatitis B Surface Antigen-Positive Women to Their Infants
Pan CQ, Zou HB, Chen Y, Zhang X, Zhang H, Li J, Duan Z. Clin Gastroenterol Hepatol. 2013 Apr 29. pii: S1542-3565(13)00586-7. doi: 10.1016/j.cgh.2013.04.026. [Epub ahead of print]
 
  Early serum hepatitis B virus large surface protein level: A stronger predictor of virological response to peginterferon alfa-2a than that to entecavir in HBeAg-positive patients with chronic hepatitis B
Zhu X, Gong Q, Yu D, Zhang D, Gu L, Han Y, Chen J, Zhang Y, Zhang X. J Clin Virol. 2013 Apr 29. pii: S1386-6532(13)00123-6. doi: 10.1016/j.jcv.2013.04.003. [Epub ahead of print]
 
  Country of birth and other factors associated with hepatitis B prevalence in a population with high levels of immigration
Reekie J, Gidding HF, Kaldor JM, Liu B. J Gastroenterol Hepatol. 2013 Apr 26. doi: 10.1111/jgh.12245. [Epub ahead of print]
 
  Are liver transplant recipients protected against hepatitis a and B?
Andersson D, Castedal M, Friman V. Transplant Proc. 2013 Apr;45(3):1193-7. doi: 10.1016/j.transproceed.2012.10.012.
 
  Excellent liver transplantation survival and prevention of hepatitis B recurrence using hepatitis B immunoglobulin and nucleoside or nucleotide analogue along with treating physician adherence to treatment protocol
Lindenger C, Castedal M, Cahlin C, Friman S. Transplant Proc. 2013 Apr;45(3):1188-92. doi: 10.1016/j.transproceed.2012.10.007.
 
  Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections
Vermeulen M, Coleman C, Mitchel J, Reddy R, van Drimmelen H, Ficket T, Lelie N. Transfusion. 2013 Apr 29. doi: 10.1111/trf.12218. [Epub ahead of print]
 
  Prevalence of occult hepatitis B virus infection in hemodialysis patients
Yoo JH, Hwang SG, Yang DH, Son MS, Kwon CI, Ko KH, Hong SP, Park PW, Rim KS. Korean J Gastroenterol. 2013 Apr 25;61(4):209-14.
 
  Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review
Lieveld FI, van Vlerken LG, Siersema PD, van Erpecum KJ. Ann Hepatol. 2013 May-Jun;12(3):380-91.
 
  Lack of correlation between the antibody to hepatitis B core antigen and survival after surgical resection for hepatitis C virus-related hepatocellular carcinoma
Nishikawa H, Arimoto A, Wakasa T, Kita R, Kimura T, Osaki Y. Oncol Rep. 2013 Apr 24. doi: 10.3892/or.2013.2422. [Epub ahead of print]
 
  Dynamics of lamivudine-resistant hepatitis B virus strains in patients with entecavir rescue therapy
Deng XL, Li QL, Guo JJ. Virus Genes. 2013 Apr 25. [Epub ahead of print]
 
  Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants
Yang SC, Lee CM, Hu TH, Wang JH, Lu SN, Hung CH, Changchien CS, Chen CH. J Antimicrob Chemother. 2013 Apr 25. [Epub ahead of print]
 
  The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis
Yu S, Jianqin H, Wei W, Jianrong H, Yida Y, Jifang S, Liang Y, Zhi C, Hongyu J. Ann Hepatol. 2013 May-Jun;12(3):364-72.
 
  Extended treatment with peginterferon ?-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion
Cao ZH, Ma LN, Zhang HW, Liu YL, Chen XY. J Dig Dis. 2013 Apr 25. doi: 10.1111/1751-2980.12065. [Epub ahead of print]
 
  Contributing factors to colorectal cancer and hepatitis B screening among vietnamese americans
Nguyen-Truong CK, Lee-Lin F, Gedaly-Duff V. Oncol Nurs Forum. 2013 May 1;40(3):238-51. doi: 10.1188/13.ONF.238-251.
 
  Dried blood spot sampling for hepatitis B virus serology and molecular testing
Mohamed S, Raimondo A, Pénaranda G, Camus C, Ouzan D, Ravet S, Bourlière M, Khiri H, Dukan P, Olive D, Halfon P. PLoS One. 2013 Apr 16;8(4):e61077. doi: 10.1371/journal.pone.0061077. Print 2013.
 
  Association between Interferon-Inducible Protein 6 (IFI6) Polymorphisms and Hepatitis B Virus Clearance
Park GH, Kim KY, Cho SW, Cheong JY, Yu GI, Shin DH, Kwack KB. Genomics Inform. 2013 Mar;11(1):15-23. doi: 10.5808/GI.2013.11.1.15. Epub 2013 Mar 31.
 
  Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the chinese experience from 1999 to 2010
Hu Z, Zhou J, Wang H, Zhang M, Li S, Huang Y, Wu J, Li Z, Zhou L, Zheng S. PLoS One. 2013 Apr 16;8(4):e61620. doi: 10.1371/journal.pone.0061620. Print 2013.
 
  Non-Hodgkin lymphomas and carrier state of viral hepatitis B and C
Grudeva-Popova J, Nenova I, Mateva N, Ananoshtev N, Popov V, Atanasova M. J BUON. 2013 Jan-Mar;18(1):239-44.
 
  Increasing hepatitis B screening for hmong adults: results from a randomized controlled community-based study
Chen MS Jr, Fang DM, Stewart SL, Ly MY, Lee S, Dang JH, Nguyen TT, Maxwell AE, Bowlus CL, Bastani R, Nguyen TT. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):782-91. doi: 10.1158/1055-9965.EPI-12-1399. Epub 2013 Apr 23.
 
  Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients
Lin YJ, Lee MH, Yang HI, Jen CL, You SL, Wang LY, Lu SN, Liu J, Chen CJ. PLoS One. 2013 Apr 17;8(4):e61448. doi: 10.1371/journal.pone.0061448. Print 2013.
 
  Antiviral therapy after curative treatment of hepatitis B/C virus-related hepatocellular carcinoma: A systematic review of randomized trials.
Sun P, Yang X, He RQ, Hu QG, Song ZF, Xiong J, Zheng QC. Hepatol Res. 2013 Apr 2. doi: 10.1111/hepr.12115. [Epub ahead of print]
 
  Advance in molecular diagnostic tools for hepatitis B virus detection
Pazienza V, Niro GA, Fontana R, Vinciguerra M, Andriulli A. Clin Chem Lab Med. 2013 Apr 6:1-11. doi: 10.1515/cclm-2013-0136. [Epub ahead of print]
 
  Liver Imaging with a Novel Hepatitis B Surface Protein Derived SPECT-Tracer
Müller T, Mehrle S, Schieck A, Haberkorn U, Urban S, Mier W. Mol Pharm. 2013 May 3. [Epub ahead of print]
 
  Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma
Cho JY, Paik YH, Lim HY, Kim YG, Lim HK, Min YW, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Liver Int. 2013 Apr 2. doi: 10.1111/liv.12168. [Epub ahead of print]
 
  Optimal Testing of the Live Organ Donor for Blood-Borne Viral Pathogens: The Report of a Consensus Conference
Blumberg EA, Ison MG, Pruett TL, Segev DL; on behalf of the Optimal Testing of the Live Organ Donor Consensus Conference Participants. Am J Transplant. 2013 Apr 19. doi: 10.1111/ajt.12205. [Epub ahead of print]
 
  Molecular virology of chronic hepatitis B and C: Parallels, contrasts and impact on drug development and treatment outcome
Delaney WE 4th. Antiviral Res. 2013 Apr 18. pii: S0166-3542(13)00096-X. doi: 10.1016/j.antiviral.2013.04.010. [Epub ahead of print]
 
  Association of the rs3077 and rs9277535 polymorphisms in HLA-DP with hepatitis B virus infection and spontaneous clearance: A meta-analysis
Zhang XL, Ni XC, Jia JH, Dong JH, Yu FX, Ma N, Liu XH, Li M, Liu DW. Scand J Gastroenterol. 2013 Apr 22. [Epub ahead of print]
 
  Diagnostic accuracy of hepatic venous pressure gradient measurement in the prediction of stage 1 compensated liver cirrhosis in patients with chronic hepatitis B
Suk KT, Kim HC, Namkung S, Han SH, Choi KC, Park SH, Sung HT, Kim CH, Kim SH, Ham YL, Kang HM, Kim DJ. Eur J Gastroenterol Hepatol. 2013 Apr 18. [Epub ahead of print]
 
  Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B
Tanaka E, Matsumoto A. Hepatol Res. 2013 Mar 8. doi: 10.1111/hepr.12108. [Epub ahead of print]
 
  Diagnostic accuracy of hepatic venous pressure gradient measurement in the prediction of stage 1 compensated liver cirrhosis in patients with chronic hepatitis B
Suk KT, Kim HC, Namkung S, Han SH, Choi KC, Park SH, Sung HT, Kim CH, Kim SH, Ham YL, Kang HM, Kim DJ. Eur J Gastroenterol Hepatol. 2013 Apr 18. [Epub ahead of print]
 
  Does Guasha Offer Hepatoprotective Effect to Chronic Inactive Hepatitis B Carriers? A Built-in Design to Control Subject Expectation
Chan ST, Yuen JW, Gohel MD, Wong HC, Chung CP, Sun Y, Ng JN, Lie R, Kwong KK. J Altern Complement Med. 2013 Apr 11. [Epub ahead of print]
 
  Association between gene polymorphisms of IL-28 and response to lamivudine in Chinese rural patients with chronic hepatitis B
Yu F, Wang Y, Yuan S, Ma J, Ma N, Zhang X, Liu X, Liu D. Scand J Gastroenterol. 2013 Apr 16. [Epub ahead of print]
 
  Impact of peginterferon alpha-2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B
Hagiwara S, Kudo M, Osaki Y, Matsuo H, Inuzuka T, Matsumoto A, Tanaka E, Sakurai T, Ueshima K, Inoue T, Yada N, Nishida N. J Med Virol. 2013 Jun;85(6):987-95. doi: 10.1002/jmv.23564.
 
  Reactivation of hepatitis B virus associated with chemotherapy and immunosuppressive agent
Wijaya I, Hasan I. Acta Med Indones. 2013 Jan;45(1):61-6.
 
  Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice
Salpini R, Alteri C, Cento V, Pollicita M, Micheli V, Gubertini G, De Sanctis GM, Visca M, Romano S, Sarrecchia C, Andreoni M, Angelico M, Parruti G, Svicher V, Perno CF. J Med Virol. 2013 Jun;85(6):996-1004. doi: 10.1002/jmv.23567.
 
  Coinfection with Hepatitis B and D: Epidemiology, Prevalence and Disease in Patients in Northern California
Gish RG, Yi DH, Kane S, Clark M, Mangahas M, Baqai S, Winters MA, Proudfoot J, Glenn JS. J Gastroenterol Hepatol. 2013 Apr 11. doi: 10.1111/jgh.12217. [Epub ahead of print]
 
  Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study
Marcellin P, Arama V, Leblebicioglu H, Zarski JP, Zeuzem S, Mauss S, Sieklucki J, Acalovschi M, Usluer G, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Simon K; the AI; Longitudinal Study Group. Antivir Ther. 2013 Apr 10. doi: 10.3851/IMP2573. [Epub ahead of print]
 
  Long-term therapy for chronic hepatitis B: HBV DNA suppression leading to cirrhosis reversal
Marcellin P, Asselah T. J Gastroenterol Hepatol. 2013 Apr 11. doi: 10.1111/jgh.12213. [Epub ahead of print]
 
  Peginterferon-2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients: a pilot study
Huang Z, Deng H, Zhao Q, Zheng Y, Peng L, Lin C, Zhao Z, Gao Z.
 
  Hepatitis B and C infection in international travelers
Johnson DF, Leder K, Torresi J. J Travel Med. 2013 May;20(3):194-202. doi: 10.1111/jtm.12026. Epub 2013 Apr 4.
 
  Liver transplantation in hepatitis B core negative recipients using livers from hepatitis B core positive donor: 13 years experience
Bohorquez HE, Cohen AJ, Girgrah N, Bruce DS, Carmody IC, Joshi S, Reichman TW, Therapondos G, Mason AL, Loss GE. Liver Transpl. 2013 Mar 22. doi: 10.1002/lt.23644. [Epub ahead of print]
 
  Significance of anti-HBc only in blood donors: a serological and virological study after hepatitis B vaccination
Gessoni G, Beggio S, Barin P, Favarato M, Galli C, Valverde S, Nata MB, Salvadego MM, Marchiori G. Blood Transfus. 2013 Feb 21:1-6. doi: 10.2450/2013.0227-12. [Epub ahead of print]
 
  Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease
Chen FW, Coyle L, Jones BE, Pattullo V. Liver Int. 2013 Mar 2. doi: 10.1111/liv.12154. [Epub ahead of print]
 
  Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B
Tanaka M, Suzuki F, Seko Y, Hara T, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H. J Gastroenterol. 2013 Mar 26. [Epub ahead of print]
 
  Update in the management of chronic hepatitis B
Tujios SR, Lee WM. Curr Opin Gastroenterol. 2013 May;29(3):250-6. doi: 10.1097/MOG.0b013e32835ff1e9.
 
  Adefovir treatment for chronic hepatitis B in heart transplant recipients
Durante-Mangoni E, Iossa D, Pinto D, Molaro R, Agrusta F, Amarelli C, Ragone E, Grimaldi M, Maiello C, Utili R. Clin Transplant. 2013 Mar 21. doi: 10.1111/ctr.12109. [Epub ahead of print]
 
  Assessing Adherence to Accepted National Guidelines for Immigrant and Refugee Screening and Vaccines in an Urban Primary Care Practice: A Retrospective Chart Review
Waldorf B, Gill C, Crosby SS. J Immigr Minor Health. 2013 Mar 20. [Epub ahead of print]
 
  Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection
Gressner OA, Fang M, Li H, Lu LG, Gressner AM, Gao CF. Clin Chim Acta. 2013 Mar 15;421C:126-131. doi: 10.1016/j.cca.2013.02.029. [Epub ahead of print]
 
  Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive, nucleoside-naive patients treated with entecavir
Gish RG, Chang TT, Lai CL, de Man RA, Gadano A, Llamoso C, Tang H. Antivir Ther. 2013 Mar 19. doi: 10.3851/IMP2559. [Epub ahead of print]
 
  The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients
Erdogan S, Dogan HO, Sezer S, Uysal S, Ozhamam E, Kayacetin S, Koca Y. Scand J Clin Lab Invest. 2013 Mar 20. [Epub ahead of print]
 
  APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B
Ucar F, Sezer S, Ginis Z, Ozturk G, Albayrak A, Basar O, Ekiz F, Coban S, Yuksel O, Armutcu F, Akbal E. Eur J Gastroenterol Hepatol. 2013 Mar 18. [Epub ahead of print]
 
  Immunoglobulin g4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review
Zhao XY, Rakhda MI, Wang TI, Jia JD. Transplant Proc. 2013 Mar;45(2):824-7. doi: 10.1016/j.transproceed.2012.02.049.
 
  Role of maternal viremia and placental infection in hepatitis B virus intrauterine transmission
Chen Y, Wang L, Xu Y, Liu X, Li S, Qian Q, Hu B, Zhou A, Chen T, Zhao Y. Microbes Infect. 2013 Mar 14. pii: S1286-4579(13)00037-3. doi: 10.1016/j.micinf.2013.02.008. [Epub ahead of print]
 
  Association Between Metabolic Syndrome and Its Individual Components With Viral Hepatitis B
Jinjuvadia R, Liangpunsakul S. Am J Med Sci. 2013 Mar 19. [Epub ahead of print]
 
  Occult hepatitis B virus infection as a cause of posttransfusion hepatitis in patients with cancers
Sodhi JS, Wani N, Jeelani S, Geelani S, Akhtar F, Javid G, Yattoo GN, Shah A, Gulzar GM, Khan MA, Parveen S, Saif RU, Showkat A. Indian J Gastroenterol. 2013 Mar 20. [Epub ahead of print]
 
  Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
Marcellin P, Bonino F, Yurdaydin C, Hadziyannis S, Moucari R, Kapprell HP, Rothe V, Popescu M, Brunetto MR. Hepatol Int. 2013 Mar;7(1):88-97. Epub 2012 Mar 23.
 
  Prediction models of long-term cirrhosis and HCC risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles
Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ; for the R.E.V.E.A.L.-HBV Study Group. Hepatology. 2013 Mar 15. doi: 10.1002/hep.26385. [Epub ahead of print]
 
  Mother-to-Infant Transmission of Hepatitis B Virus Infection: Significance of Maternal Viral Load and Strategies for Intervention
Wen WH, Chang MH, Zhao LL, Ni YH, Hsu HY, Wu JF, Chen PJ, Chen DS, Chen HL. J Hepatol. 2013 Feb 25. pii: S0168-8278(13)00137-2. doi: 10.1016/j.jhep.2013.02.015. [Epub ahead of print]
 
  Individualized treatment of HBeAg-negative CHB using peg-interferon alfa-2a as first-line and week 12 HBV-DNA\HBsAg stopping rule. A cost-effectiveness analysis
Iannazzo S, Coco B, Brunetto MR, Rossetti F, Caputo A, Latour A, Espinos B, Bonino F.
 
  Ocular effects of pegylated interferon-? in patients with chronic hepatitis B
Koktekir BE, Sumer S, Bakbak B, Gedik S, Gonul S, Ural O. Cutan Ocul Toxicol. 2013 Mar 12. [Epub ahead of print]
 
  Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus Infection
Gatanaga H, Hayashida T, Tanuma J, Oka S. Clin Infect Dis. 2013 Mar 28. [Epub ahead of print]
 
  Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy
Saitta C, Musolino C, Marabello G, Martino D, Leonardi MS, Pollicino T, Altavilla G, Raimondo G. Dig Liver Dis. 2013 Mar 11. pii: S1590-8658(13)00042-X. doi: 10.1016/j.dld.2013.01.022. [Epub ahead of print]
 
  Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence
Yan Q, Ni J, Zhang GL, Yao X, Yuan WB, Zhou L, Zheng SS. Chin Med J (Engl). 2013 Mar;126(5):855-9.
 
  Telbivudine treatment in chronic hepatitis B: experience from China
You H, Jia J. J Viral Hepat. 2013 Apr;20 Suppl 1:3-8. doi: 10.1111/jvh.12058.
 
  Acute Hepatitis B in an Urban Tertiary Care Hospital in the United States: A Cohort Evaluation
Sharif O, Krishnan PV, Thekdi AD, Gordon SC. J Clin Gastroenterol. 2013 Mar 6. [Epub ahead of print]
 
  Efficacy of Entecavir Treatment for up to 5 Years in Nucleos(t)ide-Naïve Chronic Hepatitis B Patients in Real Life
Luo J, Li X, Wu Y, Lin G, Pang Y, Zhang X, Ao Y, Du Z, Zhao Z, Chong Y. Int J Med Sci. 2013;10(4):427-33. doi: 10.7150/ijms.5472. Epub 2013 Mar 1.
 
  Differential Plasma MicroRNA Profiles in HBeAg Positive and HBeAg Negative Children with Chronic Hepatitis B
Winther TN, Bang-Berthelsen CH, Heiberg IL, Pociot F, Hogh B. PLoS One. 2013;8(3):e58236. doi: 10.1371/journal.pone.0058236. Epub 2013 Mar 4.
 
  Reduction of hepatitis B surface antigen levels and HBsAg seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy
Seto WK, Wong DK, Fung J, Huang FY, Lai CL, Yuen MF. Hepatology. 2013 Mar 6. doi: 10.1002/hep.26376. [Epub ahead of print]
 
  IL28B Polymorphism Correlates with Active Hepatitis in Patients with HBeAg-Negative Chronic Hepatitis B
Lee IC, Lin CH, Huang YH, Huo TI, Su CW, Hou MC, Huang HC, Lee KC, Chan CC, Lin MW, Lin HC, Lee SD. PLoS One. 2013;8(2):e58071. doi: 10.1371/journal.pone.0058071. Epub 2013 Feb 28.
 
  Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis
Han Z, Shi Y, Zhu J, Chen Y, Yin F, Xia L, Luo G, Gao Z, Liu J, Jia G, Li C, Zhou X, Han Y. J Viral Hepat. 2013 Apr;20 Suppl 1:58-64. doi: 10.1111/jvh.12065.
 
  Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study
Huang Z, Zhao Z, Zheng Y, Peng L, Lin C, Deng H, Gao Z. J Viral Hepat. 2013 Apr;20 Suppl 1:52-7. doi: 10.1111/jvh.12064.
 
  Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil
Li Y, Zhang Y, Wang JP, Lian JQ, Bai XF. J Viral Hepat. 2013 Apr;20 Suppl 1:46-51. doi: 10.1111/jvh.12063.
 
  Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy
Liu M, Cai H, Yi W. J Viral Hepat. 2013 Apr;20 Suppl 1:65-70. doi: 10.1111/jvh.12066.
 
  Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil
Lu JJ, Liu K, Ma YJ, Wang J, Chen EQ, Tang H. J Viral Hepat. 2013 Apr;20 Suppl 1:40-5. doi: 10.1111/jvh.12062.
 
  Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients
Wang GQ, Ding YP, Dong YH. J Viral Hepat. 2013 Apr;20 Suppl 1:9-17. doi: 10.1111/jvh.12059.
 
  Hepatitis B
Tong MJ, Trieu J. J Dig Dis. 2013 Feb 21. doi: 10.1111/1751-2980.12051. [Epub ahead of print]
 
  Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy
Cheung KW, Seto MT, Wong SF. Eur J Obstet Gynecol Reprod Biol. 2013 Mar 4. pii: S0301-2115(13)00087-0. doi: 10.1016/j.ejogrb.2013.02.001. [Epub ahead of print]
 
  Post-transplantation sequential entecavir monotherapy following 1-year combination therapy with hepatitis B immunoglobulin
Yi NJ, Choi JY, Suh KS, Cho JY, Baik M, Hong G, Lee KW, Kim W, Kim YJ, Yoon JH, Lee HS, Kim DG. J Gastroenterol. 2013 Mar 6. [Epub ahead of print]
 
  Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation
Seo JY, Kim W, Kwon JH, Jin EH, Yu SJ, Kim HY, Jung YJ, Kim D, Kim YJ, Yoon JH, Lee HS. Liver Int. 2013 Jan 30. doi: 10.1111/liv.12132. [Epub ahead of print]
 
  Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure
Duan XZ, Liu FF, Tong JJ, Yang HZ, Chen J, Liu XY, Mao YL, Xin SJ, Hu JH. World J Gastroenterol. 2013 Feb 21;19(7):1104-10. doi: 10.3748/wjg.v19.i7.1104.
 
  Use of the International Classification of Diseases, 9th revision, coding in identifying chronic hepatitis B virus infection in health system data: implications for national surveillance
Mahajan R, Moorman AC, Liu SJ, Rupp L, Klevens RM; for the Chronic Hepatitis Cohort Study (CHeCS) investigators*. J Am Med Inform Assoc. 2013 Mar 5. [Epub ahead of print]
 
  Expression of Interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection
Du WJ, Zhen JH, Zeng ZQ, Zheng ZM, Xu Y, Qin LY, Chen SJ. Diagn Pathol. 2013 Feb 28;8:40. doi: 10.1186/1746-1596-8-40.
 
  A randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal post-liver transplant
Teperman LW, Poordad F, Bzowej N, Martin P, Pungpapong S, Schiano T, Flaherty J, Dinh P, Rossi S, Subramanian GM, Spivey J. Liver Transpl. 2013 Feb 27. doi: 10.1002/lt.23628. [Epub ahead of print]
 
  Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
Su TH, Liu CJ, Tseng TC, Liu CH, Yang HC, Chen CL, Chen PJ, Kao JH, Chen DS. PLoS One. 2013;8(2):e55916. doi: 10.1371/journal.pone.0055916. Epub 2013 Feb 20.
 
  Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates
Gane EJ, Patterson S, Strasser SI, McCaughan GW, Angus PW. Liver Transpl. 2013 Mar;19(3):268-74. doi: 10.1002/lt.23600.
 
  Prevention of mother-to-child transmission of hepatitis B virus (HBV) during pregnancy and the puerperium: Current standards of care
Giles ML, Grace R, Tai A, Michalak K, Walker SP. Aust N Z J Obstet Gynaecol. 2013 Mar 4. doi: 10.1111/ajo.12061. [Epub ahead of print]
 
  NK cells: a double-edged sword in chronic hepatitis B virus infection
Maini MK, Peppa D. Front Immunol. 2013;4:57. doi: 10.3389/fimmu.2013.00057. Epub 2013 Mar 1.
 
  Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C
Efe C, Wahlin S, Ozaslan E, Purnak T, Muratori L, Quarneti C, Tatar G, Simsek H, Muratori P, Schiano TD. Scand J Gastroenterol. 2013 Mar 1. [Epub ahead of print]
 
  Efficacy of entecavir switch therapy in chronic hepatitis B patients with incomplete virological response to telbivudine
Lo AO, Wong VW, Wong GL, Chan HY, Cheung CM, Chan HL. Antivir Ther. 2013 Mar 5. doi: 10.3851/IMP2526. [Epub ahead of print]
 
  Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
Takaki A, Yagi T, Yasunaka T, Sadamori H, Shinoura S, Umeda Y, Yoshida R, Sato D, Nobuoka D, Utsumi M, Yasuda Y, Nakayama E, Miyake Y, Ikeda F, Shiraha H, Nouso K, Fujiwara T, Yamamoto K. J Gastroenterol. 2013 Feb 23. [Epub ahead of print]
 
  Risk of Pancreatic Cancer in Relation to ABO Blood Group and Hepatitis C Virus Infection in Korea: A Case-Control Study
Woo SM, Joo J, Lee WJ, Park SJ, Han SS, Kim TH, Koh YH, Kim HB, Hong EK. J Korean Med Sci. 2013 Feb;28(2):247-51. doi: 10.3346/jkms.2013.28.2.247. Epub 2013 Jan 29.
 
  Abnormal regional homogeneity of resting-state brain activity in patients with HBV-related cirrhosis without overt hepatic encephalopathy
Lv XF, Qiu YW, Tian JZ, Xie CM, Han LJ, Su HH, Liu ZY, Peng JP, Lin CL, Wu MS, Jiang GH, Zhang XL. Liver Int. 2013 Mar;33(3):375-83. doi: 10.1111/liv.12096.
 
  Cost-minimization analysis of the U.S. Army accession screening and immunization program
Tzeng J, Jankosky C, Hughes H. Mil Med. 2012 Dec;177(12):1508-12.
 
  Association of cytokine gene polymorphisms and serum concentrations with the outcome of chronic hepatitis B
Conde SR, Feitosa RN, Freitas FB, Hermes RB, Demachki S, Araújo MT, Soares MC, Ishak R, Vallinoto AC. Cytokine. 2013 Feb 5. pii: S1043-4666(13)00034-3. doi: 10.1016/j.cyto.2013.01.004. [Epub ahead of print]
 
  Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C
Sturm N, Marlu A, Arvers P, Zarski JP, Leroy V. Liver Int. 2013 Mar;33(3):428-38. doi: 10.1111/liv.12092.
 
  Chronic hepatitis B: What should be the goal for new therapies?
Block TM, Gish R, Guo H, Mehta A, Cuconati A, Thomas London W, Guo JT. Antiviral Res. 2013 Feb 4. pii: S0166-3542(13)00021-1. doi: 10.1016/j.antiviral.2013.01.006. [Epub ahead of print]
 
  Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection
Kondo Y, Ninomiya M, Kakazu E, Kimura O, Shimosegawa T. ISRN Gastroenterol. 2013;2013:935295. doi: 10.1155/2013/935295. Epub 2013 Jan 16.
 
  Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?
Sherman M. Hepatology. 2013 Feb 11. doi: 10.1002/hep.26317. [Epub ahead of print]
 
  Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients
Tsuge M, Murakami E, Imamura M, Abe H, Miki D, Hiraga N, Takahashi S, Ochi H, Nelson Hayes C, Ginba H, Matsuyama K, Kawakami H, Chayama K. J Gastroenterol. 2013 Feb 9. [Epub ahead of print]
 
  Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma
Lao XM, Luo G, Ye LT, Luo C, Shi M, Wang D, Guo R, Chen M, Li S, Lin X, Yuan Y. Liver Int. 2013 Jan 12. doi: 10.1111/liv.12112. [Epub ahead of print]
 
  Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients
Martinot-Peignoux M, Carvalho-Filho R, Lapalus M, Netto-Cardoso AC, Lada O, Batrla R, Krause F, Asselah T, Marcellin P. J Hepatol. 2013 Jan 28. pii: S0168-8278(13)00075-5. doi: 10.1016/j.jhep.2013.01.028. [Epub ahead of print]
 
  Invasive fungal infections secondary to acute-on-chronic liver failure: a retrospective study
Lin LN, Zhu Y, Che FB, Gu JL, Chen JH. Mycoses. 2013 Feb 1. doi: 10.1111/myc.12044. [Epub ahead of print]
 
  Infectivity of blood products from donors with occult hepatitis B virus infection
Allain JP, Mihaljevic I, Gonzalez-Fraile MI, Gubbe K, Holm-Harritshøj L, Garcia JM, Brojer E, Erikstrup C, Saniewski M, Wernish L, Bianco L, Ullum H, Candotti D, Lelie N, Gerlich WH, Chudy M. Transfusion. 2013 Jan 30. doi: 10.1111/trf.12096. [Epub ahead of print]
 
  Evolving Frequency and Outcomes of Liver Transplantation Based on Etiology of Liver Disease
Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH. Transplantation. 2013 Jan 30. [Epub ahead of print]
 
  Comparative Efficacy of Oral Nucleoside or Nucleotide Analog Monotherapy Used in Chronic Hepatitis B: A Mixed-Treatment Comparison Meta-analysis
Wiens A, Lenzi L, Venson R, Correr CJ, Rotta I, Pedroso ML, Pontarolo R. Pharmacotherapy. 2013 Feb;33(2):144-51. doi: 10.1002/phar.1188. Epub 2013 Jan 28.
 
  Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis b with high baseline viral load (? 9 log10 copies/mL)
Gordon SC, Krastev Z, Horban A, Petersen J, Sperl J, Dinh P, Martins EB, Yee LJ, Flaherty JF, Kitrinos KM, Rustgi VK, Marcellin P. Hepatology. 2013 Jan 30. doi: 10.1002/hep.26277. [Epub ahead of print]
 
  Efficacy of 3 years of adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance
Song MN, Hong MZ, Luo DQ, Huang WQ, Min F, Fan RH, Wu WB, Zhang L. World J Hepatol. 2012 Dec 27;4(12):389-93. doi: 10.4254/wjh.v4.i12.389.
 
  Interferon-alpha plus adefovir combination therapy versus interferon-alpha monotherapy for chronic hepatitis B treatment: A meta-analysis
Huang R, Hao Y, Zhang J, Wu C. Hepatol Res. 2013 Jan 10. doi: 10.1111/hepr.12058. [Epub ahead of print]
 
  IL21 and IL21R polymorphisms and their interactive effects on serum IL-21 and IgE levels in patients with chronic hepatitis B virus infection
Li N, Zhu Q, Li Z, Han Q, Chen J, Lv Y, Wang Y, Zeng X, Chen Y, Yang C, Liu Z. Hum Immunol. 2013 Jan 24. pii: S0198-8859(13)00016-5. doi: 10.1016/j.humimm.2013.01.005. [Epub ahead of print]
 
  The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients
Ali S, Mealing S, Hawkins N, Lescrauwaet B, Bjork S, Mantovani L, Lampertico P. BMJ Open. 2013 Jan 24;3(1). pii: e001309. doi: 10.1136/bmjopen-2012-001309. Print 2013.
 
  Hepatitis B testing and access to care among racial and ethnic minorities in selected communities across the United States, 2009-2010
Hu DJ, Xing J, Tohme RA, Liao Y, Pollack H, Ward JW, Holmberg SD. Hepatology. 2013 Jan 28. doi: 10.1002/hep.26286. [Epub ahead of print]
 
  Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection
Ma J, Jiang Y, Gong G. Eur J Gastroenterol Hepatol. 2013 Jan 24. [Epub ahead of print]
 
  Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
Kwak MS, Kim D, Chung GE, Kang SJ, Park MJ, Kim YJ, Yoon JH, Lee HS. Clin Mol Hepatol. 2012 Dec;18(4):383-90. doi: 10.3350/cmh.2012.18.4.383. Epub 2012 Dec 21.
 
  Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China
Sun Z, Chen T, Thorgeirsson SS, Zhan Q, Chen J, Park JH, Lu P, Hsia CC, Wang N, Xu L, Lu L, Huang F, Zhu Y, Lu J, Ni Z, Zhang Q, Wu Y, Liu G, Wu Z, Qu C, Gail MH. Carcinogenesis. 2013 Jan 14. [Epub ahead of print]
 
  Efficacy of pegylated interferon alpha2a in patients without HBeAg loss after the withdrawal of long-term lamivudine therapy
Zhang XQ, Zhang HY, You JP, Mao Q. Virol J. 2013 Jan 15;10(1):21. [Epub ahead of print]
 
  Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues
Song ZL, Cui YJ, Zheng WP, Teng DH, Zheng H. World J Gastroenterol. 2012 Dec 28;18(48):7149-57. doi: 10.3748/wjg.v18.i48.7149.
 
  Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B?
Ceylan B, Fincanci M, Yardimci C, Eren G, Tözalgan U, Müderriso?lu C, Pa?ao?lu E. Eur J Gastroenterol Hepatol. 2013 Jan 15. [Epub ahead of print]
 
  Treatment strategies using adefovir dipivoxil for individuals with lamivudine-resistant chronic hepatitis B
Yun TJ, Jung JY, Kim CH, Um SH, An H, Seo YS, Kim JD, Yim HJ, Keum B, Kim YS, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS. World J Gastroenterol. 2012 Dec 21;18(47):6987-95. doi: 10.3748/wjg.v18.i47.6987.
 
  Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures
Kim YJ, Sinn DH, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. World J Gastroenterol. 2012 Dec 21;18(47):6996-7002. doi: 10.3748/wjg.v18.i47.6996.
 
  Telbivudine on-treatment HBsAg loss in naive HBeAg negative chronic hepatitis B: a case report and brief review of the literature
Bertino G, Ardiri AM, Calvagno GS, Bertino N, Ruggeri MI, Malaguarnera M, Malaguarnera G, Toro A, Di Carlo I. Clin Ter. 2012 Nov;163(6):e429-34.
 
  HBV infection increases the risk of pancreatic cancer: a meta-analysis
Luo G, Hao NB, Hu CJ, Yong X, Lü MH, Cheng BJ, Zhang Y, Yang SM. Cancer Causes Control. 2013 Jan 10. [Epub ahead of print]
 
  Knowledge and Behaviors Toward Hepatitis B and the Hepatitis B Vaccine in the Laotian Community in Minnesota
Xiong M, Nguyen RH, Strayer L, Chanthanouvong S, Yuan JM. J Immigr Minor Health. 2013 Jan 11. [Epub ahead of print]
 
  Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D
Boglione L, D'Avolio A, Cariti G, Gregori G, Burdino E, Baietto L, Cusato J, Ghisetti V, De Rosa FG, Perri GD. Liver Int. 2012 Dec 12. doi: 10.1111/liv.12091. [Epub ahead of print]
 
  Hepatitis B in immunosuppressed cancer patients: Pathogenesis, incidence and prophylaxis
Mandalà M, Fagiuoli S, Francisci D, Bruno R, Merelli B, Pasulo L, Tondini C, Labianca R, Roila F. Crit Rev Oncol Hematol. 2013 Jan 10. pii: S1040-8428(12)00250-8. doi: 10.1016/j.critrevonc.2012.12.004. [Epub ahead of print]
 
  Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance
Zoulim F, Locarnini S. Liver Int. 2013 Feb;33 Suppl 1:116-24. doi: 10.1111/liv.12069.
 
  Impact of therapy on the outcome of chronic hepatitis B
Liaw YF. Liver Int. 2013 Feb;33 Suppl 1:111-5. doi: 10.1111/liv.12057.
 
  Antiviral therapy for patients with chronic hepatitis B with multi-drug resistance to nucleoside analogues
Ozeki I, Hige S, Karino Y, Kimura M, Arakawa T, Nakajima T, Kuwata Y, Ohmura T, Sato T, Toyota J. Nihon Shokakibyo Gakkai Zasshi. 2013;110(1):44-55.
 
  IL28B GENOTYPE IS NOT USEFUL FOR PREDICTING TREATMENT OUTCOME IN ASIAN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGYLATED-INTERFERON-?
Holmes JA, Nguyen T, Ratnam D, Heerasing NM, Tehan JV, Bonanzinga S, Dev A, Bell S, Pianko S, Chen R, Visvanathan K, Hammond R, Iser D, Rusli F, Sievert W, Desmond PV, Bowden DS, Thompson AJ. J Gastroenterol Hepatol. 2013 Jan 9. doi: 10.1111/jgh.12110. [Epub ahead of print]
 
  The role of HBsAg quantification for monitoring natural history and treatment outcome
Martinot-Peignoux M, Lapalus M, Asselah T, Marcellin P. Liver Int. 2013 Feb;33 Suppl 1:125-32. doi: 10.1111/liv.12075.
 
  Outbreak of hepatitis B virus infections associated with assisted monitoring of blood glucose in an assisted living facility-virginia, 2010
Bender TJ, Wise ME, Utah O, Moorman AC, Sharapov U, Drobeniuc J, Khudyakov Y, Fricchione M, White-Comstock MB, Thompson ND, Patel PR. PLoS One. 2012;7(12):e50012. doi: 10.1371/journal.pone.0050012. Epub 2012 Dec 26.
 
  Trends in viral hepatitis cost-effectiveness studies
Saab S, Choi Y, Rahal H, Li K, Tong M. Am J Manag Care. 2012 Dec;18(12):790-8.
 
  Association of chronic liver disease with depression: a population-based study
Lee K, Otgonsuren M, Younoszai Z, Mir HM, Younossi ZM. Psychosomatics. 2013 Jan;54(1):52-9. doi: 10.1016/j.psym.2012.09.005.
 
  Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma
Yang Y, Xia T, Li N, Zhang J, Yang Y, Cong W, Deng Q, Lan K, Zhou W. Protein Cell. 2013 Jan;4(1):71-81. doi: 10.1007/s13238-012-2067-9. Epub 2012 Dec 22.
 
  Study on noninvasive laboratory tests for fibrosis in chronic HBV infection and their evaluation
Chen J, Liu C, Chen H, Liu Q, Yang B, Ou Q. J Clin Lab Anal. 2013 Jan;27(1):5-11. doi: 10.1002/jcla.21554. Epub 2013 Jan 4.
 
  Lack of association between hepatitis B virus pre-S mutations and recurrence after surgical resection in hepatocellular carcinoma
Heo NY, Lee HC, Park YK, Park JW, Lim YS, Kim KM, Shim JH, Lee YJ. J Med Virol. 2013 Jan 7. doi: 10.1002/jmv.23502. [Epub ahead of print]
 
  Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy
Kim BK, Oh HJ, Park JY, Kim do Y, Ahn SH, Han KH, Park Y, J Yoo E, Park YN, Kim SU. Liver Int. 2013 Feb;33(2):180-9. doi: 10.1111/liv.12020.
 
  Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial
Yim HJ, Seo YS, Yoon EL, Kim CW, Lee CD, Park SH, Lee MS, Park CK, Chae HB, Kim MY, Baik SK, Kim YS, Kim JH, Lee JI, Lee JW, Hong SP, Um SH. Liver Int. 2013 Feb;33(2):244-54. doi: 10.1111/liv.12036.
 
  Trends in viral hepatitis cost-effectiveness studies
Saab S, Choi Y, Rahal H, Li K, Tong M. Am J Manag Care. 2012 Dec;18(12):790-8.
 
  Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection
Li Z, Li N, Zhu Q, Zhang G, Han Q, Zhang P, Xun M, Wang Y, Zeng X, Yang C, Liu Z. Infect Genet Evol. 2013 Jan 2. pii: S1567-1348(12)00390-5. doi: 10.1016/j.meegid.2012.12.008. [Epub ahead of print]
 
  IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection
Li N, Zhu Q, Li Z, Han Q, Zhang G, Chen J, Lv Y, Xing F, Chen Y, Zeng X, Liu Z. Mol Carcinog. 2012 Dec 31. doi: 10.1002/mc.21992. [Epub ahead of print]
 
  Hepatitis B Screening in US Travelers Seen at the Boston Area Travel Medicine Network
Chen LH, Barnett ED, Wilson ME, Macleod W, Yanni EA, Ooi W, Karchmer AW, Kogelman L, Marano N, Hamer DH. J Travel Med. 2013 Jan;20(1):29-36. doi: 10.1111/jtm.12002.
 
  Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus
Yin Y, Wu L, Zhang J, Zhou J, Zhang P, Hou H. J Infect. 2012 Dec 31. pii: S0163-4453(12)00389-1. doi: 10.1016/j.jinf.2012.12.008. [Epub ahead of print]
 
  Evaluation of Hepatitis B Viraemia Levels in Patients with HBeAg-negative Chronic Hepatitis B Virus Infection
Atay AE, Seven G, Yalcin K, Pasa S, Degertekin H. J Int Med Res. 2012;40(5):1891-6.
 
  Antibody persistence and the effect of a booster dose given 5, 10 or 15years after vaccinating preadolescents with a recombinant hepatitis B vaccine
Gilca V, De Serres G, Boulianne N, Murphy D, De Wals P, Ouakki M, Trudeau G, Massé R, Dionne M. Vaccine. 2012 Dec 1. pii: S0264-410X(12)01630-1. doi: 10.1016/j.vaccine.2012.11.037. [Epub ahead of print]
 
  The Frequency of Adjusted Renal Dosing of Tenofovir DF and Its Effects on Patient Outcomes
Langness JA, Hindman JT, Johnson SC, Kiser JJ. J Pharm Pract. 2012 Dec 2. [Epub ahead of print]
 
  Liver stiffness measurement in cirrhotic patient - Implications of disease activity and treatment efficacy
Xu HW, Lu SN, Hung CH, Chang KC, Hu TH, Wang JH. Kaohsiung J Med Sci. 2012 Dec;28(12):641-8. doi: 10.1016/j.kjms.2012.04.032. Epub 2012 Aug 1.
 
  Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
Hosaka T, Suzuki F, Kobayashi M, Seko Y, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H. Hepatology. 2012 Dec 5. doi: 10.1002/hep.26180. [Epub ahead of print]
 
  Atypical serological profiles in hepatitis B virus infection
Pondé RA. Eur J Clin Microbiol Infect Dis. 2012 Nov 29. [Epub ahead of print]
 
  Public health issues of hepatitis C virus infection
Papatheodoridis G, Hatzakis A. Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):371-80. doi: 10.1016/j.bpg.2012.09.012.
 
  Hepatitis B-core Antibody Positive Donors in Liver Transplantation and Their Impact on Graft Survival: Evidence From The Liver Match Cohort Study
Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN. J Hepatol. 2012 Nov 27. pii: S0168-8278(12)00894-X. doi: 10.1016/j.jhep.2012.11.025. [Epub ahead of print]
 
  Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study
Lee SJ, Yim HJ, Hwang SG, Seo YS, Kim JH, Yoon EL, Lee JM, Kim BH, Park SJ, Park YM, Kim HS, Lee SH, Ahn SH, Lee JI, Lee JW, Kim IH, Kim HS, Hong SP. Scand J Gastroenterol. 2012 Nov 30. [Epub ahead of print]
 
  Reactivation of hepatitis viruses following immunomodulationg systemic chemotherapy
Watanabe T, Tanaka Y. Hepatol Res. 2012 Oct 30. doi: 10.1111/hepr.12014. [Epub ahead of print]
 
  The Short-Term Efficacy of Entecavir in Lamivudine-Resistant Chronic Hepatitis B: Influence of Sequential Adefovir-Refractoriness
Kim JH, Kim YS, Jung YK, Kim YS, Kwon OS, Ku YS, Choi DJ, Kim JH. Hepatogastroenterology. 2012 Nov 28;60(125). doi: 10.5754/hge12917. [Epub ahead of print]
 
  Reactivation of Hepatitis B Virus in Patients Receiving Chemotherapy
Ikeda M. Jpn J Clin Oncol. 2012 Nov 25. [Epub ahead of print]
 
  Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
Lin CW, Lin CC, Mo LR, Chang CY, Perng DS, Hsu CC, Lo GH, Chen YS, Yen YC, Hu JT, Yu ML, Lee PH, Lin JT, Yang SS. J Hepatol. 2012 Dec 6. pii: S0168-8278(12)00916-6. doi: 10.1016/j.jhep.2012.11.045. [Epub ahead of print]
 
  The Diversity and Management of Chronic Hepatitis B Virus Infections in the UK - A Wake up Call
Tedder RS, Rodger AJ, Fries L, Ijaz S, Thursz M, Rosenberg W, Naoumov N, Banatvala J, Williams R, Dusheiko G, Chokshi S, Wong T, Rosenberg G, Moreea S, Bassendine M, Jacobs M, Mills PR, Mutimer D, Ryder S, Bathgate A, Hussaini H, Dillon J, Wright M, Bird G, Collier J, Anderson M, Johnson A; for the CUSHIB Study Group. Clin Infect Dis. 2012 Dec 7. [Epub ahead of print]
 
  Long-term Hepatitis B Surface Antigen (HBsAg) Kinetics during Nucleoside/Nucleotide Analogue Therapy: Finite Treatment Duration Unlikely
Chevaliez S, Hézode C, Bahrami S, Grare M, Pawlotsky JM. J Hepatol. 2012 Dec 3. pii: S0168-8278(12)00909-9. doi: 10.1016/j.jhep.2012.11.039. [Epub ahead of print]
 
  Hepatitis B screening: who to target? A French Sexually Transmitted Infection Clinic Experience
Spenatto N, Boulinguez S, Mularczyk M, Molinier L, Bureau C, Saune K, Viraben R. J Hepatol. 2012 Dec 5. pii: S0168-8278(12)00914-2. doi: 10.1016/j.jhep.2012.11.044. [Epub ahead of print]
 
  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Schall RA, Bornstein JD, Kitrinos KM, Subramanian GM, McHutchison JG, Heathcote EJ. Lancet. 2012 Dec 7. pii: S0140-6736(12)61425-1. doi: 10.1016/S0140-6736(12)61425-1. [Epub ahead of print]
 
  Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma
Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, Ren WH, Long XD, Zhang H, Ma XP, Wang Z, Jiang W, Chen TY, Gao Y, Sun LD, Long JR, Huang HX, Wang D, Yu H, Zhang P, Tang LS, Peng B, Cai H, Liu TT, Zhou P, Liu F, Lin X, Tao S, Wan B, Sai-Yin HX, Qin LX, Yin J, Liu L, Wu C, Pei Y, Zhou YF, Zhai Y, Lu PX, Tan A, Zuo XB, Fan J, Chang J, Gu X, Wang NJ, Li Y, Liu YK, Zhai K, Zhang H, Hu Z, Liu J, Yi Q, Xiang Y, Shi R, Ding Q, Zheng W, Shu XO, Mo Z, Shugart YY, Zhang XJ, Zhou G, Shen H, Zheng SL, Xu J, Yu L. Nat Genet. 2012 Dec 16;45(1):72-5. doi: 10.1038/ng.2483. Epub 2012 Dec 16.
 
  Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion
Cheng Y, Guindon S, Rodrigo A, Wee LY, Inoue M, Thompson AJ, Locarnini S, Lim SG. Gut. 2012 Dec 15. [Epub ahead of print]
 
  Influence of Information Sources on Hepatitis B Screening Behavior and Relevant Psychosocial Factors Among Asian Immigrants
Tanaka M, Strong C, Lee S, Juon HS. J Immigr Minor Health. 2012 Dec 13. [Epub ahead of print]
 
  A Predictive Scoring System for the Seroclearance of HBsAg in HBeAg-seronegative Chronic Hepatitis B Patients with Genotype B or C Infection
Lee MH, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, Wang LY, You SL, Hsiao CK, Yang HI, Chen CJ. J Hepatol. 2012 Dec 12. pii: S0168-8278(12)00954-3. doi: 10.1016/j.jhep.2012.12.006. [Epub ahead of print]
 
  Safety of lamivudine treatment for chronic hepatitis B in early pregnancy
Yi W, Liu M, Cai HD. World J Gastroenterol. 2012 Dec 7;18(45):6645-50. doi: 10.3748/wjg.v18.i45.6645.
 
  Hepatitis B and C in liver transplantation: new strategies to combat the enem
Beckebaum S, Kabar I, Cicinnati VR. Rev Med Virol. 2012 Dec 13. doi: 10.1002/rmv.1734. [Epub ahead of print]
 
  Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
Petersen J, Buti M. Expert Rev Gastroenterol Hepatol. 2012 Dec;6(6):683-94. doi: 10.1586/egh.12.52.
 
  The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis
Zhang Q, Chen X, Zang Y, Zhang L, Chen H, Wang L, Niu Y, Ren X, Shen Z, Shang L. PLoS One. 2012;7(12):e50919. doi: 10.1371/journal.pone.0050919. Epub 2012 Dec 7.
 
  Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy
Watanabe R, Ishii T, Nakamura K, Shirai T, Tajima Y, Fujii H, Harigae H. Mod Rheumatol. 2012 Nov 21. [Epub ahead of print]
 
  The Efficacy of Adefovir Plus Entecavir Combination Therapy in Patients with Chronic Hepatitis B Refractory to Both Lamivudine and Adefovir
Cho Y, Lee DH, Chung KH, Jin E, Lee JH, Cho EJ, Yu SJ, Kim JW, Jeong SH, Yoon JH, Lee HS, Kim CY, Kim YJ. Dig Dis Sci. 2012 Nov 23. [Epub ahead of print]
 
  Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patients
Pan CQ, Hu KQ, Tsai N. Antivir Ther. 2012 Nov 23. doi: 10.3851/IMP2481. [Epub ahead of print]
 
  Influence of Age and HBeAg Status on the Correlation Between HBV DNA and Hepatic Inflammation and Fibrosis in Chronic Hepatitis B Patients
Bai H, Liu H, Chen X, Xu C, Dou X. Dig Dis Sci. 2012 Nov 22. [Epub ahead of print]
 
  Community Health Education at Student-Run Clinics Leads to Sustained Improvement in Patients' Hepatitis B Knowledge
Ouyang D, Yuan N, Sheu L, Lau G, Chen C, Lai CJ. J Community Health. 2012 Nov 18. [Epub ahead of print]
 
  Hepatitis B virus status and the risk of pancreatic cancer: a meta-analysis
Wang Y, Yang S, Song F, Cao S, Yin X, Xie J, Tu X, Xu J, Xu X, Dong X, Lu Z. Eur J Cancer Prev. 2012 Nov 16. [Epub ahead of print]
 
  Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-Naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma
Wang M, Qiu N, Lu S, Xiu D, Yu J, Wang XT, Lu F, Li T, Liu X, Zhuang H. J Med Virol. 2012 Nov 20. doi: 10.1002/jmv.23461. [Epub ahead of print]
 
  Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice
Liu A, Ha NB, Lin B, Yip B, Trinh HN, Nguyen HA, Nguyen KK, Ahmed A, Garcia G, Nguyen MH. Eur J Gastroenterol Hepatol. 2012 Nov 18. [Epub ahead of print]
 
  Long-term treatment efficacy and safety of clevudine therapy in naïve patients with chronic hepatitis B
Choung BS, Kim IH, Jeon BJ, Lee S, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG. Gut Liver. 2012 Oct;6(4):486-92. doi: 10.5009/gnl.2012.6.4.486. Epub 2012 Oct 18.
 
  How to manage HBeAg-negative chronic HBV infection with normal alanine aminotransferase levels in clinical practice?
Puoti C. Eur J Intern Med. 2012 Nov 17. pii: S0953-6205(12)00286-5. doi: 10.1016/j.ejim.2012.10.013. [Epub ahead of print]
 
  Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy
Wang YH, Fan L, Wang L, Zhang R, Xu J, Fang C, Li JY, Xu W. Support Care Cancer. 2012 Nov 15. [Epub ahead of print]
 
  Occult hepatitis B virus and the risk for chronic liver disease: A meta-analysis
Covolo L, Pollicino T, Raimondo G, Donato F. Dig Liver Dis. 2012 Nov 9. pii: S1590-8658(12)00380-5. doi: 10.1016/j.dld.2012.09.021. [Epub ahead of print]
 
  Association of chronic viral hepatitis B with insulin resistance
Lee JG, Lee S, Kim YJ, Cho BM, Park JS, Kim HH, Cheong J, Jeong DW, Lee YH, Cho YH, Bae MJ, Choi EJ. World J Gastroenterol. 2012 Nov 14;18(42):6120-6. doi: 10.3748/wjg.v18.i42.6120.
 
  Managing chronic hepatitis B - The role of the GP
Wallace J, Hajarizadeh B, Richmond J, McNally S, Pitts M. Aust Fam Physician. 2012 Nov;41(11):893-8.
 
  Effectiveness of a culturally integrated liver cancer education in improving HBV knowledge among Asian Americans
Juon HS, Park BJ. Prev Med. 2012 Nov 15. pii: S0091-7435(12)00557-9. doi: 10.1016/j.ypmed.2012.11.003. [Epub ahead of print]
 
  Natural Killer Cells Are Characterized by the Concomitantly Increased Interferon-? and Cytotoxicity in Acute Resolved Hepatitis B Patients
Zhao J, Li Y, Jin L, Zhang S, Fan R, Sun Y, Zhou C, Shang Q, Li W, Zhang Z, Wang FS. PLoS One. 2012;7(11):e49135. doi: 10.1371/journal.pone.0049135. Epub 2012 Nov 1.
 
  Safety and Efficacy of Subcutaneous Hepatitis B Immunoglobulin After Liver Transplantation: An Open Single-Arm Prospective Study
Di Costanzo GG, Lanza AG, Picciotto FP, Imparato M, Migliaccio C, De Luca M, Scuderi V, Tortora R, Cordone G, Utech W, Calise F. Am J Transplant. 2012 Nov 8. doi: 10.1111/j.1600-6143.2012.04319.x. [Epub ahead of print]
 
  Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B
Ikeda K, Izumi N, Tanaka E, Yotsuyanagi H, Takahashi Y, Fukushima J, Kondo F, Fukusato T, Koike K, Hayashi N, Kumada H. Hepatol Res. 2012 Nov 2. doi: 10.1111/j.1872-034X.2012.01115.x. [Epub ahead of print]
 
  Pretreatment viral DNA stratifies mortality risk in patients receiving antiviral therapy for severe acute exacerbation of chronic hepatitis B
Hsu YC, Wu CY, Chang CY, Tai CM, Tseng CH, Perng DS, Mo LR, Lin JT. Antivir Ther. 2012 Nov 6. doi: 10.3851/IMP2435. [Epub ahead of print]
 
  The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis
Isgro G, Calvaruso V, Andreana L, Luong TV, Garcovich M, Manousou P, Alibrandi A, Maimone S, Marelli L, Davies N, Patch D, Dhillon AP, Burroughs AK. J Gastroenterol. 2012 Nov 3. [Epub ahead of print]
 
  Internist diagnosis and management of chronic hepatitis B virus infection
McMahon BJ, Block J, Haber B, London T, McHugh JA, Perrillo R, Neubauer R. Am J Med. 2012 Nov;125(11):1063-7. doi: 10.1016/j.amjmed.2012.03.010.
 
  Genotype/subgenotype distribution of hepatitis B virus among hemodialysis patients with chronical hepatitis B
Sayan M, Dogan C. Ann Hepatol. 2012 Nov;11(6):849-54.
 
  Antiviral therapy for hepatitis B virus-related decompensated cirrhosis
Wang JY. J Dig Dis. 2012 Nov;13(11):555-7. doi: 10.1111/j.1751-2980.2012.00630.x.
 
  Infectious Disease Burden and Vaccination Needs Among Asylees Versus Refugees -- District of Columbia
Chai SJ, Davies-Cole J, Cookson ST. Clin Infect Dis. 2012 Nov 1. [Epub ahead of print]
 
  High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
Cholongitas E, Papatheodoridis GV. Am J Transplant. 2012 Nov 8. doi: 10.1111/j.1600-6143.2012.04315.x. [Epub ahead of print]
 
  Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients
Jin YJ, Kim KM, Yoo DJ, Shim JH, Lee HC, Chung YH, Lee YS, Suh DJ. Virol J. 2012 Oct 18;9(1):239. [Epub ahead of print]
 
  The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy
Chang J, Block TM, Guo JT. Antiviral Res. 2012 Oct 13. pii: S0166-3542(12)00231-8. doi: 10.1016/j.antiviral.2012.10.001. [Epub ahead of print]
 
  Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog
Tseng TC, Kao JH. J Gastroenterol. 2012 Oct 24. [Epub ahead of print]
 
  Does chronic hepatitis B infection affect the clinical course of acute hepatitis A?
Shin SR, Moh IH, Jung SW, Kim JB, Park SH, Kim HS, Jang MK, Lee MS. J Med Virol. 2012 Oct 16. doi: 10.1002/jmv.23433. [Epub ahead of print]
 
  Subgenotyping of genotype C hepatitis B virus: correcting misclassifications and identifying a novel subgenotype
Shi W, Zhu C, Zheng W, Zheng W, Ling C, Carr MJ, Higgins DG, Zhang Z. PLoS One. 2012;7(10):e47271. doi: 10.1371/journal.pone.0047271. Epub 2012 Oct 15.
 
  Response to Higher Dose of Entecavir 1.0 mg Daily in Patients With Partial Response to Entecavir 0.5 mg Daily
Ha NB, Ha NB, Trinh HN, Nguyen HA, Nguyen KK, Nguyen MH. J Clin Gastroenterol. 2012 Oct 17. [Epub ahead of print]
 
  Electronic Messages Increase Hepatitis B Screening in At-Risk Asian American Patients: A Randomized, Controlled Trial
Hsu L, Bowlus CL, Stewart SL, Nguyen TT, Dang J, Chan B, Chen MS Jr. Dig Dis Sci. 2012 Oct 17. [Epub ahead of print]
 
  Causes of death in patients with hepatitis B: A natural history cohort study in the United States
Szpakowski JL, Tucker LY. Hepatology. 2012 Oct 18. doi: 10.1002/hep.26110. [Epub ahead of print]
 
  Randomized trial of lamivudine, adefovir, and the combination in HBeAg-positive chronic hepatitis B
He Z, Wang J, Liu K, Huang H, Du Y, Lin Z, Cai M, Feng X. Clin Res Hepatol Gastroenterol. 2012 Oct 12. pii: S2210-7401(12)00173-8. doi: 10.1016/j.clinre.2012.05.012. [Epub ahead of print]
 
  Yield of Screening for Long-Term Complications Using the Children's Oncology Group Long-Term Follow-Up Guidelines
Landier W, Armenian SH, Lee J, Thomas O, Wong FL, Francisco L, Herrera C, Kasper C, Wilson KD, Zomorodi M, Bhatia S. J Clin Oncol. 2012 Oct 22. [Epub ahead of print]
 
  Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy
Lee YH, Bae SC, Song GG. Clin Exp Rheumatol. 2012 Oct 30. [Epub ahead of print]
 
  Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: Clonal evolution during lamivudine plus adefovir therapy
Kim SS, Cho SW, Kim SO, Hong SP, Cheong JY. J Med Virol. 2012 Oct 23. doi: 10.1002/jmv.23440. [Epub ahead of print]
 
  Role of Leptin Receptor (LEPR) Gene Polymorphisms and Haplotypes in Susceptibility to Hepatocellular Carcinoma in Subjects with Chronic Hepatitis B Virus Infection
Li Z, Yuan W, Ning S, Li J, Zhai W, Zhang S. Mol Diagn Ther. 2012 Oct 23. [Epub ahead of print]
 
  Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis
Kumada T, Toyoda H, Tada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Niinomi T, Yasuda S, Andou Y, Yamamoto K, Tanaka J. J Hepatol. 2012 Oct 30. pii: S0168-8278(12)00826-4. doi: 10.1016/j.jhep.2012.10.025. [Epub ahead of print]
 
  Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients
Orito E, Fujiwara K, Kanie H, Ban T, Yamada T, Hayashi K. World J Gastroenterol. 2012 Oct 21;18(39):5570-5. doi: 10.3748/wjg.v18.i39.5570.
 
  HBVdb: a knowledge database for Hepatitis B Virus
Hayer J, Jadeau F, Deléage G, Kay A, Zoulim F, Combet C. Nucleic Acids Res. 2012 Nov 3. [Epub ahead of print]
 
  Safety and efficacy of four steroid-minimization protocols in liver transplant recipients: 3-year follow-up in a single center
Hu AB, Wu LW, Tai Q, He XS, Zhu XF. J Dig Dis. 2012 Oct 31. doi: 10.1111/1751-2980.12008. [Epub ahead of print]
 
  Prevalence and Factors Associated with Hepatitis B Immunization and Infection among Men Who Have Sex with Men in Beijing, China
Wang C, Wang Y, Huang X, Li X, Zhang T, Song M, Wu L, Du J, Lu X, Shao S, Zhao F, Ball MA, Wu H, Wang W. PLoS One. 2012;7(10):e48219. doi: 10.1371/journal.pone.0048219. Epub 2012 Oct 25.
 
  Changing epidemiology of Hepatitis B and migration--a comparison of six Northern and North-Western European countries
Chu JJ, Wörmann T, Popp J, Pätzelt G, Akmatov MK, Krämer A, Reintjes R. Eur J Public Health. 2012 Jun 8. [Epub ahead of print]
 
  Elecsys Hepatitis B Surface Antigen Quantitative Assay: Performance Evaluation and Correlation with Hepatitis B Virus DNA during 96 Weeks of Follow-up in Chronic Hepatitis B Patients
Lee HJ, Kim SY, Lee SM, Heo J, Kim HH, Chang CL, Lee EY, Son HC. Ann Lab Med. 2012 Nov;32(6):420-5. doi: 10.3343/alm.2012.32.6.420. Epub 2012 Oct 17.
 
  Young Chronic Hepatitis B Patients with Nucleos(t)ide Analogues-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation
Tseng TC, Liu CJ, Su TH, Yang HC, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. J Infect Dis. 2012 Sep 10. [Epub ahead of print]
 
  Management of chronic hepatitis B in pregnancy
Han GR, Xu CL, Zhao W, Yang YF. World J Gastroenterol. 2012 Sep 7;18(33):4517-21.
 
  Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma
Fiorino S, Lorenzini S, Masetti M, Deleonardi G, Grondona AG, Silvestri T, Chili E, Del Prete P, Bacchi-Reggiani L, Cuppini A, Jovine E. Med Hypotheses. 2012 Sep 5. [Epub ahead of print]
 
  What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients?
Yan Y, Mai L, Zheng YB, Zhang SQ, Xu WX, Gao ZL, Ke WM. World J Gastroenterol. 2012 Sep 7;18(33):4604-9.
 
  Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels
Shin JW, Jung SW, Park BR, Kim CJ, Eum JB, Kim BG, Jeong ID, Bang SJ, Lee SH, Kim SR, Park NH. J Viral Hepat. 2012 Oct;19(10):724-31. doi: 10.1111/j.1365-2893.2012.01599.x. Epub 2012 Mar 15.
 
  First WHO International Reference Panel containing hepatitis B virus genotypes A-G for assays of the viral DNA
Chudy M, Hanschmann KM, Kress J, Nick S, Campos R, Wend U, Gerlich W, Nübling CM. J Clin Virol. 2012 Sep 11. pii: S1386-6532(12)00317-4. doi: 10.1016/j.jcv.2012.08.013. [Epub ahead of print]
 
  Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity
Tandoi F, Romagnoli R, Martini S, Mazza E, Nada E, Cocchis D, Lupo F, Salizzoni M. Transplant Proc. 2012 Sep;44(7):1960-2. doi: 10.1016/j.transproceed.2012.07.061.
 
  Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective
Tsai N, Jeffers L, Cragin L, Sorensen S, Su W, Rosenblatt L, Tang H, Hebden T, Juday T. Clinicoecon Outcomes Res. 2012;4:227-35. Epub 2012 Aug 23.
 
  Management of hepatitis B reactivation in patients receiving cancer chemotherapy
Huang YW, Chung RT. Therap Adv Gastroenterol. 2012 Sep;5(5):359-70.
 
  Impact of mild to moderate elevations of alanine aminotransferase on liver stiffness measurement in chronic hepatitis B patients during antiviral therapy
Yan LB, Zhu X, Bai L, Liang LB, Chen EQ, Du LY, Wang LC, Chen LY, Tang H. Hepatol Res. 2012 Jun 26. doi: 10.1111/j.1872-034X.2012.01068.x. [Epub ahead of print]
 
  Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B
Aghoram R, Cai P, Dickinson JA. Cochrane Database Syst Rev. 2012 Sep 12;9:CD002799.
 
  Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States
Tenner CT, Herzog K, Chaudhari S, Bini EJ, Weinshel EH. Int J Clin Pract. 2012 Oct;66(10):1009-13. doi: 10.1111/ijcp.12013.
 
  Viral hepatitis: Global goals for vaccination
Lavanchy D. J Clin Virol. 2012 Sep 20. pii: S1386-6532(12)00326-5. doi: 10.1016/j.jcv.2012.08.022. [Epub ahead of print]
 
  Revaccination with Fendrix(®) or HBVaxPro(®) results in better response rates than does revaccination with three doses of Engerix-B(®) in previous non-responders
Hoebe CJ, Vermeiren AP, Dukers-Muijrers NH. Vaccine. 2012 Sep 11. pii: S0264-410X(12)01293-5. doi: 10.1016/j.vaccine.2012.08.074. [Epub ahead of print]
 
  Hepatitis B in pregnancy
Borgia G, Carleo MA, Gaeta GB, Gentile I. World J Gastroenterol. 2012 Sep 14;18(34):4677-83.
 
  Dating the origin and dispersal of hepatitis B virus infection in humans and primates
Paraskevis D, Magiorkinis G, Magiorkinis E, Ho SY, Belshaw R, Allain JP, Hatzakis A. Hepatology. 2012 Sep 17. doi: 10.1002/hep.26079. [Epub ahead of print]
 
  Are novel combination therapies needed for chronic hepatitis B?
Zoulim F. Antiviral Res. 2012 Sep 19. pii: S0166-3542(12)00203-3. doi: 10.1016/j.antiviral.2012.09.006. [Epub ahead of print]
 
  Genotype D of hepatitis B virus and its subgenotypes: An update
Yousif M, Kramvis A. Hepatol Res. 2012 Sep 16. doi: 10.1111/j.1872-034X.2012.01090.x. [Epub ahead of print]
 
  Viral load and ALT correlate with serologic response in chronic hepatitis B patients treated with entecavir
Wang CC, Tseng KC, Peng CY, Hsieh TY, Lin CL, Su TH, Tseng TC, Hsu CS, Lin HH, Kao JH. J Gastroenterol Hepatol. 2012 Sep 18. doi: 10.1111/j.1440-1746.2012.07269.x. [Epub ahead of print]
 
  Postvaccination serologic testing results for infants aged ?24 months exposed to hepatitis B virus at birth - United States, 2008-2011
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2012 Sep 28;61:768-71.
 
  A comparison of human immunodeficiency virus, hepatitis?C virus, hepatitis?B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010
Dorsey KA, Moritz ED, Steele WR, Eder AF, Stramer SL. Transfusion. 2012 Sep 25. doi: 10.1111/j.1537-2995.2012.03904.x. [Epub ahead of print]
 
  Hepatitis B Virus Reactivation Associated with Anti-Neoplastic Therapy
Yeo W, Farrell G, Chan HL. J Gastroenterol Hepatol. 2012 Sep 28. doi: 10.1111/j.1440-1746.2012.07280.x. [Epub ahead of print]
 
  Prediction of significant fibrosis and cirrhosis in hepatitis B e-antigen negative patients with chronic hepatitis B using routine parameters
Wang Y, Xu MY, Zheng RD, Xian JC, Xu HT, Shi JP, Li SB, Qu Y, Dong YW, Lu LG. Hepatol Res. 2012 Sep 25. doi: 10.1111/j.1872-034X.2012.01094.x. [Epub ahead of print]
 
  Evaluation of Anti-HBV Drug Resistant Mutations Among Patients with Acute Symptomatic Hepatitis B in the United States
Baxa DM, Thekdi AD, Golembieski A, Krishnan PV, Sharif O, Kizy A, Shetron-Rama L, Jovanovich J, Chappell BJ, Snow-Lampart A, Borroto-Esoda K, Gordon SC. J Hepatol. 2012 Sep 26. pii: S0168-8278(12)00745-3. doi: 10.1016/j.jhep.2012.09.014. [Epub ahead of print]
 
  Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
Shao YY, Lu LC, Lin ZZ, Hsu C, Shen YC, Hsu CH, Cheng AL. Br J Cancer. 2012 Oct 11. doi: 10.1038/bjc.2012.466. [Epub ahead of print]
 
  A Meta-Analysis of Nucleos(t)ide Analogues in Patients with Decompensated Cirrhosis Due to Hepatitis B
Huang Y, Wu H, Wu S, Fu D, Ma Y, Shen X. Dig Dis Sci. 2012 Sep 30. [Epub ahead of print]
 
  Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
Micco L, Peppa D, Loggi E, Schurich A, Jefferson L, Cursaro C, Panno AM, Bernardi M, Brander C, Bihl F, Andreone P, Maini MK. J Hepatol. 2012 Oct 6. pii: S0168-8278(12)00761-1. doi: 10.1016/j.jhep.2012.09.029. [Epub ahead of print]
 
  High Frequency of Genotype D and Spontaneous Hepatitis B Virus Genomic Mutations Among Haitians in a Multiethnic North American Population
Couto CA, Levy C, Morris CJ, Hill M, de Medina M, Sanborn MR, Cloherty GA, Schiff ER, Martin P. J Clin Gastroenterol. 2012 Oct 10. [Epub ahead of print]
 
  Predictors of the outcomes of acute-on-chronic hepatitis B liver failure
Fan HL, Yang PS, Chen HW, Chen TW, Chan DC, Chu CH, Yu JC, Kuo SM, Hsieh CB. World J Gastroenterol. 2012 Sep 28;18(36):5078-83. doi: 10.3748/wjg.v18.i36.5078.
 
  De novo HBV infection in a Mayo Clinic hemodialysis population: Economic impact of reduced HBV testing and a call for changes in current US CDC guidelines on HBV testing protocols
Onuigbo MA, Onuigbo NT. Hemodial Int. 2012 Oct;16 Suppl 1:S32-8. doi: 10.1111/j.1542-4758.2012.00748.x.
 
  Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study
Hosaka T, Suzuki F, Kobayashi M, Seko Y, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H. J Gastroenterol. 2012 Oct 12. [Epub ahead of print]
 
  The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation
Tanaka T, Benmousa A, Marquez M, Therapondos G, Renner EL, Lilly LB. Clin Transplant. 2012 Sep;26(5):E561-9. doi: 10.1111/ctr.12022.
 
  Serum cytokine levels in chronic hepatitis B patients receiving peginterferon alpha-2a therapy
Park Y, Park JY, Han KH, Kim HS. Hepatobiliary Pancreat Dis Int. 2012 Oct;11(5):499-506.
 
  Cytokine Levels and Histopathology in Chronic Hepatitis B and Chronic Hepatitis C
Akcam FZ, Tigli A, Kaya O, Ciris M, Vural H. J Interferon Cytokine Res. 2012 Oct 15. [Epub ahead of print]
 
  Long-Term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of HBV-Related Cirrhosis
Köklü S, Tuna Y, Gül?en MT, Demir M, Köksal AS, Koçkar MC, Aygün C, Coban S, Ozdil K, Ataseven H, Ak?n E, Pürnak T, Yüksel I, Ataseven H, Ibi? M, Y?ld?r?m B, Nadir I, Küçükazman M, Akbal E, Yüksel O, Ba?ar O. Clin Gastroenterol Hepatol. 2012 Oct 9. pii: S1542-3565(12)01157-3. doi: 10.1016/j.cgh.2012.10.003. [Epub ahead of print]
 
  Ammonium metabolism in humans
Adeva MM, Souto G, Blanco N, Donapetry C. Metabolism. 2012 Aug 23. [Epub ahead of print]
 
  Hepatitis in the elderly: still a scourge
Wick JY. Consult Pharm. 2012 Jul;27(7):472-81.
 
  Future Prevention and Treatment of Chronic Hepatitis B Infection
Seto WK, Fung J, Yuen MF, Lai CL. J Clin Gastroenterol. 2012 Aug 23. [Epub ahead of print]
 
  Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers
Liu CC, Wang YH, Chuang EY, Tsai MH, Chuang YH, Lin CL, Liu CJ, Hsiao BY, Lin SM, Liu LY, Yu MW. Mol Carcinog. 2012 Aug 21. doi: 10.1002/mc.21952. [Epub ahead of print]
 
  Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus
Shima T, Uto H, Ueki K, Takamura T, Kohgo Y, Kawata S, Yasui K, Park H, Nakamura N, Nakatou T, Tanaka N, Umemura A, Mizuno M, Tanaka J, Okanoue T. J Gastroenterol. 2012 Aug 22. [Epub ahead of print]
 
  Limited infection with occult hepatitis B virus in drug users in the USA
Blackard JT, Martin CM, Sengupta S, Forrester J. Hepatol Res. 2012 Jul 9. doi: 10.1111/j.1872-034X.2012.01072.x. [Epub ahead of print]
 
  Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule
Han K, Shao X, Zheng H, Wu C, Zhu J, Zheng X, Zhang Y. Hum Vaccin Immunother. 2012 Dec 1;8(12). [Epub ahead of print]
 
  Hepatitis B virus management to prevent reactivation after chemotherapy: a review
Hwang JP, Vierling JM, Zelenetz AD, Lackey SC, Loomba R. Support Care Cancer. 2012 Aug 30. [Epub ahead of print]
 
  Increased Risk of Acute Hepatitis B among Adults with Diagnosed Diabetes MellitusIncreased Risk of Acute Hepatitis B among Adults with Diagnosed Diabetes Mellitus
Reilly ML, Schillie SF, Smith E, Poissant T, Vonderwahl CW, Gerard K, Baumgartner J, Mercedes L, Sweet K, Muleta D, Zaccaro DJ, Klevens RM, Murphy TV. J Diabetes Sci Technol. 2012 Jul 1;6(4):858-66.
 
  Does genotype predict response to treatment in children infected with hepatitis B perinatally?
Boxall E, Sira J, Kaskar S, Workman J, Kelly D. J Med Virol. 2012 Oct;84(10):1535-40. doi: 10.1002/jmv.23308.
 
  Subgenotype reclassification of genotype B hepatitis B virus
Shi W, Zhu C, Zheng W, Carr MJ, Higgins DG, Zhang Z.
 
  Unexpected distribution of Hepatitis B genotypes in patients with kidney disease: Comparison with immunocompetent subjects
Souza LO, Perez RM, Carvalho-Filho RJ, Matos CA, Moutinho RS, Silva IS, Medina-Pestana JO, Silva AE, Ferraz ML. J Med Virol. 2012 Oct;84(10):1548-52. doi: 10.1002/jmv.23357.
 
  Chronic HBV infection outside treatment guidelines: is treatment needed?
Evans AA, London WT, Gish RG, Cohen C, Block TM. Antivir Ther. 2012 Aug 20. doi: 10.3851/IMP2325. [Epub ahead of print]
 
  High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B
Seto WK, Wong DK, Fung J, Ip PP, Yuen JC, Hung IF, Lai CL, Yuen MF. PLoS One. 2012;7(8):e43087. Epub 2012 Aug 20.
 
  Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis B by injecting hepatitis B immune globulin
Guo Y, Zhang W, Zhang Y, Lin X, Zhang B, Chen C, Du Y. Eur J Gastroenterol Hepatol. 2012 Aug 23. [Epub ahead of print]
 
  Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B
Buti M, Homs M. Expert Rev Gastroenterol Hepatol. 2012 Aug;6(4):413-21.
 
  Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients
Lai HW, Chang CC, Chen TH, Tsai MC, Chen TY, Lin CC. J Formos Med Assoc. 2012 Aug;111(8):439-44. Epub 2012 Apr 30.
 
  Long-term impact of entecavir monotherapy in chronic hepatitis B patients with a partial virologic response to entecavir therapy
Ko SY, Choe WH, Kwon SY, Kim JH, Seo JW, Kim KH, Lee CH. Scand J Gastroenterol. 2012 Aug 31. [Epub ahead of print]
 
  Serum hepatitis B surface antigen levels help predict disease progression in patients with low HBV loads
Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Hsu CA, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Hepatology. 2012 Sep 3. doi: 10.1002/hep.26041. [Epub ahead of print]
 
  High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy
Chaung KT, Ha NB, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Garcia G, Ahmed A, Keeffe EB, Nguyen MH. J Clin Gastroenterol. 2012 Aug 30. [Epub ahead of print]
 
  Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes
Hoerger TJ, Schillie S, Wittenborn JS, Bradley CL, Zhou F, Byrd K, Murphy TV. Diabetes Care. 2012 Aug 28. [Epub ahead of print]
 
  The impact of new vaccine introduction on immunization and health systems: A review of the published literature
Hyde TB, Dentz H, Wang SA, Burchett HE, Mounier-Jack S, Mantel CF; The New Vaccine Introduction Impact Published Literature Working Group. Vaccine. 2012 Aug 29. [Epub ahead of print]
 
  Association of response to hepatitis B vaccination and survival in dialysis patients
Lin SY, Liu JH, Wang SM, Wang IK, Tsai CA, Liu YL, Lin HH, Chang CC, Huang CC. BMC Nephrol. 2012 Aug 30;13(1):97. [Epub ahead of print]
 
  Update on tenofovir toxicity in the kidney
Hall AM. Pediatr Nephrol. 2012 Aug 10. [Epub ahead of print]
 
  A 96-week randomized trial of switching to entecavir in chronic hepatitis B patients with a partial virologic response to lamivudine
Heo J, Park JY, Lee HJ, Tak WY, Um SH, Kim DY, Yoon KT, Park SY, Seo YS, Han KH, Cho M, Ahn SH. Antivir Ther. 2012 Aug 8. doi: 10.3851/IMP2277. [Epub ahead of print]
 
  Posthepatectomy HBV Reactivation in Hepatitis B-Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels
Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, Fu SY, Wu MC. Ann Surg. 2012 Aug 3. [Epub ahead of print]
 
  Clinical prediction of failure of lamivudine prophylaxis for patients with hepatitis B infection undergoing cytotoxic chemotherapy for malignancy
Kim IK, Kim BG, Kim W, Kim D, Kim YJ, Yoon JH, Lee HS. Antimicrob Agents Chemother. 2012 Aug 13. [Epub ahead of print]
 
  Comparison of four prognostic models and a new Logistic regression model to predict short-term prognosis of acute-on-chronic hepatitis B liver failure
He WP, Hu JH, Zhao J, Tong JJ, Ding JB, Lin F, Wang HF. Chin Med J (Engl). 2012 Jul;125(13):2272-8.
 
  Impact of maternal carrier status on immunologic markers for protection after hepatitis B vaccination in infancy: A meta-analysis
Schönberger K, Riedel C, Rückinger S, Mansmann U, Jilg W, von Kries R. Vaccine. 2012 Aug 8. [Epub ahead of print]
 
  Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B
Cho HJ, Kim SS, Ahn SJ, Bae CB, Kim HG, Kim YJ, Lee SK, Song GW, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Cho SW, Cheong JY. Clin Biochem. 2012 Aug 3. [Epub ahead of print]
 
  Tattooing and risk of hepatitis B: a systematic review and meta-analysis
Jafari S, Buxton JA, Afshar K, Copes R, Baharlou S. Can J Public Health. 2012 May-Jun;103(3):207-12.
 
  Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy
Peng JW, Lin GN, Xiao JJ, Jiang XM. Asia Pac J Clin Oncol. 2012 May 15. doi: 10.1111/j.1743-7563.2012.01534.x. [Epub ahead of print]
 
  Hepatitis B reactivation in cancer patients: role of prechemotherapy screening and antiviral prophylaxis
Kawsar HI, Shahnewaz J, Gopalakrishna KV, Spiro TP, Daw HA. Clin Adv Hematol Oncol. 2012 Jun;10(6):370-8.
 
  Management of chemotherapy-induced hepatitis B virus reactivation
Huang YH, Lin HC, Lee SD. J Chin Med Assoc. 2012 Aug;75(8):359-62. Epub 2012 Jul 21.
 
  A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier
Bae JH, Sohn JH, Lee HS, Park HS, Hyun YS, Kim TY, Eun CS, Jeon YC, Han DS. Clin Mol Hepatol. 2012 Jun;18(2):225-8. Epub 2012 Jun 26.
 
  PS2-03: Chronic Hepatitis B Testing in US-born and Foreign-born Asia Pacific Islanders of Kaiser Permanente, Hawai'i
Vijayadeva V, Lu M, Nakasato C, Gordon S, Rupp L, Henkle E. Clin Med Res. 2012 Aug;10(3):172.
 
  Value of Abdominal Susceptibility-weighted Magnetic Resonance Imaging for Quantitative Assessment of Hepatic Iron Deposition in Patients with Chronic Hepatitis B: Comparison with Serum Iron Markers
Lv W, Yan F, Zeng M, Zhang J, Yuan Y, Ma J. J Int Med Res. 2012;40(3):1005-15.
 
  Effects of hepatitis B e-antigen on recurrence of hepatitis B-related hepatocellular carcinoma after curative resection: A meta-analysis
Qu LS, Zhu J, Chen H, Jin F, Ni RZ, Lu CH. Hepatol Res. 2012 Jul 23. doi: 10.1111/j.1872-034X.2012.01079.x. [Epub ahead of print]
 
  Clinical and Virological Characteristics Post HBsAg Seroclearance in Hepatitis B Virus Carriers With Hepatic Steatosis Versus Those Without
Chu CM, Lin DY, Liaw YF. Dig Dis Sci. 2012 Aug 18. [Epub ahead of print]
 
  Diagnosis and personalized management of hepatitis B including significance of genotypes
Wong VW, Sung JJ. Curr Opin Infect Dis. 2012 Aug 16. [Epub ahead of print]
 
  CB3-02: Demographic Differences Between US-born and Foreign-born Asia Pacific Islanders Among the Hepatitis B Patients of Kaiser Permanente, Hawai'i
Vijayadeva V, Nakasato C, Gordon S, Rupp L, Lu M, Henkle E, Boscarino J. Clin Med Res. 2012 Aug;10(3):172-3.
 
  Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
Chung WG, Kim HJ, Choe YG, Seok HS, Chon CW, Cho YK, Kim BI, Koh YY. Clin Mol Hepatol. 2012 Jun;18(2):195-202. Epub 2012 Jun 26.
 
  Adherence, Persistence, Healthcare Utilization, and Cost Benefits of Guideline-Recommended Hepatitis B Pharmacotherapy
Han SH, Jing W, Mena E, Li M, Pinsky B, Tang H, Hebden T, Juday T. J Med Econ. 2012 Jul 10. [Epub ahead of print]
 
  HBsAg variants: Diagnostic-escape and diagnostic dilemma
Alavian SM, Carman WF, Jazayeri SM. J Clin Virol. 2012 Jul 10. [Epub ahead of print]
 
  Healthcare workers' perceptions of occupational exposure to blood-borne viruses and reporting barriers: a questionnaire-based study
Winchester SA, Tomkins S, Cliffe S, Batty L, Ncube F, Zuckerman M. J Hosp Infect. 2012 Jul 9. [Epub ahead of print]
 
  Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis
Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. World J Gastroenterol. 2012 Jun 28;18(24):3119-28.
 
  Hepatitis B Virus and Human Immunodeficiency Virus Drugs in Pregnancy: Findings from the Antiretroviral Pregnancy Registry
Brown RS, Verna EC, Pereira MR, Tilson HH, Aguilar C, Leu CS, Buti M, Fagan EA. J Hepatol. 2012 Jul 2. [Epub ahead of print]
 
  Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation
Park H, Kim SU, Kim D, Kim do Y, Ahn SH, Han KH, Chon CY, Park JY. J Clin Gastroenterol. 2012 Aug;46(7):602-7.
 
  Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis
Zhou Y, Zhao Y, Li B, Huang J, Wu L, Xu D, Yang J, He J. BMC Cancer. 2012 Jul 16;12(1):289. [Epub ahead of print]
 
  Comparison of LecT-Hepa and FibroScan for assessment of liver fibrosis in hepatitis B virus infected patients with different ALT levels
Du D, Zhu X, Kuno A, Matsuda A, Tsuruno C, Yu D, Zhang Y, Ikehara Y, Tanaka Y, Zhang X, Narimatsu H. Clin Chim Acta. 2012 Jul 12. [Epub ahead of print]
 
  Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy
Lai CL, Yuen MF. Hepatology. 2012 Jul 13. doi: 10.1002/hep.25937. [Epub ahead of print]
 
  The role of innate immunity in HBV infection
Han Q, Zhang C, Zhang J, Tian Z. Semin Immunopathol. 2012 Jul 20. [Epub ahead of print]
 
  Health state utilities and quality of life in patients with hepatitis B
Woo G, Tomlinson G, Yim C, Lilly L, Therapondos G, Wong DK, Ungar WJ, Einarson TR, Sherman M, Heathcote JE, Krahn M. Can J Gastroenterol. 2012 Jul;26(7):445-51.
 
  Restored Function of HBV-Specific T Cells after Long-Term Effective Therapy with Nucleos(t)ide Analogues
Boni C, Laccabue D, Lampertico P, Giuberti T, Viganò M, Schivazappa S, Alfieri A, Pesci M, Gaeta GB, Brancaccio G, Colombo M, Missale G, Ferrari C. Gastroenterology. 2012 Jul 12. [Epub ahead of print]
 
  Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: A case report and literature review
Ferreira R, Carvalheiro J, Torres J, Fernandes A, Giestas S, Mendes S, Agostinho C, Campos MJ. Saudi J Gastroenterol. 2012 Jul;18(4):277-81.
 
  Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects
Wu WC, Wu CY, Wang YJ, Hung HH, Yang HI, Kao WY, Su CW, Wu JC, Chan WL, Lin HC, Lee FY, Lee SD. Aliment Pharmacol Ther. 2012 Jul 23. doi: 10.1111/j.1365-2036.2012.05224.x. [Epub ahead of print]
 
  Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B
Kim SS, Lee D, Lee MH, Cheong JY, Cho SW. Hepatol Res. 2012 Jun 27. doi: 10.1111/j.1872-034X.2012.01065.x. [Epub ahead of print]
 
  Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
Toh HC, Chen PJ, Carr BI, Knox JJ, Gill S, Ansell P, McKeegan EM, Dowell B, Pedersen M, Qin Q, Qian J, Scappaticci FA, Ricker JL, Carlson DM, Yong WP. Cancer. 2012 Jul 25. doi: 10.1002/cncr.27758. [Epub ahead of print]
 
  Randomised study comparing 48 and 96 weeks peginterferon ?-2a therapy in genotype D HBeAg-negative chronic hepatitis B
Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M; on behalf of the PegBeLiver Study Group. Gut. 2012 Aug 2. [Epub ahead of print]
 
  Sleep and antibody response to hepatitis B vaccination
Prather AA, Hall M, Fury JM, Ross DC, Muldoon MF, Cohen S, Marsland AL. Sleep. 2012 Aug 1;35(8):1063-9.
 
  Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey - PolSenior
Hartleb M, Gutkowski K, Zejda JE, Chudek J, Wi?cek A. Eur J Gastroenterol Hepatol. 2012 Aug 1. [Epub ahead of print]
 
  A community-based participatory approach to a hepatitis B intervention for Korean Americans
Ma GX, Gao W, Tan Y, Chae WG, Rhee J. Prog Community Health Partnersh. 2012 Spring;6(1):7-16.
 
  Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders
Rijckborst V, Ferenci P, Akdogan M, Pinarbasi B, Ter Borg MJ, Simon K, Flisiak R, Akarca US, Raptopoulou-Gigi M, Verhey E, van Vuuren AJ, Boucher CA, Hansen BE, Janssen HL; for the PARC Study Group. Eur J Gastroenterol Hepatol. 2012 Jun 3. [Epub ahead of print]
 
  Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients
Ono A, Suzuki F, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Saitou S, Arase Y, Ikeda K, Kobayashi M, Watahiki S, Mineta R, Kumada H. J Hepatol. 2012 May 30. [Epub ahead of print]
 
  Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients with Chronic Hepatitis B Who Stop Long-Term Treatment with Adefovir
Hadziyannis SJ, Sevastianos V, Rapti I, Vassilopoulos D, Hadziyannis E. Gastroenterology. 2012 May 31. [Epub ahead of print]
 
  Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B
Lou Y, Wang M, Mao W. PLoS One. 2012;7(5):e37644. Epub 2012 May 23.
 
  Minimization of HBV Infection by A 25-Year Universal Vaccination Program
Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL, Chen DS. J Hepatol. 2012 Jun 2. [Epub ahead of print]
 
  Evaluation of elevated alanine aminotransferase and hepatitis B virus DNA in healthy seronegative blood donors
Ali N, Moiz B, Moatter T. BMC Res Notes. 2012 Jun 7;5(1):272. [Epub ahead of print]
 
  Assessing Long-Term Treatment Efficacy in Chronic Hepatitis B and C: Between Evidence and Common Sense
Aghemo A, Lampertico P, Colombo M. J Hepatol. 2012 Jun 27. [Epub ahead of print]
 
  Real-time Elastography for Diagnosis of Liver Fibrosis in Chronic Hepatitis B
Xie L, Chen X, Guo Q, Dong Y, Guang Y, Zhang X. J Ultrasound Med. 2012 Jul;31(7):1053-60.
 
  Exploring hepatitis B: a neglected disease
Loo NM, Pryce DJ. Minn Med. 2012 May;95(5):37-40.
 
  Precore mutation of hepatitis B virus may contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis
Liao Y, Hu X, Chen J, Cai B, Tang J, Ying B, Wang H, Wang L. PLoS One. 2012;7(6):e38394. Epub 2012 Jun 1.
 
  Antiviral therapy: old and current issues
Antonelli G, Turriziani O. Int J Antimicrob Agents. 2012 Jun 21. [Epub ahead of print]
 
  Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant
Bzowej NH. Curr Hepat Rep. 2012 Jun;11(2):82-89. Epub 2012 May 26.
 
  A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women
Sun KX, Li J, Zhu FC, Liu JX, Li RC, Zhai XJ, Li YP, Chang ZJ, Nie JJ, Zhuang H. Vaccine. 2012 Jun 26. [Epub ahead of print]
 
  Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy
Oketani M, Ido A, Uto H, Tsubouchi H. Hepatol Res. 2012 Jul;42(7):627-36. doi: 10.1111/j.1872-034X.2012.00998.x.
 
  Updated CDC Recommendations for the Management of Hepatitis B Virus-Infected Health-Care Providers and Students
Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. MMWR Recomm Rep. 2012 Jul 6;61(RR-3):1-12.
 
  Rescue Therapy for Lamivudine-resistant Chronic Hepatitis B: Adefovir Monotherapy, Adefovir Plus Lamivudine or Entecavir Combination Therapy
Ha M, Zhang G, Diao S, Lin M, Wu J, Sun L, She H, Shen L, Huang C, Shen W, Huang Z. Intern Med. 2012;51(12):1509-15. Epub 2012 Jun 15.
 
  Prevention and Management of Drug Resistant HBV Infections
Wang C, Fan R, Sun J, Hou J. J Gastroenterol Hepatol. 2012 Jun 13. doi: 10.1111/j.1440-1746.2012.07198.x. [Epub ahead of print]
 
  Diverse roles of hepatitis B virus in liver cancer
Fallot G, Neuveut C, Buendia MA. Curr Opin Virol. 2012 Jun 19. [Epub ahead of print]
 
  Hepatitis B Virus Screening Before Chemotherapy for Lymphoma: A Cost-Effectiveness Analysis
Zurawska U, Hicks LK, Woo G, Bell CM, Krahn M, Chan KK, Feld JJ. J Clin Oncol. 2012 Jun 18. [Epub ahead of print]
 
  Serologic Testing for Protection against Hepatitis B Virus Infection among Students at a Health Sciences University in the United States
Spradling PR, Williams RE, Xing J, Soyemi K, Towers J. Infect Control Hosp Epidemiol. 2012 Jul;33(7):732-6. Epub 2012 May 22.
 
  Lamivudine plus adefovir or telbivudine plus adefovir for chronic hepatitis B patients with suboptimal response to adefovir
Chen EQ, Zhou TY, Bai L, Wang JR, Yan LB, Liang LB, Tang H. Antivir Ther. 2012 Jun 22. doi: 10.3851/IMP2190. [Epub ahead of print]
 
  Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management
Abramson A, Menter A, Perrillo R. J Am Acad Dermatol. 2012 Jun 21. [Epub ahead of print]
 
  Chronic hepatitis B in children and adolescents
Paganelli M, Stephenne X, Sokal EM. J Hepatol. 2012 May 22. [Epub ahead of print]
 
  High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG
Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM. J Hepatol. 2012 May 19. [Epub ahead of print]
 
  Efficacy of Entecavir with or without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naïve Patients with Chronic Hepatitis B
Lok AS, Trinh H, Carosi G, Akarca US, Gadano A, Habersetzer F, Sievert W, Wong D, Lovegren M, Cohen D, Llamoso C. Gastroenterology. 2012 May 26. [Epub ahead of print]
 
  Rapid Point-of-Care First-Line Screening Tests for Hepatitis B Infection: A Meta-Analysis of Diagnostic Accuracy (1980-2010)
Shivkumar S, Peeling R, Jafari Y, Joseph L, Pai NP. Am J Gastroenterol. 2012 May 29. doi: 10.1038/ajg.2012.141. [Epub ahead of print]
 
  Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation
Liu CY, Chandrasekar PH, Masood A, Schiffer CA. J Oncol Pharm Pract. 2012 May 25. [Epub ahead of print]
 
  Hepatitis B vaccine: prophylactic, therapeutic, and diagnostic dilemma
Alavian SM, Miri SM, Jazayeri SM. Minerva Gastroenterol Dietol. 2012 Jun;58(2):167-78.
 
  Multiple outbreaks of hepatitis B virus infection related to assisted monitoring of blood glucose among residents of assisted living facilities - virginia, 2009-2011
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2012 May 18;61:339-43.
 
  Improving adult immunization practices using a team approach in the primary care setting
Gannon M, Qaseem A, Snooks Q, Snow V. Am J Public Health. 2012 Jul;102(7):e46-52. Epub 2012 May 17.
 
  Investigation of viral hepatitis infections possibly associated with health-care delivery - new york city, 2008-2011
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2012 May 18;61:333-8.
 
  Long-term outcomes of add-on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine-resistant chronic hepatitis B
Toyama T, Ishida H, Ishibashi H, Yatsuhashi H, Nakamuta M, Shimada M, Ohta H, Satoh T, Kato M, Hijioka T, Takano H, Komeda T, Yagura M, Mano H, Watanabe Y, Kobayashi M, Mita E. Hepatol Res. 2012 Apr 19. doi: 10.1111/j.1872-034X.2012.01038.x. [Epub ahead of print]
 
  Factors influencing inadequate or suboptimal response to adefovir with or without genotypic resistance
Zhou X, Kuang X, Fan K, Zhang C, Deng G, Wang H, Wang Y. J Med Virol. 2012 Jul;84(7):1030-6. doi: 10.1002/jmv.23270.
 
  First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice
Pol S, Lampertico P. J Viral Hepat. 2012 Jun;19(6):377-86. doi: 10.1111/j.1365-2893.2012.01602.x. Epub 2012 Mar 28.
 
  Genotype impact on long-term virological outcome of chronic hepatitis B virus infection
Malmström S, Eilard A, Larsson SB, Hannoun C, Norkrans G, Lindh M. J Clin Virol. 2012 May 17. [Epub ahead of print]
 
  Improving Adult Immunization Practices Using a Team Approach in the Primary Care Setting
Gannon M, Qaseem A, Snooks Q, Snow V. Am J Public Health. 2012 May 17. [Epub ahead of print]
 
  The prevalence of hepatitis B and C viral infections among pregnant women
Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O. N Am J Med Sci. 2011 May;3(5):238-41.
 
  Modest Alcohol Consumption has an Inverse Association with Liver Fat Content
Gunji T, Sato H, Iijima K, Fujibayashi K, Okumura M, Sasabe N, Matsuhashi N. Hepatogastroenterology. 2012 Apr 25;59(120). doi: 10.5754/hge12175. [Epub ahead of print]
 
  Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma
Chen H, Sun LY, Zheng HQ, Zhang QF, Jin XM. Pathology. 2012 Apr 23. [Epub ahead of print]
 
  Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
Kim BK, Kim SU, Kim HS, Park JY, Ahn SH, Chon CY, Cho IR, Joh DH, Park YN, Han KH, Kim do Y. PLoS One. 2012;7(4):e35825. Epub 2012 Apr 20.
 
  Association between obesity, hypertriglyceridemia and low hepatitis B viral load
Chiang CH, Yang HI, Jen CL, Lu SN, Wang LY, You SL, Su J, Iloeje UH, Chen CJ. Int J Obes (Lond). 2012 Apr 24. doi: 10.1038/ijo.2012.63. [Epub ahead of print]
 
  Effectiveness of hepatitis B treatment in clinical practice
Scaglione SJ, Lok AS. Gastroenterology. 2012 May;142(6):1360-1368.e1.
 
  New virologic tools for management of chronic hepatitis B and C
Chevaliez S, Rodriguez C, Pawlotsky JM. Gastroenterology. 2012 May;142(6):1303-1313.e1.
 
  Impact of comorbidities on the severity of chronic hepatitis B at presentation
Sagnelli E, Stroffolini T, Mele A, Imparato M, Sagnelli C, Coppola N, Almasio PL. World J Gastroenterol. 2012 Apr 14;18(14):1616-21.
 
  Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis
Naing C, Mak JW, Ahmed SI, Maung M. World J Gastroenterol. 2012 Apr 14;18(14):1642-51.
 
  Management of HBV- and HCV-induced end stage liver disease
Mutimer DJ, Lok A. Gut. 2012 May;61 Suppl 1:i59-i67.
 
  Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection
Falade-Nwulia O, Seaberg EC, Rinaldo CR, Badri S, Witt M, Thio CL. Clin Infect Dis. 2012 Apr 20. [Epub ahead of print]
 
  New insight in the pathobiology of hepatitis B virus infection
Dandri M, Locarnini S. Gut. 2012 May;61 Suppl 1:i6-i17.
 
  Hepatitis B: treatment to prevent perinatal transmission
Tran TT. Clin Obstet Gynecol. 2012 Jun;55(2):541-9.
 
  Randomized Controlled Study of Plasma Exchange Combined With Molecular Adsorbent Re-Circulating System for the Treatment of Liver Failure Complicated with Hepatic Encephalopathy
Huang YK, Tan DM, Xie YT, Fan XG, Huang Y, Liu ZB, Li SL. Hepatogastroenterology. 2012 Apr 25;59(117). doi: 10.5754/hge12203. [Epub ahead of print]
 
  Increased levels of Arginase in patients with acute hepatitis B suppress antiviral T cells
Sandalova E, Laccabue D, Boni C, Watanabe T, Tan A, Zong HZ, Ferrari C, Bertoletti A. Gastroenterology. 2012 Apr 1. [Epub ahead of print]
 
  Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis B
Jin X, Chen YP, Yang YD, Li YM, Zheng L, Xu CQ. PLoS One. 2012;7(3):e34198. Epub 2012 Mar 30.
 
  High Rates of Viral Suppression After Long-Term Entecavir Treatment of Asian Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B
Pan CQ, Tong M, Kowdley KV, Hu KQ, Chang TT, Lai CL, Yoon SK, Lee SS, Cohen D, Tang H, Tsai N. Clin Gastroenterol Hepatol. 2012 Apr 1. [Epub ahead of print]
 
  Different models in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure
Yang WB, Chen EQ, Bi HX, Bai L, Chen XB, Feng P, Tang H. Ann Hepatol. 2012 May;11(3):311-9.
 
  Saliva as a tool in the detection of hepatitis B surface antigen in patients
Arora G, Sheikh S, Pallagatti S, Singh B, Singh VA, Singh R. Compend Contin Educ Dent. 2012 Mar;33(3):174-6, 178; quiz 180, 182.
 
  Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression?
Wu Q, Liu Q. Hepatol Res. 2012 Mar 2. doi: 10.1111/j.1872-034X.2012.00994.x. [Epub ahead of print]
 
  Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression?
Wu Q, Liu Q. Hepatol Res. 2012 Mar 2. doi: 10.1111/j.1872-034X.2012.00994.x. [Epub ahead of print]
 
  Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years
Wong GL, Wong VW, Chan HY, Tse PC, Wong J, Chim AM, Yiu KK, Chu SH, Chan HL. Aliment Pharmacol Ther. 2012 Apr 16. doi: 10.1111/j.1365-2036.2012.05098.x. [Epub ahead of print]
 
  Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
Zoutendijk R, Reijnders JG, Zoulim F, Brown A, Mutimer DJ, Deterding K, Hofmann WP, Petersen J, Fasano M, Buti M, Berg T, Hansen BE, Sonneveld MJ, Wedemeyer H, Janssen HL; for the VIRGIL Surveillance Study Group. Gut. 2012 Apr 5. [Epub ahead of print]
 
  Is there an association between the measurement of qualitative HBsAg and virologic response in chronic HBV infection?
Altinbas A, Aktas B, Basar O, Yüksel O, Ekiz F, Yilmaz B, Coban S. Ann Hepatol. 2012 May;11(3):320-5.
 
  Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection
Li N, Gao YF, Zhang TC, Chen P, Li X, Su F. World J Hepatol. 2012 Mar 27;4(3):105-9.
 
  Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B
Gara N, Zhao X, Collins MT, Chong WH, Kleiner DE, Jake Liang T, Ghany MG, Hoofnagle JH. Aliment Pharmacol Ther. 2012 Apr 16. doi: 10.1111/j.1365-2036.2012.05093.x. [Epub ahead of print]
 
  Similar Risk of Renal Events Among Patients Treated with Tenofovir or Entecavir for Chronic Hepatitis B
Gish RG, Clark MD, Kane SD, Shaw RE, Mangahas MF, Baqai S. Clin Gastroenterol Hepatol. 2012 Apr 13. [Epub ahead of print]
 
  Natural history of chronic hepatitis B: what exactly has REVEAL Revealed?
Iloeje UH, Yang HI, Chen CJ. Liver Int. 2012 Apr 17. doi: 10.1111/j.1478-3231.2012.02805.x. [Epub ahead of print]
 
  New advances in chronic hepatitis B
Tujios SR, Lee WM. Curr Opin Gastroenterol. 2012 Mar 23. [Epub ahead of print]
 
  Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study
Zhang S, Ristau JT, Trinh HN, Garcia RT, Nguyen HA, Nguyen MH. Dig Dis Sci. 2012 Mar 31. [Epub ahead of print]
 
  Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B
Ghany MG, Feld JJ, Zhao X, Heller T, Doo E, Rotman Y, Nagabhyru P, Koh C, Kleiner DE, Wright EC, Liang TJ, Hoofnagle JH. Aliment Pharmacol Ther. 2012 Mar 26. doi: 10.1111/j.1365-2036.2012.05059.x. [Epub ahead of print]
 
  Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir
Son CY, Ryu HJ, Lee JM, Ahn SH, Kim DY, Lee MH, Han KH, Chon CY, Park JY. Liver Int. 2012 Mar 27. doi: 10.1111/j.1478-3231.2012.02793.x. [Epub ahead of print]
 
  Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review
Papatheodoridis GV, Manolakopoulos S, Liaw YF, Lok A. J Hepatol. 2012 Mar 23. [Epub ahead of print]
 
  IL28B polymorphisms predict interferon-related HBsAg seroclearance in genotype D HBeAg-negative patients with chronic hepatitis B
Lampertico P, Viganò M, Cheroni C, Facchetti F, Invernizzi F, Valveri V, Soffredini R, Abrignani S, De Francesco R, Colombo M. Hepatology. 2012 Apr 2. doi: 10.1002/hep.25749. [Epub ahead of print]
 
  Patients with hematological malignancies and serological signs of prior resolved hepatitis B
Marignani M, Gigante E, Begini P, Marzano A, di Fonzo M, Deli I, Gallina S, Cox MC, Delle Fave G. World J Gastrointest Oncol. 2012 Mar 15;4(3):37-45.
 
  Circulating Hepatitis B Surface Antigen Particles Carry Hepatocellular microRNAs
Novellino L, Rossi RL, Bonino F, Cavallone D, Abrignani S, Pagani M, Brunetto MR. PLoS One. 2012;7(3):e31952. Epub 2012 Mar 28.
 
  Hepatitis B serology
Towell V, Cowie B. Aust Fam Physician. 2012 Apr;41(4):212-4.
 
  Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: a nested case-control analysis
Wan S, Hann HW, Myers RE, Fu X, Hann RS, Kim SH, Tang H, Xing J, Yang H. Liver Int. 2012 Apr 4. doi: 10.1111/j.1478-3231.2012.02801.x. [Epub ahead of print]
 
  Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination
Byrd KK, Lu PJ, Murphy TV. Vaccine. 2012 Mar 31. [Epub ahead of print]
 
  Improved Efficacy by Individualized Combination Therapy with Peg IFN-a 2a and ADV in HBeAg Positive Chronic Hepatitis B Patients
Wang YD, Zhao CY, Wang W, Shen C, Lu HZ, Zhang L, Yu WY, Zhou JY, Yan WZ. Hepatogastroenterology. 2012 Mar 20;59(115). doi: 10.5754/hge12183. [Epub ahead of print]
 
  Transient elastography and simple blood markers in diagnosis of oesophageal varices for compensated patients with hepatitis B virus-related cirrhosis
Wang JH, Chuah SK, Lu SN, Hung CH, Chen CH, Kee KM, Chang KC, Tai WC, Hu TH. J Gastroenterol Hepatol. 2012 Mar 20. doi: 10.1111/j.1440-1746.2012.07132.x. [Epub ahead of print]
 
  High hepatitis B virus infection in B-cell lymphoma tissue and its potential clinical relevance
Wang F, Yuan S, Teng KY, Garcia-Prieto C, Luo HY, Zeng MS, Rao HL, Xia Y, Jiang WQ, Huang HQ, Xia ZJ, Sun XF, Xu RH. Eur J Cancer Prev. 2012 May;21(3):261-7.
 
  Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires
Giang L, Selinger CP, Lee AU. World J Hepatol. 2012 Feb 27;4(2):43-9.
 
  A large case-control study on the predictability of hepatitis B surface antigen (HBsAg) levels three years before HBsAg seroclearance
Seto WK, Wong DK, Fung J, Hung IF, Fong DY, Yuen JC, Tong T, Lai CL, Yuen MF. Hepatology. 2012 Mar 15. doi: 10.1002/hep.25718. [Epub ahead of print]
 
  Prevention of de novo hepatitis B with adefovir dipivoxil (ADV) in recipients of liver grafts from hepatitis B core antibody positive (HBcAb+) donors
Chang MS, Olsen SK, Pichardo EM, Heese S, Stiles JB, Abdelmessih R, Verna EC, Guarrera JV, Emond JC, Brown RS. Liver Transpl. 2012 Mar 16. doi: 10.1002/lt.23429. [Epub ahead of print]
 
  Model for End-stage Liver Disease and Model for End-stage Liver Disease-Na Scores Predict Both Before-Listing and Wait-List Mortality
Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N. Transplant Proc. 2012 Mar;44(2):389-92.
 
  Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak
Williams RE, Sena AC, Moorman AC, Moore ZS, Sharapov UM, Drobenuic J, Hu DJ, Wood HW, Xing J, Spradling PR. Vaccine. 2012 Mar 12. [Epub ahead of print]
 
  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review
Marcucci F, Spada E, Mele A, Caserta CA, Pulsoni A. Am J Blood Res. 2012;2(1):18-28. Epub 2012 Jan 1.
 
  A Large Population Histology Study Showing the Lack of Association between ALT Elevation and Significant Fibrosis in Chronic Hepatitis B
Seto WK, Lai CL, Ip PP, Fung J, Wong DK, Yuen JC, Hung IF, Yuen MF. PLoS One. 2012;7(2):e32622. Epub 2012 Feb 28.
 
  Analysis of Precore/Core Covariances Associated with Viral Kinetics and Genotypes in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients
Cheng CP, Lee PF, Liu WC, Wu IC, Chin CY, Chang TT, Tseng VS. PLoS One. 2012;7(2):e32553. Epub 2012 Feb 27
 
  Discordance between Liver Biopsy and FibroScan® in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation
Kim SU, Kim JK, Park YN, Han KH. PLoS One. 2012;7(2):e32233. Epub 2012 Feb 23.
 
  Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients
Buti M, Morillas RM, Prietoj M, Diago M, Pérez J, Solà R, Bonet L, Palauj A, Testillano M, García-Samaniego J, Rodríguez M; the ORIENTE Study Group. Eur J Gastroenterol Hepatol. 2012 Feb 29. [Epub ahead of print]
 
  Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis
Zheng XY, Wei RB, Tang L, Li P, Zheng XD. World J Gastroenterol. 2012 Feb 28;18(8):821-32.
 
  Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
Matsumoto A, Tanaka E, Morita S, Yoshizawa K, Umemura T, Joshita S. J Gastroenterol. 2012 Feb 29. [Epub ahead of print]
 
  Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection
Mori N, Suzuki F, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saito S, Suzuki Y, Arase Y, Ikeda K, Kobayashi M, Kumada H. J Gastroenterol. 2012 Feb 29. [Epub ahead of print]
 
  Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapy
Dupouey J, Gerolami R, Solas C, Colson P. Clin Res Hepatol Gastroenterol. 2012 Feb 17. [Epub ahead of print]
 
  Hepatitis B Infection in the Asian and Latino Communities of Alameda County, California
Hur K, Wong M, Lee J, Lee J, Juon HS. J Community Health. 2012 Feb 24. [Epub ahead of print]
 
  Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication
Hodgson AA, Hyser JM, Keasler VV, Cang Y, Slagle BL. Virology. 2012 Feb 16. [Epub ahead of print]
 
  Role of hyaluronic acid and laminin as serum markers for predicting significant fibrosis in patients with chronic hepatitis B
Li F, Zhu CL, Zhang H, Huang H, Wei Q, Zhu X, Cheng XY. Braz J Infect Dis. 2012 Feb;16(1):9-14.
 
  Neuromuscular disorders associated with hepatitis B virus infection
Stübgen JP. J Clin Neuromuscul Dis. 2011 Sep;13(1):26-37.
 
  Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNF? agents: A retrospective analysis of 49 cases
Ryu HH, Lee EY, Shin K, Choi IA, Lee YJ, Yoo B, Park MC, Park YB, Bae SC, Yoo WH, Kim SI, Lee EB, Song YW. Clin Rheumatol. 2012 Feb 17. [Epub ahead of print]
 
  Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation
Todd Stravitz R, Shiffman ML, Kimmel M, Puri P, Luketic VA, Sterling RK, Sanyal AJ, Cotterell AH, Posner MP, Fisher RA. Liver Int. 2012 Feb 21. doi: 10.1111/j.1478-3231.2012.02770.x. [Epub ahead of print]
 
  The role of adherence in virological suppression in patients receiving anti-HBV analogues
Sogni P, Carrieri MP, Fontaine H, Mallet V, Vallet-Pichard A, Trabut JB, Méritet JF, Pol S. Antivir Ther. 2011 Nov 3. doi: 10.3851/IMP1944. [Epub ahead of print]
 
  Viral Hepatitis in the Elderly
Carrion AF, Martin P. Am J Gastroenterol. 2012 Jan 31. doi: 10.1038/ajg.2012.7. [Epub ahead of print]
 
  Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance
Yang HJ, Lee JH, Kim YJ, Yoon JH, Lee HS. J Med Virol. 2012 Mar;84(3):424-30. doi: 10.1002/jmv.23229.
 
  Hepatitis B infection: current concepts and future challenges
Nebbia G, Peppa D, Maini MK. QJM. 2012 Feb;105(2):109-13.
 
  Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir
de Niet A, Takkenberg RB, Benayed R, Riley-Gillis B, Weegink CJ, Zaaijer HL, Koot M, Jansen PL, Beld MG, Lopatin U, Reesink HW. Scand J Gastroenterol. 2012 Jan 23. [Epub ahead of print]
 
  Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure
Ling Q, Xu X, Wei Q, Liu X, Guo H, Zhuang L, Chen J, Xia Q, Xie H, Wu J, Zheng S, Li L. PLoS One. 2012;7(1):e30322. Epub 2012 Jan 24.
 
  Estimating the Prevalence of Chronic Hepatitis B Virus Infection-New York City, 2008
France AM, Bornschlegel K, Lazaroff J, Kennedy J, Balter S. J Urban Health. 2012 Jan 13. [Epub ahead of print]
 
  Adult vaccination coverage - United States, 2010
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2012 Feb 3;61:66-72.
 
  Can we direct organ allocation based on predicted outcome? Hepatocellular carcinoma outside of UCSF criteria or retransplant?
Rochon C, Sheiner P, Mahadevappa B, Gunasekaran G, Sharma J, Wolf DC, Facciuto M. Langenbecks Arch Surg. 2012 Jan 28. [Epub ahead of print]
 
  Interventional Radiologic Treatment of Hepatocellular Carcinoma-A Cost Analysis from the Payer Perspective
Ray CE Jr, Battaglia C, Libby AM, Prochazka A, Xu S, Funaki B. J Vasc Interv Radiol. 2012 Jan 23. [Epub ahead of print]
 
  Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation
Hsu YC, Mo LR, Chang CY, Perng DS, Tseng CH, Lo GH, Tai CM, Lin CW, Hsu CC, Hsu CY, Huang SC, Lin JT. Antivir Ther. 2011 Dec 20. doi: 10.3851/IMP2027. [Epub ahead of print]
 
  Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis B
Wang J, Cai Y, Ji H, Feng J, Ayana DA, Niu J, Jiang Y. J Interferon Cytokine Res. 2012 Feb 3. [Epub ahead of print]
 
  Hepatitis B virus in transfusion medicine: Still a problem?
Allain JP, Candotti D; the ISBT HBV Safety Collaborative Group. Biologicals. 2012 Feb 1. [Epub ahead of print]
 
  The current economic burden of cirrhosis
Neff GW, Duncan CW, Schiff ER. Gastroenterol Hepatol (N Y). 2011 Oct;7(10):661-71.
 
  Correlation of improved hepatitis?B surface antigen detection limits with hepatitis?B virus DNA nucleic acid test yield in blood donations
Martin LA, Stramer SL, Kuhns MC, Schlauder GG. Transfusion. 2012 Feb 10. doi: 10.1111/j.1537-2995.2011.03553.x. [Epub ahead of print]
 
  How Many Valid Measurements Are Necessary to Assess Liver Fibrosis Using FibroScan® in Patients with Chronic Viral Hepatitis? An Analysis of Subjects with at Least 10 Valid Measurements
Jang HW, Kim SU, Park JY, Ahn SH, Han KH, Chon CY, Park YN, Choi EH, Kim do Y. Yonsei Med J. 2012 Mar 1;53(2):337-45. doi: 10.3349/ymj.2012.53.2.337.
 
  Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B
Song JC, Min BY, Kim JW, Kim JY, Kim YM, Shin CM, Lee SH, Hwang JH, Jeong SH, Kim N, Lee DH. Korean J Hepatol. 2011 Dec;17(4):268-73. doi: 10.3350/kjhep.2011.17.4.268.
 
  Does Interleukin-28B (IL-28B) single nucleotide polymorphisms influence the natural history of hepatitis B?
Martin-Carbonero L, Rallón N, Benito JM, Poveda E, González-Lahoz J, Soriano V. AIDS Res Hum Retroviruses. 2012 Feb 12. [Epub ahead of print]
 
  Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma
Ren S, Lu J, Du X, Huang Y, Ma L, Huo H, Chen X, Wei L. Cancer Immunol Immunother. 2012 Feb 4. [Epub ahead of print]
 
  Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants
Billioud G, Pichoud C, Parent R, Zoulim F. J Hepatol. 2012 Feb 4. [Epub ahead of print]
 
  Napa Immunization Study: Immunization Rates for Children with Publicly Funded Insurance Compared with those with Private Health Insurance in a Suburban Medical Office
Cotter JC. Perm J. 2011 Fall;15(4):12-22.
 
  Safety and efficacy of two-step peginterferon ?-2a treatment in patients of chronic hepatitis B with acute exacerbation
Chen CC, Wang PC, Chang HW, Chen CF. J Viral Hepat. 2012 Mar;19(3):161-72. doi: 10.1111/j.1365-2893.2011.01469.x. Epub 2011 Jul 4.
 
  Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs
Chotiyaputta W, Hongthanakorn C, Oberhelman K, Fontana RJ, Licari T, Lok AS. J Viral Hepat. 2012 Mar;19(3):205-12. doi: 10.1111/j.1365-2893.2011.01494.x. Epub 2011 Jul 14.
 
  Prognosis predictability of hepatocellular carcinoma according to staging systems in hepatitis B virus-endemic area
Kang HY, Shin HD, Kim SB, Song IH. Clin Res Hepatol Gastroenterol. 2012 Feb 8. [Epub ahead of print]
 
  Association of polymorphisms in interleukin-18 and interleukin-28B with Hepatitis B recurrence after liver transplantation in Chinese Han population
Li Y, Shi Y, Chen J, Cai B, Ying B, Wang L. Int J Immunogenet. 2012 Feb 10. doi: 10.1111/j.1744-313X.2012.01097.x. [Epub ahead of print]
 
  Quality of Life and the Relevant Factors in Patients with Chronic Hepatitis B
Wang L, Wang Y, Tang L, Feng C, Liu X, Zhang R, Liu D. Hepatogastroenterology. 2012 Feb 10;59(116). doi: 10.5754/hge11867. [Epub ahead of print]
 
  Selection of chronic hepatitis B therapy with high barrier to resistance
Gish R, Jia JD, Locarnini S, Zoulim F. Lancet Infect Dis. 2012 Feb 8. [Epub ahead of print]
 
  Peginteferon-? does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis
Penna A, Laccabue D, Libri I, Giuberti T, Schivazappa S, Alfieri A, Mori C, Canetti D, Lampertico P, Viganò M, Colombo M, Loggi E, Missale G, Ferrari C. J Hepatol. 2012 Feb 9. [Epub ahead of print]
 
  Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir
Pan CQ, Hu KQ, Yu AS, Chen W, Bunchorntavakul C, Reddy KR. J Viral Hepat. 2012 Mar;19(3):213-9. doi: 10.1111/j.1365-2893.2011.01533.x. Epub 2011 Oct 17.
 
  Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age
Halperin SA, Ward B, Cooper C, Predy G, Diaz-Mitoma F, Dionne M, Embree J, McGeer A, Zickler P, Moltz KH, Martz R, Meyer I, McNeil S, Langley JM, Martins E, Heyward WL, Martin JT. Vaccine. 2012 Feb 8. [Epub ahead of print]
 
  Kinetics of HBs and HBe antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-HBV infected patients
Maylin S, Boyd A, Lavocat F, Gozlan J, Lascoux-Combe C, Miailhes P, Lassel L, Delaugerre C, Girard PM, Zoulim F, Lacombe K. AIDS. 2012 Feb 13. [Epub ahead of print]
 
  Antiviral therapy of decompensated hepatitis B virus-related cirrhosis
Chen GC, Yu T, Huang KH, Chen QK. Chin Med J (Engl). 2012 Jan;125(2):373-7.
 
  Consumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma
Sawada N, Inoue M, Iwasaki M, Sasazuki S, Shimazu T, Yamaji T, Takashi R, Tanaka Y, Mizokami M, Tsugane S; Japan Public Health Center-based Prospective StudyGroup.. Gastroenterology. 2012 Feb 16. [Epub ahead of print]
 
  Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients
Idilman R, Cinar K, Seven G, Bozkus Y, Elhan A, Bozdayi M, Yurdaydin C, Bahar K. J Viral Hepat. 2012 Mar;19(3):220-6. doi: 10.1111/j.1365-2893.2011.01542.x. Epub 2011 Oct 19.
 
  High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients with Low HBV Load
Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Gastroenterology. 2012 Feb 11. [Epub ahead of print]
 
  Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B
Huang Z, van Velkinburgh JC, Ni B, Wu Y. Liver Int. 2012 Feb 19. doi: 10.1111/j.1478-3231.2012.02764.x. [Epub ahead of print]
 
  Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B
Huang Z, van Velkinburgh JC, Ni B, Wu Y. Liver Int. 2012 Feb 19. doi: 10.1111/j.1478-3231.2012.02764.x. [Epub ahead of print]
 
  Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis
Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S. BMC Gastroenterol. 2012 Feb 14;12(1):14. [Epub ahead of print]
 
  Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B
Chen Y, Ju T. Int J Infect Dis. 2012 Jan 4. [Epub ahead of print]
 
  Viral infections and human cancers: the legacy of Denis Burkitt
Harford JB. Br J Haematol. 2012 Jan 11. doi: 10.1111/j.1365-2141.2011.09017.x. [Epub ahead of print]
 
  Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901
Manns MP, Akarca US, Chang TT, Sievert W, Yoon SK, Tsai N, Min A, Pangerl A, Beebe S, Yu M, Wongcharatrawee S. Expert Opin Drug Saf. 2012 Jan 11. [Epub ahead of print]
 
  Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
Peng CY, Lai HC, Li YF, Su WP, Chuang PH, Kao JT. Aliment Pharmacol Ther. 2012 Feb;35(4):458-68. doi: 10.1111/j.1365-2036.2011.04973.x. Epub 2012 Jan 8.
 
  Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
Kurokawa M, Hiramatsu N, Oze T, Yakushijin T, Miyazaki M, Hosui A, Miyagi T, Yoshida Y, Ishida H, Tatsumi T, Kiso S, Kanto T, Kasahara A, Iio S, Doi Y, Yamada A, Oshita M, Kaneko A, Mochizuki K, Hagiwara H, Mita E, Ito T, Inui Y, Katayama K, Yoshihara H, Imai Y, Hayashi E, Hayashi N, Takehara T. J Gastroenterol. 2012 Jan 11. [Epub ahead of print]
 
  "Never Events": Hepatitis B Outbreaks and Patient Notifications Resulting from Unsafe Practices during Assisted Monitoring of Blood Glucose, 2009-2010
Thompson ND, Schaefer MK. J Diabetes Sci Technol. 2011 Nov 1;5(6):1396-402.
 
  Efficacy of Lamivudine or entecavir on acute exacerbation of chronic hepatitis B
Kanda T, Shinozaki M, Kamezaki H, Wu S, Nakamoto S, Arai M, Fujiwara K, Goto N, Imazeki F, Yokosuka O. Int J Med Sci. 2012;9(1):27-32. Epub 2011 Nov 10.
 
  Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B
Chen Y, Ju T. Int J Infect Dis. 2012 Jan 4. [Epub ahead of print]
 
  Do prior contraceptive methods impact maternal carriage in patients with hepatitis B?
Lao TT, Chan OK, Suen SS, Leung TY. Hepat Mon. 2011 Oct 1;11(10):829-34.
 
  Frequency and Mutation Patterns of Resistance in Patients with Chronic Hepatitis B Infection Treated with Nucleos(t)ide Analogs in Add-On and Switch Strategies
Sayan M, Akhan SC, Senturk O. Hepat Mon. 2011 Oct 1;11(10):835-42.
 
  ABO Blood Group and the Risk of Hepatocellular Carcinoma: A Case-Control Study in Patients with Chronic Hepatitis B
Li Q, Yu CH, Yu JH, Liu L, Xie SS, Li WW, Yang X, Fan WB, Gai ZT, Chen SJ, Kato N. PLoS One. 2012;7(1):e29928. Epub 2012 Jan 3.
 
  Adefovir dipivoxil in chronic hepatitis B: history and current uses
Segovia MC, Chacra W, Gordon SC. Expert Opin Pharmacother. 2012 Feb;13(2):245-54.
 
  Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues
Lim YS, Lee TH, Heo NY, Shim JH, Lee HC, Suh DJ. Antivir Ther. 2012;17(1):53-60.
 
  Serial HBV DNA levels in patients with persistently normal transaminase over 10?years following spontaneous HBeAg seroconversion
Chen YC, Huang SF, Chu CM, Liaw YF. J Viral Hepat. 2012 Feb;19(2):138-46. doi: 10.1111/j.1365-2893.2011.01450.x. Epub 2011 Mar 14.
 
  Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B
Kwon JH, Jang JW, Lee S, Lee J, Chung KW, Lee YS, Choi JY. J Viral Hepat. 2012 Feb;19(2):e41-7. doi: 10.1111/j.1365-2893.2011.01509.x. Epub 2011 Nov 20.
 
  The Option of HBIG-Free Prophylaxis Against Recurrent HBV
Fox AN, Terrault NA. J Hepatol. 2012 Jan 21. [Epub ahead of print]
 
  Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance
Arai M, Togo S, Kanda T, Fujiwara K, Imazeki F, Yokosuka O. Eur J Gastroenterol Hepatol. 2012 Jan 23. [Epub ahead of print]
 
  Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Vaccine. 2012 Jan 21. [Epub ahead of print]
 
  High Hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study
Zhou JY, Zhang L, Li L, Gu GY, Zhou YH, Chen JH. Virol J. 2012 Jan 13;9(1):16. [Epub ahead of print]
 
  IL28B rs12979860 polymorphism dose not influence outcomes of hepatitis B virus infection
Peng LJ, Guo JS, Zhang Z, Shi H, Wang J, Wang JY. Tissue Antigens. 2012 Jan 13. doi: 10.1111/j.1399-0039.2011.01835.x. [Epub ahead of print]
 
  Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis
Singal AK, Fontana RJ. Aliment Pharmacol Ther. 2012 Jan 19. doi: 10.1111/j.1365-2036.2011.04990.x. [Epub ahead of print]
 
  Surveillance for chronic hepatitis B virus infection - new york city, june 2008-november 2009
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2012 Jan 13;61:6-9.
 
  Validation of A Stopping Rule at Week 12 Using HBsAg and HBV DNA for HBeAg-Negative Patients Treated with Peginterferon Alfa-2a
Rijckborst V, Hansen BE, Ferenci P, Brunetto MR, Tabak F, Cakaloglu Y, Galeota Lanza A, Messina V, Iannacone C, Massetto B, Regep L, Colombo M, Janssen HL, Lampertico P. J Hepatol. 2012 Jan 12. [Epub ahead of print]
 
  Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-?2b: relation to response and HBV genotype
Sonneveld MJ, Rijckborst V, Cakaloglu Y, Simon K, Heathcote EJ, Tabak F, Mach T, Boucher CA, Hansen BE, Zeuzem S, Janssen HL. Antivir Ther. 2012;17(1):9-17.
 
  Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer
Torres HA, Davila M. Nat Rev Clin Oncol. 2012 Jan 24. doi: 10.1038/nrclinonc.2012.1. [Epub ahead of print]
 
  Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy
Pei SN, Ma MC, Wang MC, Kuo CY, Rau KM, Su CY, Chen CH. Ann Hematol. 2012 Jan 25. [Epub ahead of print]
 
  Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Tsan YT, Lee CH, Wang JD, Chen PC. J Clin Oncol. 2012 Jan 23. [Epub ahead of print]
 
  Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007
Ladak F, Gjelsvik A, Feller E, Rosenthal S, Montague BT. Infection. 2012 Jan 12. [Epub ahead of print]
 
  Factors predicting the efficacy of adefovir dipivoxil on treatment-naïve chronic hepatitis B patients at 48 weeks
Wang LC, Chen EQ, Zhu XF, Xiong ZH, Liu L, Xu L, Lei XZ, Liu C, Tang H. Gut Liver. 2011 Dec;5(4):478-85. Epub 2011 Nov 21.
 
  Use of Nucleoside (Tide) Analogues in Patients with Hepatitis B-Related Acute Liver Failure
Dao DY, Seremba E, Ajmera V, Sanders C, Hynan LS, Lee WM; The Acute Liver Failure Study Group. Dig Dis Sci. 2011 Dec 25. [Epub ahead of print]
 
  Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients
Kim KM, Eo SJ, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Gut Liver. 2011 Dec;5(4):500-5. Epub 2011 Nov 21.
 
  A systematic review of the fetal safety of interferon alpha
Yazdani Brojeni P, Matok I, Garcia Bournissen F, Koren G. Reprod Toxicol. 2011 Dec 19. [Epub ahead of print]
 
  Effects of Maternal Screening and Universal Immunization to Prevent Mother-To-Infant Transmission of HBV
Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, Huang FC, Wu SF, Chen SC, Wen WH, Chu CH, Ni YH, Hsu HY, Tsai PL, Chiang CL, Shyu MK, Lee PI, Chang FY, Chang MH. Gastroenterology. 2011 Dec 22. [Epub ahead of print]
 
  Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B
Jiang X, Zhang M, Lai Q, Huang X, Li Y, Sun J, Abbott WG, Ma S, Hou J. PLoS One. 2011;6(12):e28871. Epub 2011 Dec 16.
 
  Emerging pipeline drugs for hepatitis B infection
Cox N, Tillmann H. Expert Opin Emerg Drugs. 2011 Dec;16(4):713-29.
 
  Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60:1709-11.
 
  Protective hepatitis B surface antibodies in blood and ascites fluid in the early stage after liver transplantation for hepatitis B diseases
Wang K, Zhu ZJ, Zheng H, Deng YL, Pan C, Sun LY, Shen ZY. Hepatol Res. 2011 Dec 16. doi: 10.1111/j.1872-034X.2011.00926.x. [Epub ahead of print]
 
  Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management
Viganò M, Degasperi E, Aghemo A, Lampertico P, Colombo M. Expert Opin Biol Ther. 2011 Dec 22. [Epub ahead of print]
 
  Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients
Kwak MS, Cho EJ, Jang ES, Lee JH, Yu SJ, Kim YJ, Yoon JH, Lee HS. Digestion. 2011;84 Suppl 1:23-8. Epub 2011 Dec 2.
 
  Prediction and prevention of intrahepatic recurrence of hepatocellular carcinoma
Izumi N. Hepatol Res. 2011 Dec 19. doi: 10.1111/j.1872-034X.2011.00922.x. [Epub ahead of print]
 
  Treatment of chronic hepatitis B with nucleos(t)ide analogues
Ohishi W, Chayama K. Hepatol Res. 2011 Dec 19. doi: 10.1111/j.1872-034X.2011.00921.x. [Epub ahead of print]
 
  Hepatitis B virus serology to predict antiviral response in chronic hepatitis B
Kim BK, Han KH, Ahn SH. Digestion. 2011;84 Suppl 1:29-34. Epub 2011 Dec 2.
 
  The increasing burden of imported chronic hepatitis B - United States, 1974-2008
Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA. PLoS One. 2011;6(12):e27717. Epub 2011 Dec 7.
 
  Hepatitis B virus infection and the risk of hepatocellular carcinoma
Tan YJ. World J Gastroenterol. 2011 Nov 28;17(44):4853-7.
 
  The Efficacy and Tolerability of Pegylated Interferon-?-2a in Chronic Hepatitis B: A Multicenter Clinical Experience
Ratnam D, Dev A, Nguyen T, Sundararajan V, Harley H, Cheng W, Lee A, Rusli F, Chen R, Bell S, Pianko S, Sievert W. J Gastroenterol Hepatol. 2011 Dec 14. doi: 10.1111/j.1440-1746.2011.07051.x. [Epub ahead of print]
 
  Efficacy of High-Dose Intra-dermal Hepatitis B Virus Vaccine in Previous Vaccination Non-responders with Chronic Liver Disease
Dhillon S, Moore C, Li SD, Aziz A, Kakar A, Dosanjh A, Beesla A, Murphy L, Van Thiel DH. Dig Dis Sci. 2011 Dec 9. [Epub ahead of print]
 
  Recent advances in the management of chronic hepatitis B
Kim SR, Yang J, Kudo M, Hino O. Hepat Mon. 2011 Aug 1;11(8):601-11.
 
  Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease
Keating GM. Drugs. 2011 Dec 24;71(18):2511-29. doi: 10.2165/11208510-000000000-00000.
 
  Prevention of Hepatitis B Recurrence in Liver Transplant Patients Using Oral Antiviral Therapy without Long-Term Hepatitis B Immunoglobulin
Ahn J, Cohen SM. Hepat Mon. 2011 Aug 1;11(8):638-45.
 
  Entecavir Monotherapy is Eeffective in Suppressing Hepatitis B Virus after Liver Transplantation
Fung J, Cheung C, Chan SC, Yuen MF, Chok KS, Sharr W, Dai WC, Chan AC, Cheung TT, Tsang S, Lam B, Lai CL, Lo CM. Gastroenterology. 2011 Jul 12.
 
  Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice
Ridruejo E, Adrover R, Cocozzella D, Reggiardo MV, Estepo C, Schroder T, Paz S, Mendizábal M, Fainboim H, Mandó OG, Silva MO. Int J Clin Pract. 2011 Aug;65(8):866-870. doi: 10.1111/j.1742-1241.2011.02719.x.
 
  Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels
Cheong JY, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Cho SW. Liver Int. 2011 Jun 23. doi: 10.1111/j.1478-3231.2011.02570.x.
 
  Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age
Ray P, Black S, Shinefield H, Dillon A, Carpenter D, Lewis E, Ross P, Chen RT, Klein NP, Baxter R; for the Vaccine Safety Datalink Team. Vaccine. 2011 Jul 13.
 
  A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol
Xie W, Shi G, Zhang H, Zhao G, Yu Z, Lang Z, Zhao H, Yan J, Cheng J. Hepatol Int. 2011 Jul 20.
 
  Frequency and Risk Factors of Renal Impairment During Long-term Adefovir Dipivoxil Treatment in Chronic Hepatitis B Patients
Kim YJ, Cho HC, Sinn DH, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. J Gastroenterol Hepatol. 2011 Jul 20. doi: 10.1111/j.1440-1746.2011.06852.x.
 
  Cost effectiveness of screening immigrants for hepatitis B
Wong WW, Woo G, Jenny Heathcote E, Krahn M. Liver Int. 2011 Jun 14. doi: 10.1111/j.1478-3231.2011.02559.x.
 
  Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: A European multicenter study
Si-Ahmed SN, Pradat P, Zoutendijk R, Buti M, Mallet V, Cruiziat C, Deterding K, Dumortier J, Bailly F, Esteban R, Wedemeyer H, Janssen HL, Zoulim F. Antiviral Res. 2011 Jul 15.
 
  Update on childhood and adolescent immunizations: selected review of US recommendations and literature: part 1
Fay KE, Lai J, Bocchini JA Jr. Curr Opin Pediatr. 2011 Aug;23(4):460-9.
 
  Hepatitis B Vaccination Coverage and Documented Seroprotection among Matriculating Healthcare Students at an Academic Institution in the United States
Tohme RA, Ribner B, Huey MJ, Spradling PR. Infect Control Hosp Epidemiol. 2011 Aug;32(8):818-21.
 
  The effect of caffeine and alcohol consumption on liver fibrosis - a study of 1045 Asian hepatitis B patients using transient elastography
Ong A, Wong VW, Wong GL, Chan HL. Liver Int. 2011 Aug;31(7):1047-53. doi: 10.1111/j.1478-3231.2011.02555.x. Epub 2011 May 31.
 
  Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis
Shi Y, Wu YH, Wei W, Zhang WJ, Yang J, Chen Z. Liver Int. 2011 Feb 23. doi: 10.1111/j.1478-3231.2011.02481.x.
 
  Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2?cm in a hepatitis B virus-endemic area
Kim SE, Lee HC, Shim JH, Park HJ, Kim KM, Kim PN, Shin YM, Yu ES, Chung YH, Suh DJ. Liver Int. 2011 Apr 11. doi: 10.1111/j.1478-3231.2011.02529.x.
 
  The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a long-term follow-up
Hu TH, Tsai MC, Chen YT, Chien YS, Hung CH, Chen TC, Tseng PL, Chang KC, Yen YH.
 
  Antiviral Drug Resistance Testing in Patients with Chronic Hepatitis B
Wong VW, Wong GL, Tse CH, Yuen LK, Chan HY, Locarnini SA, Chan HL. Dig Dis Sci. 2011 Jul 9.
 
  Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation
Isaacs D, Kilham HA, Alexander S, Wood N, Buckmaster A, Royle J. Vaccine. 2011 Jun 29.
 
  Hepatitis B surface antigen Quantification: Why and How to use it in 2011 - A Core Group Report
Chan HL, Thompson A, Martinot-Peignoux M, Piratvisuth T, Cornberg M, Brunetto MR, Tillmann HL, Kao JH, Jia JD, Wedemeyer H, Locarnini S, Janssen HL, Marcellin P; for the Good Practice in using sAg in Chronic Hepatitis B Study Group (GPs-CHB Study Group). J Hepatol. 2011 Jun 27.
 
  Correlation between maternal hepatitis B surface antigen carrier status with social, medical and family factors in an endemic area: have we overlooked something?
Chan OK, Lao TT, Suen SS, Lau TK, Leung TY. Infection. 2011 Jun 29.
 
  Predictive Effect of Serial Serum Alanine Aminotransferase Levels on Spontaneous HBeAg Seroconversion in Chronic Genotypes B and C HBV infected Children
Wu JF, Su YR, Chen CH, Chen HL, Ni YH, Hsu HY, Wang JL, Chang MH. J Pediatr Gastroenterol Nutr. 2011 Jun 28.
 
  Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy
Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS. Ann Rheum Dis. 2011 Jun 29.
 
  Knowledge of Hepatitis B Risk Factors and Prevention Practices among Individuals Chronically Infected with Hepatitis B in San Francisco, California
Nishimura A, Shiono P, Stier D, Shallow S, Sanchez M, Huang S. J Community Health. 2011 Jun 30.
 
  Tenofovir nephrotoxicity: 2011 update
Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-Niño MD, Izquierdo MC, Poveda J, Sainz-Prestel V, Ortiz-Martin N, Parra-Rodriguez A, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A. AIDS Res Treat. 2011;2011:354908. Epub 2011 Jun 7.
 
  Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the united states population
Younossi ZM, Stepanova M. Hepatology. 2011 Jul 2. doi: 10.1002/hep.24510.
 
  Alcohol Consumption Is Inversely Correlated With Insulin Resistance, Independent of Metabolic Syndrome Factors and Fatty Liver Diseas
Gunji T, Matsuhashi N, Sato H, Iijima K, Fujibayashi K, Okumura M, Sasabe N, Urabe A. J Clin Gastroenterol. 2011 Jun 20.
 
  Should chronic hepatitis B mothers breastfeed? A meta analysis
Zheng Y, Lu Y, Ye Q, Xia Y, Zhou Y, Yao Q, Wei S. BMC Public Health. 2011 Jun 27;11(1):502.
 
  Managing patients with hepatitis B-related or hepatitis C-related decompensated cirrhosis
Fink SA, Jacobson IM. Nat Rev Gastroenterol Hepatol. 2011 May;8(5):285-95.
 
  Hepatitis B surface antigen monitoring and management of chronic hepatitis B
Sonneveld MJ, Zoutendijk R, Janssen HL. J Viral Hepat. 2011 Jul;18(7):449-57. doi: 10.1111/j.1365-2893.2011.01465.x. Epub 2011 May 23.
 
  Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: A meta-analysis of randomized controlled trials
Zhang CH, Xu GL, Jia WD, Li JS, Ma JL, Ge YS. Int J Cancer. 2011 Sep 1;129(5):1254-64. doi: 10.1002/ijc.25767. Epub 2011 Jan 6.
 
  A Proinflammatory Role For Interleukin-22 In The Immune Response To Hepatitis B Virus
Zhang Y, Cobleigh MA, Lian JQ, Huang CX, Booth CJ, Bai XF, Robek MD. Gastroenterology. 2011 Jun 24.
 
  Adefovir serum levels do not differ between responders and nonresponders
Deterding K, Naesens L, Buti M, Janssen H, Kirschner J, Guerrero A, Reijnders J, Neyts J, Zoulim F, Wedemeyer H. J Viral Hepat. 2011 Jul;18(7):e175-8. doi: 10.1111/j.1365-2893.2010.01404.x. Epub 2011 Jan 7.
 
  The clinical implications of hepatitis B virus genotype: Recent advances
Lin CL, Kao JH. J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:123-30.
 
  An early decrease in serum HBeAg titre is a strong predictor of virological response to entecavir in HBeAg-positive patients
Zhang X, Lin SM, Ye F, Chen TY, Liu M, Chen YR, Zheng SQ, Zhao YR, Zhang SL. J Viral Hepat. 2011 Jul;18(7):e184-90. doi: 10.1111/j.1365-2893.2010.01423.x. Epub 2011 Jan 13.
 
  Frequency and clinical outcomes of flares related to nucleos(t)ide analogue therapy in patients with chronic hepatitis B
Zhang NP, Reijnders JG, Perquin M, Hansen BE, Janssen HL. J Viral Hepat. 2011 Jul;18(7):e252-7. doi: 10.1111/j.1365-2893.2011.01448.x. Epub 2011 Mar 1.
 
  Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B
Sanai FM, Helmy A, Bzeizi KI, Babatin MA, Al-Qahtani A, Al-Ashgar HA, Al-Mdani AS, Al-Akwaa A, Almutharea S, Khan MQ, Alghamdi AS, Farah T, Al-Hamoudi W, Saadeh M, Abdo AA. J Viral Hepat. 2011 Jul;18(7):e217-e225. doi: 10.1111/j.1365-2893.2011.01437.x. Epub 2011 Mar 1.
 
  Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance
Sun J, Hou JL, Xie Q, Li XH, Zhang JM, Wang YM, Wang H, Lai JY, Chen SJ, Jia JD, Sheng JF, Chan HL, Wang JF, Li MK, Jiang M, Popescu M, Sung JJ. Aliment Pharmacol Ther. 2011 Jun 22. doi: 10.1111/j.1365-2036.2011.04750.x.
 
  Pregnancy outcomes associated with viral hepatitis
Reddick KL, Jhaveri R, Gandhi M, James AH, Swamy GK. J Viral Hepat. 2011 Jul;18(7):e394-8. doi: 10.1111/j.1365-2893.2011.01436.x. Epub 2011 Feb 8.
 
  Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study
Fung J, Lai CL, Wong DK, Seto WK, Hung I, Yuen MF. J Viral Hepat. 2011 Jul;18(7):e200-5. doi: 10.1111/j.1365-2893.2010.01428.x. Epub 2011 Jan 7.
 
  Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection
Seto WK, Yuen MF, Fung J, Lai CL. Hepatol Int. 2011 Jun 19.
 
  Drug safety evaluation of adefovir in HBV infection
Viganò M, Lampertico P, Colombo M. Expert Opin Drug Saf. 2011 Jun 15.
 
  Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B
Poynard T, Ngo Y, Munteanu M, Thabut D, Ratziu V. Curr Hepat Rep. 2011 Jun;10(2):87-97. Epub 2011 Mar 1.
 
  Hepatitis B virus infection and pregnancy
Pol S, Corouge M, Fontaine H. Clin Res Hepatol Gastroenterol. 2011 Jun 7.
 
  Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
Liu CJ, Chen PJ, Chen DS, Kao JH. Hepatol Int. 2011 Jun 14.
 
  Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
Liang Y, Jiang J, Su M, Liu Z, Guo W, Huang X, Xie R, Ge S, Hu J, Jiang Z, Zhu M, Wong VW, Chan HL. Aliment Pharmacol Ther. 2011 Jun 14. doi: 10.1111/j.1365-2036.2011.04738.x.
 
  Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters
Tseng TC, Liu CJ, Su TH, Wang CC, Chen CL, Chen PJ, Chen DS, Kao JH. Gastroenterology. 2011 Apr 28.
 
  Adverse effects of hepatitis B virus on sperm motility and fertilization ability during IVF
Oger P, Yazbeck C, Gervais A, Dorphin B, Gout C, Jacquesson L, Ayel JP, Kahn V, Rougier N. Reprod Biomed Online. 2011 May 12.
 
  Combination Therapy for Chronic Hepatitis B: Current Indications
Paul N, Han SH. Curr Hepat Rep. 2011 Jun;10(2):98-105. Epub 2011 Feb 19.
 
  Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials
Li WC, Wang MR, Kong LB, Ren WG, Zhang YG, Nan YM. BMC Infect Dis. 2011 Jun 9;11(1):165. [
 
  Treatment of special populations with chronic hepatitis B infection
Rapti IN, Hadziyannis SJ. Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):323-39.
 
  Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: Virological breakthrough is also dependent on adherence to medication
Kamezaki H, Kanda T, Wu S, Nakamoto S, Arai M, Maruyama H, Fujiwara K, Imazeki F, Yokosuka O. Scand J Gastroenterol. 2011 May 30.
 
  Chronic hepatitis B, non-Hodgkin's lymphoma, and effect of prophylactic antiviral therapy
Kim YM, Jeong SH, Kim JW, Lee SH, Hwang JH, Park YS, Kim N, Lee JS, Kim HY, Lee DH. J Clin Virol. 2011 May 29.
 
  Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy
Ohishi W, Chayama K. Clin Exp Nephrol. 2011 Jun 1.
 
  Chronic Liver Disease in the Hispanic Population of the United States
Carrion AF, Ghanta R, Carrasquillo O, Martin P. Clin Gastroenterol Hepatol. 2011 May 12.
 
  Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the united states population
Younossi ZM, Stepanova M. Hepatology. 2011 Jul 2. doi: 10.1002/hep.24510. [Epub ahead of print]
 
  Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation
Isaacs D, Kilham HA, Alexander S, Wood N, Buckmaster A, Royle J. Vaccine. 2011 Jun 29. [Epub ahead of print]
 
  Hepatitis B surface antigen Quantification: Why and How to use it in 2011 - A Core Group Report
Chan HL, Thompson A, Martinot-Peignoux M, Piratvisuth T, Cornberg M, Brunetto MR, Tillmann HL, Kao JH, Jia JD, Wedemeyer H, Locarnini S, Janssen HL, Marcellin P; for the Good Practice in using sAg in Chronic Hepatitis B Study Group (GPs-CHB Study Group). J Hepatol. 2011 Jun 27. [Epub ahead of print]
 
  Correlation between maternal hepatitis B surface antigen carrier status with social, medical and family factors in an endemic area: have we overlooked something?
Chan OK, Lao TT, Suen SS, Lau TK, Leung TY. Infection. 2011 Jun 29. [Epub ahead of print]
 
  Predictive Effect of Serial Serum Alanine Aminotransferase Levels on Spontaneous HBeAg Seroconversion in Chronic Genotypes B and C HBV infected Children
Wu JF, Su YR, Chen CH, Chen HL, Ni YH, Hsu HY, Wang JL, Chang MH. J Pediatr Gastroenterol Nutr. 2011 Jun 28. [Epub ahead of print]
 
  Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy
Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS. Ann Rheum Dis. 2011 Jun 29. [Epub ahead of print]
 
  Knowledge of Hepatitis B Risk Factors and Prevention Practices among Individuals Chronically Infected with Hepatitis B in San Francisco, California
Nishimura A, Shiono P, Stier D, Shallow S, Sanchez M, Huang S. J Community Health. 2011 Jun 30. [Epub ahead of print]
 
  Tenofovir nephrotoxicity: 2011 update
Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-Niño MD, Izquierdo MC, Poveda J, Sainz-Prestel V, Ortiz-Martin N, Parra-Rodriguez A, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A. AIDS Res Treat. 2011;2011:354908. Epub 2011 Jun 7.
 
  The effect of caffeine and alcohol consumption on liver fibrosis - a study of 1045 Asian hepatitis B patients using transient elastography
Ong A, Wong VW, Wong GL, Chan HL. Liver Int. 2011 Aug;31(7):1047-53. doi: 10.1111/j.1478-3231.2011.02555.x. Epub 2011 May 31.
 
  Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis
Shi Y, Wu YH, Wei W, Zhang WJ, Yang J, Chen Z. Liver Int. 2011 Feb 23. doi: 10.1111/j.1478-3231.2011.02481.x. [Epub ahead of print]
 
  Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2?cm in a hepatitis B virus-endemic area
Kim SE, Lee HC, Shim JH, Park HJ, Kim KM, Kim PN, Shin YM, Yu ES, Chung YH, Suh DJ. Liver Int. 2011 Apr 11. doi: 10.1111/j.1478-3231.2011.02529.x. [Epub ahead of print]
 
  The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a long-term follow-up
Hu TH, Tsai MC, Chen YT, Chien YS, Hung CH, Chen TC, Tseng PL, Chang KC, Yen YH.
 
  Antiviral Drug Resistance Testing in Patients with Chronic Hepatitis B
Wong VW, Wong GL, Tse CH, Yuen LK, Chan HY, Locarnini SA, Chan HL. Dig Dis Sci. 2011 Jul 9. [Epub ahead of print]
 
  Antiretroviral use during pregnancy for treatment or prophylaxis
Sturt AS, Read JS. Expert Opin Pharmacother. 2011 May 3. [Epub ahead of print]
 
  Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection
Li J, Han Y, Jin K, Wan Y, Wang S, Liu B, Liu Y, Lu S, Huang Z. Virol J. 2011 May 2;8(1):199. [Epub ahead of print]
 
  The epidemiological pattern of chronic liver diseases in a community undergoing voluntary screening for hepatitis B and C
Zani C, Pasquale L, Bressanelli M, Puoti M, Paris B, Coccaglio R, Lascioli I, Pieriacci G, Donato F. Dig Liver Dis. 2011 Apr 28. [Epub ahead of print]
 
  Hepatitis B virus infection from an evolutionary point of view: How viral, host, and environmental factors shape genotypes and subgenotypes
Araujo NM, Waizbort R, Kay A. Infect Genet Evol. 2011 Apr 22. [Epub ahead of print]
 
  Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention
Giacomin A, Cazzagon N, Sergio A, Vanin V, Farinati F. Eur J Cancer Prev. 2011 May 2. [Epub ahead of print]
 
  Efficacy and safety of lamivudine treatment in late pregnancy with high HBV DNA: a perspective for mother and infants
Köse S, Türken M, Devrim I, Taner C. J Infect Dev Ctries. 2011 Apr 26;5(4):303-6.
 
  Hepatitis B virus and renal transplantation
Kalia H, Fabrizi F, Martin P. Transplant Rev (Orlando). 2011 Apr 27. [Epub ahead of print]
 
  The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States
Eckman MH, Kaiser TE, Sherman KE. Clin Infect Dis. 2011 May 2. [Epub ahead of print]
 
  Future aspects of therapy for hepatitis B virus infection: value of surrogate markers, innovative therapy, and global collaboration
Akbar SM, Al-Mahtab M, Hiasa Y. J Gastroenterol. 2011 Apr 28. [Epub ahead of print]
 
  An overview of occult hepatitis B virus infection
Said ZN. World J Gastroenterol. 2011 Apr 21;17(15):1927-38.
 
  Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs.
Mori S. Mod Rheumatol. 2011 Apr 29. [Epub ahead of print]
 
  Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, Tai DW, Quek R, Tao M, Lim ST. Ann Hematol. 2011 Apr 26. [Epub ahead of print]
 
  Analysis of carriers of hepatitis B virus from a tertiary referral hospital: Does the viral load change during the natural course of infection?
Aakanksha, Asim M, Sharma PK, Das BC, Kar P. J Med Virol. 2011 Apr 22. doi: 10.1002/jmv.22074. [Epub ahead of print]
 
  HBV life cycle and novel drug targets
Grimm D, Thimme R, Blum HE.AbstractHepatol Int. 2011 Mar 8. [Epub ahead of print]
 
  Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B
Lampertico P, Viganò M, Facchetti F, Invernizzi F, Aroldi A, Lunghi G, Messa PG, Colombo M. Nephrol Dial Transplant. 2011 Apr 12. [Epub ahead of print]
 
  Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized open-label study
Liaw YF, Raptopoulou-Gigi M, Cheinquer H, Sarin SK, Tanwandee T, Leung N, Peng CY, Myers RP, Brown RS Jr, Jeffers L, Tsai N, Bialkowska J, Tang S, Beebe S, Cooney E. Hepatology. 2011 Apr 18. doi: 10.1002/hep.24361. [Epub ahead of print]
 
  Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance
Perrillo RP, Hann HW, Schiff E, Mutimer D, Willems B, Leung N, Lee WM, Dixon S, Woessner M, Brosgart CL, Condreay LD, Gardner SD. Hepatol Int. 2011 Jan 5. [Epub ahead of print]
 
  The influence of hepatitis B and C virus infections on patient and allograft outcomes in kidney transplantation
Uyar M, Sahin S, Dheir H, Gurkan A.Transplant Proc. 2011 Apr;43(3):850-2.
 
  De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patients
Wang LC, Chen EQ, Cao J, Liu L, Zheng L, Li DJ, Xu L, Lei XZ, Liu C, Tang H. Hepatol Int. 2011 Jan 19. [Epub ahead of print]
 
  Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data --- United States
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2011 Apr 8;60(13):410-3.
 
  Hepatitis B virus (HBV) quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy
Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA. Liver Transpl. 2011 Apr 1. doi: 10.1002/lt.22312. [Epub ahead of print]
 
  Antioxidant supplements for liver diseases
Bjelakovic G, Gluud LL, Nikolova D, Bjelakovic M, Nagorni A, Gluud C. Cochrane Database Syst Rev. 2011 Mar 16;3:CD007749.
 
  Insulin, glucose, and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort
Chao LT, Wu CF, Sung FY, Lin CL, Liu CJ, Huang CJ, Tsai KS, Yu MW. Carcinogenesis. 2011 Apr 3. [Epub ahead of print]
 
  Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B: A Systematic review
Zhao SS, Tang LH, Dai XH, Wang W, Zhou RR, Chen LZ, Fan XG. Virol J. 2011 Mar 9;8(1):111. [Epub ahead of print]
 
  Importance of maternal and cord blood viremia in pregnant women with chronic hepatitis B virus infection
Elefsiniotis IS, Tsoumakas K, Papadakis M, Vlachos G, Saroglou G, Antsaklis A. Eur J Intern Med. 2011 Apr;22(2):182-6. Epub 2011 Jan 7.
 
  Depression in patients with nonalcoholic Fatty liver disease and chronic viral hepatitis B and C
Weinstein AA, Kallman Price J, Stepanova M, Poms LW, Fang Y, Moon J, Nader F, Younossi ZM. Psychosomatics. 2011 Mar-Apr;52(2):127-32.
 
  Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection
Nguyen LH, Ko S, Wong SS, Tran PS, Trinh HN, Garcia RT, Ahmed A, Lutchman GA, Keeffe EB, Nguyen MH. Hepatology. 2011 Mar 21. doi: 10.1002/hep.24308. [Epub ahead of print]
 
  Initial high dose of lamivudine delays the appearance of viral resistance in chronic hepatitis B patients
Torre F, Giannini EG, Basso M, Fazio V, Savarino V, Picciotto A. J Gastrointestin Liver Dis. 2011 Mar;20(1):47-50.
 
  Increasing burden of liver disease in patients with HIV infection
Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K. Lancet. 2011 Apr 2;377(9772):1198-209.
 
  Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease
Gisbert JP, Chaparro M, Esteve M. Aliment Pharmacol Ther. 2011 Mar;33(6):619-33.
 
  Lamivudine treatment is associated with improved survival in fulminant hepatitis B
Yu JW, Sun LJ, Yan BZ, Kang P, Zhao YH. Liver Int. 2011 Apr;31(4):499-506.
 
  Liver transplant and chronic hepatitis B virus infection
Selcuk H, Karakayali H, Haberal M. Exp Clin Transplant. 2011 Apr;9(2):94-7.
 
  Long-term results of hepatitis B immunoglobulin and lamuvidine for hepatitis B prophylaxis after liver transplantation
Sevmis S, Aktas S, Zia HH, Atiq A, Akbas E, Selcuk H, Karakayali H, Haberal M. Transplant Proc. 2011 Mar;43(2):598-600.
 
  Response to hepatitis B vaccine differs by birthweight among neonates
Cekmez F, Canpolat FE, Erdinç K, Cetinkaya M, Ak?n O, Pamuk U, Sar?c? SU. Vaccine. 2011 Mar 5. [Epub ahead of print]
 
  Pathogenesis of occult chronic hepatitis B virus infection
de la Fuente RA, Gutiérrez ML, Garcia-Samaniego J, Fernández-Rodriguez C, Lledó JL, Castellano G. World J Gastroenterol. 2011 Mar 28;17(12):1543-8.
 
  Management of occult hepatitis B virus infection: An update for the clinician
Lledó JL, Fernández C, Gutiérrez ML, Ocaña S. World J Gastroenterol. 2011 Mar 28;17(12):1563-8.
 
  Diagnostic strategy for occult hepatitis B virus infection
Ocana S, Casas ML, Buhigas I, Lledo JL. World J Gastroenterol. 2011 Mar 28;17(12):1553-7.
 
  Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes
Selim HS, Abou-Donia HA, Taha HA, El Azab GI, Bakry AF. Eur J Intern Med. 2011 Apr;22(2):187-90. Epub 2011 Jan 14.
 
  Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine
Kobashi H, Miyake Y, Ikeda F, Yasunaka T, Nishino K, Moriya A, Kubota J, Nakamura S, Takaki A, Nouso K, Yamada G, Yamamoto K. Hepatol Res. 2011 Mar 21. doi: 10.1111/j.1872-034X.2011.00785.x. [Epub ahead of print]
 
  Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?
Brock GN, Mostajabi F, Ferguson N, Carrubba CJ, Eng M, Buell JF, Marvin MR. Transpl Int. 2011 Mar 15. doi: 10.1111/j.1432-2277.2011.01236.x. [Epub ahead of print]
 
  Prophylaxis and treatment of hepatitis B infection in the setting of liver transplantation
D Avola D, Herrero JI. Rev Esp Enferm Dig. 2011 Mar;103(3):142-149.
 
  Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on
Hwang S, Ahn CS, Song GW, Kim KH, Moon DB, Oh HB, Lim YS, Lee HC, Ha TY, Jung DH, Chung YH, Lee SG. Liver Transpl. 2011 Apr;17(4):456-65. doi: 10.1002/lt.22226.
 
  An Argument for the Universal Prophylaxis of Hepatitis B Infection in Patients Receiving Rituximab: A 7-Year Institutional Experience of Hepatitis Screening
Leung C, Tsoi E, Burns G, Sievert W. Oncologist. 2011 Apr 4. [Epub ahead of print]
 
  Six-year follow-up of hepatitis B surface antigen concentrations in tenofovir disoproxil fumarate treated HIV-HBV-coinfected patients
Thibault V, Stitou H, Desire N, Valantin MA, Tubiana R, Katlama C. Antivir Ther. 2011;16(2):199-205.
 
  A Prospective Study of Hepatitis B Vaccination - A Comparison of Responders versus Nonresponders
Brown CM, Donlon S, O'Kelly P, Casey AM, Collier C, Conlon PJ, Walshe JJ. Ren Fail. 2011;33(3):276-9.
 
  Student vaccination requirements of u.s. Health professional schools: a survey
Lindley MC, Lorick SA, Spinner JR, Krull AR, Mootrey GT, Ahmed F, Myers R, Bednash GP, Cymet TC, Maeshiro R, Raines CF, Shannon SC, Sondheimer HM, Strikas RA. Ann Intern Med. 2011 Mar 15;154(6):391-400.
 
  Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy
Lao-Araya M, Puthanakit T, Aurpibul L, Taecharoenkul S, Sirisanthana T, Sirisanthana V. Vaccine. 2011 Apr 4. [Epub ahead of print]
 
  Hepatitis B vaccination during pregnancy for preventing infant infection
Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Cochrane Database Syst Rev. 2011 Mar 16;3:CD007879.
 
  Prevalence of Hepatitis B Surface Antigen in US-Born and Foreign-Born Asian/Pacific Islander College Students
Quang YN, Vu J, Yuk J, Li CS, Chen M, Bowlus CL. J Am Coll Health. 2010 Jul-Aug;59(1):37-41.
 
  Hepatitis B virus genotyping: current methods and clinical implications
Guirgis BS, Abbas RO, Azzazy HM. Int J Infect Dis. 2010 Jul 29. [Epub ahead of print]
 
  Chronic Hepatitis B: Who and How to Treat
Landreneau SW, Herrera JL. PRACTICAL GASTROENTEROLOGY • NOVEMBER 2007;31:25-40.
 
  Virologic response at 12 months of treatment predicts sustained antiviral efficacy in patients with adefovir-treated Lamivudine-resistant chronic hepatitis B
Jung YK, Yeon JE, Han WS, Kim JH, Kim JH, Park JJ, Kim JS, Bak YT, Yoo W, Hong SP, Kim SO, Kwon SY, Byun KS, Lee CH. Gut Liver. 2010 Jun;4(2):212-8. Epub 2010 Jun 16.
 
  Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein
Lee IC, Huang YH, Chan CC, Huo TI, Chu CJ, Lai CR, Lee PC, Su CW, Hung HH, Wu JC, Lin HC, Lee SD. Liver Int. 2010 Jun 15. [Epub ahead of print]
 
  Does chemotherapy prevent HBV-related hepatocellular carcinoma? Cons
Colombo M. Dig Liver Dis. 2010 Jul;42 Suppl 3:S298-301.
 
  On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective
Chien RN. J Gastroenterol Hepatol. 2010 May;25(5):852-7.
 
  Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis
Shi Z, Yang Y, Ma L, Li X, Schreiber A. Obstet Gynecol. 2010 Jul;116(1):147-59.
 
  Chronic Viral Infections and Invasive Procedures: Risk of Vertical Transmission and Current Recommendations
López M, Coll O. Fetal Diagn Ther. 2010 Jun 19. [Epub ahead of print]
 
  Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection
Yokosuka O, Takaguchi K, Fujioka S, Shindo M, Chayama K, Kobashi H, Hayashi N, Sato C, Kiyosawa K, Tanikawa K, Ishikawa H, Masaki N, Seriu T, Omata M. J Hepatol. 2010 Mar 24. [Epub ahead of print]
 
  Liver transplant from Anti-HBc-positive, HBsAg-negative donor into HBsAg-negative recipient: is it safe? A systematic review of the literature.
Avelino-Silva VI, D Albuquerque LA, Bonazzi PR, Song AT, Miraglia JL, de Brito Neves A, Abdala E. Clin Transplant. 2010 Apr 28. [Epub ahead of print]
 
  Hepatitis B virus infection and liver transplantation
Kennedy M, Alexopoulos SP. Curr Opin Organ Transplant. 2010 May 4. [Epub ahead of print]
 
  Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy?
Park SH, Kim DJ, Cheong JY, Cho SW, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB. Clin Biochem. 2010 Apr 27. [Epub ahead of print]
 
  Viral resistance in hepatitis B: prevalence and management
Poordad F, Chee GM. Curr Gastroenterol Rep. 2010 Feb;12(1):62-9.
 
  HBV replication is significantly reduced by IL-6
Kuo TM, Hu CP, Chen YL, Hong MH, Jeng KS, Liang CC, Chen ML, Chang C. J Biomed Sci. 2009 Apr 20;16:41.
 
  Toward elimination and eradication of hepatitis B
Chen DS. J Gastroenterol Hepatol. 2010 Jan;25(1):19-25
 
  Hepatitis B and hepatocellular carcinoma
Di Bisceglie A. Hepatology 2009;49(S6):S56-60)
 
  Hepatitis B and Hepatitis C Prevalence and Treatment Referral Among Asian Americans Undergoing Community-Based Hepatitis Screening
Hwang JP, Mohseni M, Gor BJ, Wen S, Guerrero H, Vierling JM. Am J Public Health 2010[Epub ahead of print]
 
  Epdemiology of hepatitis B in the United States
Kim RW. Hepatology 2009;49:S28-S34
 
  The natural history of chronic hepatitis B virus infection
McMahon B. Hepatology 2009;49(S6):S46-S55
 
  NIH Consensus Development Conference Statement on Management of Hepatitis B
October 20-22, 2008
 
  End points of therapy in chronic hepatitis B
Si Ahmed SN, Ecochard M, Zoulim F. Expert Rev Gastroenterol Hepatol. 2010 Feb;4(1):37-49
 
  Evaluation of the patient with hepatitis B
Rotman Y, Brown TA, Hoofnagle JH. Hepatology 2009;49(S5):S22-S27
 
  Special populations with hepatitis B virus infection
Peters MG. Hepatology 2009;49(S5):S146-S155
 
  Hepatitis B: Reflections on the current approach to antiviral therapy
Zoulim F, Perrillo R. J Hepatol 2008;48:S2-S19.
 
  Past HBV Viral Load as a Predictor of Mortality and Morbidity from HCC and Chronic Liver Disease in a Prospective Study
G. Chen et al. Am J Gastroenterol 2006; 101: 1797-1803
 
  Notes from the NIH on Hepatitis B...
Dr. Jay Hoofnagle, Director, Liver Disease Research Branch NIDDK, National Institutes of Health, Bethesda, MD notes that today there are
 
 
 
 
     
© 2010 Advanced Practicum. All Rights Reserved.